15113099	12	Anderson NL	Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).	Journal of proteome research	2004	184
15148142	12	Engelhart MJ	Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.	Archives of neurology	2004	147
15851726	12	Dik MG	Serum inflammatory proteins and cognitive decline in older persons.	Neurology	2005	70
16750969	12	Schaap LA	Inflammatory markers and loss of muscle mass (sarcopenia) and strength.	The American journal of medicine	2006	138
17884841	12	Saldova R	Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG.	Glycobiology	2007	107
10431237	19	Bodzioch M	The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.	Nature genetics	1999	252
10431238	19	Rust S	Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.	Nature genetics	1999	230
10525055	19	Lawn RM	The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.	The Journal of clinical investigation	1999	106
15326314	19	Bergt C	The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.	Proceedings of the National Academy of Sciences of the United States of America	2004	108
18523221	19	Frikke-Schmidt R	Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.	JAMA	2008	78
19064999	19	Rader DJ	The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.	Journal of lipid research	2009	136
19221221	19	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	114
21840418	19	Alwaili K	The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.	Biochimica et biophysica acta	2012	35
24647144	19	Shao B	Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.	Circulation research	2014	34
25589556	19	Du XM	HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.	Circulation research	2015	37
233137	174	Aden DP	Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line.	Nature	1979	202
8594428	174	Mazzaferro V	Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.	The New England journal of medicine	1996	790
11394657	174	Trevisani F	Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.	Journal of hepatology	2001	104
12029639	174	Hsu YS	Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.	Hepatology	2002	100
12547409	174	Imamura H	Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.	Journal of hepatology	2003	187
12851874	174	Capurro M	Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.	Gastroenterology	2003	134
16137783	174	Marrero JA	GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.	Journal of hepatology	2005	87
16246200	174	Natsuizaka M	Clinical features of hepatocellular carcinoma with extrahepatic metastases.	Journal of gastroenterology and hepatology	2005	90
16282175	174	Malone FD	First-trimester or second-trimester screening, or both, for Down's syndrome.	The New England journal of medicine	2005	98
16542289	174	Farinati F	Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?	The American journal of gastroenterology	2006	68
16778155	174	Terai S	Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.	Stem cells	2006	94
18182659	174	Chan HL	High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.	Journal of clinical oncology 	2008	58
18350595	174	But DY	Natural history of hepatitis-related hepatocellular carcinoma.	World journal of gastroenterology	2008	66
18479363	174	Song W	Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.	International journal of clinical practice	2008	53
18580463	174	Zheng SS	Liver transplantation for hepatocellular carcinoma: Hangzhou experiences.	Transplantation	2008	89
18972441	174	Zhang L	The stem cell niche of human livers: symmetry between development and regeneration.	Hepatology	2008	65
19064965	174	Chan SL	New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.	Journal of clinical oncology 	2009	56
19223512	174	Goldman R	Detection of hepatocellular carcinoma using glycomic analysis.	Clinical cancer research 	2009	48
19454616	174	Wang M	Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.	Cancer epidemiology, biomarkers and prevention 	2009	46
19731239	174	N'Kontchou G	Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.	Hepatology	2009	55
19747749	174	Wu JC	Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma.	Journal of hepatology	2009	61
20066715	174	Carr BI	Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.	Cancer	2010	44
20339916	174	Malaguarnera G	Serum markers of hepatocellular carcinoma.	Digestive diseases and sciences	2010	49
20351325	174	Glazer ES	Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.	Journal of clinical oncology 	2010	44
20821352	174	Ghodsizadeh A	Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.	Stem cell reviews	2010	42
20876776	174	Mao Y	Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma.	Gut	2010	52
21278583	174	Qu KZ	Circulating microRNAs as biomarkers for hepatocellular carcinoma.	Journal of clinical gastroenterology	2011	62
21294289	174	DuBay D	Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion.	Annals of surgery	2011	45
22414760	174	Personeni N	Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.	Journal of hepatology	2012	39
22846859	174	Bertino G	Hepatocellualar carcinoma serum markers.	Seminars in oncology	2012	37
23564522	174	Asahina Y	Î±-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.	Hepatology	2013	35
23874536	174	Zhong JH	Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.	PloS one	2013	43
24462733	174	El-Serag HB	A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.	Gastroenterology	2014	23
24797281	174	Hameed B	Alpha-fetoprotein level &amp;gt; 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.	Liver transplantation 	2014	26
24836552	174	Takeda H	Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.	Liver international 	2015	17
25845839	174	Wen Y	Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.	International journal of cancer	2015	20
26287791	174	-	Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.	Obstetrics and gynecology	2015	26
1394429	183	Jeunemaitre X	Molecular basis of human hypertension: role of angiotensinogen.	Cell	1992	187
12511528	183	Kobori H	Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension.	Hypertension	2003	96
14610101	183	Schlaich MP	Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.	Hypertension	2004	80
15149345	183	de Zeeuw D	Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.	Kidney international	2004	141
16336578	183	Remuzzi G	The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.	Kidney international. Supplement	2005	68
16973970	183	Golledge J	Abdominal aortic aneurysm: pathogenesis and implications for management.	Arteriosclerosis, thrombosis, and vascular biology	2006	78
19075095	183	Kobori H	Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.	Hypertension	2009	60
19145003	183	Parving HH	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.	Nephrology, dialysis, transplantation 	2009	51
19240212	183	San-Cristobal P	Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.	Proceedings of the National Academy of Sciences of the United States of America	2009	90
20351344	183	Forman JP	Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.	Hypertension	2010	53
20442753	183	Kotsis V	Mechanisms of obesity-induced hypertension.	Hypertension research 	2010	67
20819950	183	de Cavanagh EM	Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?	Cardiovascular research	2011	35
12642050	197	Ketteler M	Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.	Lancet	2003	124
15375022	197	Moe SM	Pathophysiology of vascular calcification in chronic kidney disease.	Circulation research	2004	79
15504939	197	Reynolds JL	Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.	Journal of the American Society of Nephrology 	2004	140
16567827	197	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	88
17021608	197	Zhou H	Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.	Kidney international	2006	73
18335040	197	Hennige AM	Fetuin-A induces cytokine expression and suppresses adiponectin production.	PloS one	2008	51
18612115	197	Ix JH	Fetuin-A and incident diabetes mellitus in older persons.	JAMA	2008	64
18633113	197	Stefan N	Plasma fetuin-A levels and the risk of type 2 diabetes.	Diabetes	2008	73
19029462	197	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	58
22426755	197	Montonen J	Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress.	European journal of nutrition	2013	26
26908770	197	Brandenburg VM	Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.	Nephrology, dialysis, transplantation 	2017	7
8731095	213	Witko-Sarsat V	Advanced oxidation protein products as a novel marker of oxidative stress in uremia.	Kidney international	1996	160
8857851	213	Nakeeb A	Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.	Annals of surgery	1996	156
9819449	213	Hasenclever D	A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.	The New England journal of medicine	1998	172
10335783	213	Schmidt MI	Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.	Lancet	1999	153
10893372	213	Ibrahim EH	The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.	Chest	2000	232
11961019	213	Paniagua R	Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.	Journal of the American Society of Nephrology 	2002	91
12636159	213	Panyam J	Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells.	Pharmaceutical research	2003	81
15625072	213	Muntner P	Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study.	Journal of the American Society of Nephrology 	2005	90
15660573	213	Don BR	Serum albumin: relationship to inflammation and nutrition.	Seminars in dialysis	2004	82
15956056	213	Kalantar-Zadeh K	Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.	Nephrology, dialysis, transplantation 	2005	72
18514987	213	Tentori F	Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).	American journal of kidney diseases 	2008	150
19171851	213	Kalantar-Zadeh K	Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.	Circulation	2009	91
19736565	213	Song Z	Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.	Cell research	2009	113
20075063	213	Friedman AN	Reassessment of albumin as a nutritional marker in kidney disease.	Journal of the American Society of Nephrology 	2010	50
20833738	213	Houssiau FA	Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.	Annals of the rheumatic diseases	2010	45
21176210	213	Gupta D	Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature.	Nutrition journal	2010	82
21501670	213	Rappaport SM	Adductomics: characterizing exposures to reactive electrophiles.	Toxicology letters	2012	34
21601335	213	Mehrotra R	Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis.	American journal of kidney diseases 	2011	38
22230555	213	Fanali G	Human serum albumin: from bench to bedside.	Molecular aspects of medicine	2012	89
22550966	213	Huang AR	Medication-related falls in the elderly: causative factors and preventive strategies.	Drugs and aging	2012	47
23467560	213	Berg AH	Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure.	Science translational medicine	2013	25
23639804	213	Sleep D	Albumin as a versatile platform for drug half-life extension.	Biochimica et biophysica acta	2013	35
24025647	213	Hung SC	Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease.	Kidney international	2014	29
24037576	213	Harimoto N	Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.	The British journal of surgery	2013	31
24635772	213	Caironi P	Albumin replacement in patients with severe sepsis or septic shock.	The New England journal of medicine	2014	77
24768475	213	Roberts JA	Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.	The Lancet. Infectious diseases	2014	36
24902769	213	Zheng YR	Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery.	Journal of the American Chemical Society	2014	23
25185465	213	Artinyan A	Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients.	Annals of surgery	2015	15
26362431	213	Zhou M	Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.	Journal of experimental and clinical cancer research 	2015	29
20588161	250	Welz T	Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase.	AIDS	2010	44
26499949	250	Ma B	Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.	Tumour biology 	2016	15
8245121	268	Wang LH	Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation.	The Journal of cell biology	1993	274
12456604	268	van Rooij IA	Serum anti-MÃ¼llerian hormone levels: a novel measure of ovarian reserve.	Human reproduction	2002	127
15820810	268	van Rooij IA	Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.	Fertility and sterility	2005	96
16923748	268	La Marca A	Serum anti-Mullerian hormone throughout the human menstrual cycle.	Human reproduction	2006	74
17636277	268	Nelson SM	Serum anti-MÃ¼llerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.	Human reproduction	2007	62
19520713	268	La Marca A	Anti-Mullerian hormone (AMH): what do we still need to know?	Human reproduction	2009	55
19793843	268	La Marca A	Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).	Human reproduction update	2010	120
20522327	268	Hansen KR	Correlation of ovarian reserve tests with histologically determined primordial follicle number.	Fertility and sterility	2011	73
21074758	268	Seifer DB	Age-specific serum anti-MÃ¼llerian hormone values for 17,120 women presenting to fertility centers within the United States.	Fertility and sterility	2011	45
21789206	268	Kelsey TW	A validated model of serum anti-mÃ¼llerian hormone from conception to menopause.	PloS one	2011	54
21926054	268	Dewailly D	Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.	Human reproduction	2011	37
23997957	268	Sachs D	Minimally invasive sacroiliac joint fusion: one-year outcomes in 40 patients.	Advances in orthopedics	2013	26
24345633	268	Dewailly D	Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.	Human reproduction update	2014	21
24430863	268	Dewailly D	The physiology and clinical utility of anti-Mullerian hormone in women.	Human reproduction update	2014	50
24821925	268	Broer SL	Anti-MÃ¼llerian hormone: ovarian reserve testing and its potential clinical implications.	Human reproduction update	2014	31
11705484	335	Tounian P	Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study.	Lancet	2001	103
14592845	335	Rye KA	Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.	Arteriosclerosis, thrombosis, and vascular biology	2004	77
15060092	335	Navab M	The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.	Journal of lipid research	2004	117
15313933	335	Zhang Z	Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer.	Cancer research	2004	161
15314690	335	Zheng L	Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.	The Journal of clinical investigation	2004	165
18261682	335	van der Steeg WA	High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.	Journal of the American College of Cardiology	2008	56
18323573	335	Bloedon LT	Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients.	Journal of lipid research	2008	96
18519851	335	Kastelein JJ	Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.	Circulation	2008	65
18640459	335	McQueen MJ	Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.	Lancet	2008	122
18719128	335	Silva RA	Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes.	Proceedings of the National Academy of Sciences of the United States of America	2008	72
19802338	335	Chasman DI	Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.	Circulation. Cardiovascular genetics	2008	50
20466975	335	Fryirs MA	Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion.	Arteriosclerosis, thrombosis, and vascular biology	2010	42
20847045	335	Lewis TL	Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.	The Journal of biological chemistry	2010	44
21068008	335	Watson CE	Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.	Journal of lipid research	2011	46
21226578	335	Khera AV	Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.	The New England journal of medicine	2011	401
21383385	335	van Duijnhoven FJ	Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition.	Gut	2011	40
21399642	335	Huang R	Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.	Nature structural and molecular biology	2011	56
22219194	335	Shao B	Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.	The Journal of biological chemistry	2012	45
22842478	335	Walter S	Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival.	Nature medicine	2012	217
24388749	335	Halley P	Regulation of the apolipoprotein gene cluster by a long noncoding RNA.	Cell reports	2014	31
24464187	335	Huang Y	An abundant dysfunctional apolipoprotein A1 in human atheroma.	Nature medicine	2014	46
26025389	335	Saleheen D	Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.	The lancet. Diabetes and endocrinology	2015	45
27122601	335	Nordestgaard BG	Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.	European heart journal	2016	14
3670400	338	McLean JW	cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.	Nature	1987	161
8596596	338	DesprÃ©s JP	Hyperinsulinemia as an independent risk factor for ischemic heart disease.	The New England journal of medicine	1996	137
12072493	338	AndrÃ© P	Characterization of low- and very-low-density hepatitis C virus RNA-containing particles.	Journal of virology	2002	192
16463046	338	Adiels M	Overproduction of large VLDL particles is driven by increased liver fat content in man.	Diabetologia	2006	107
16474148	338	Nielsen SU	Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.	Journal of virology	2006	129
16476102	338	Barter PJ	Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.	Journal of internal medicine	2006	68
17938300	338	Tabas I	Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.	Circulation	2007	236
18223541	338	Williams KJ	Rapid regression of atherosclerosis: insights from the clinical and experimental literature.	Nature clinical practice. Cardiovascular medicine	2008	65
18242210	338	Fabbrini E	Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.	Gastroenterology	2008	98
18458145	338	Fonseca VA	Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.	Diabetes care	2008	51
18594118	338	Bergmark C	A novel function of lipoprotein a as a preferential carrier of oxidized phospholipids in human plasma.	Journal of lipid research	2008	61
18832751	338	Shaw JA	Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.	Circulation research	2008	64
19059906	338	Berliner JA	The role of oxidized phospholipids in atherosclerosis.	Journal of lipid research	2009	53
19381015	338	Stanhope KL	Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.	The Journal of clinical investigation	2009	302
20220185	338	Ladenson PW	Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.	The New England journal of medicine	2010	57
20227758	338	Raal FJ	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	131
21849529	338	Stanhope KL	Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women.	The Journal of clinical endocrinology and metabolism	2011	60
22653811	338	Cayo MA	JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia.	Hepatology	2012	31
23418444	338	Duvivier BM	Minimal intensity physical activity (standing and walking) of longer duration improves insulin action and plasma lipids more than shorter periods of moderate to vigorous exercise (cycling) in sedentary subjects when energy expenditure is comparable.	PloS one	2013	46
24623100	338	Fenzl A	Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals.	Diabetologia	2014	37
26210642	338	Tsimikas S	Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.	Lancet	2015	44
2063194	348	Wilson C	Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.	Science	1991	146
3277611	348	Davignon J	Apolipoprotein E polymorphism and atherosclerosis.	Arteriosclerosis	1988	201
9549720	348	Notkola IL	Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease.	Neuroepidemiology	1998	111
9823829	348	Clarke R	Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.	Archives of neurology	1998	143
10634455	348	Mehta PD	Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.	Archives of neurology	2000	114
10783137	348	Mullins RF	Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.	FASEB journal 	2000	249
11264981	348	Dietschy JM	Cholesterol metabolism in the brain.	Current opinion in lipidology	2001	159
11844848	348	Seshadri S	Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.	The New England journal of medicine	2002	338
12160362	348	Kivipelto M	Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.	Annals of internal medicine	2002	110
14729357	348	Anderson DH	Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration.	Experimental eye research	2004	85
15184238	348	Butters MA	The nature and determinants of neuropsychological functioning in late-life depression.	Archives of general psychiatry	2004	136
15911795	348	Enzinger C	Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects.	Neurology	2005	71
16155278	348	Ravaglia G	Homocysteine and folate as risk factors for dementia and Alzheimer disease.	The American journal of clinical nutrition	2005	76
16488378	348	Hansson O	Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.	The Lancet. Neurology	2006	307
16782234	348	Zipser BD	Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.	Neurobiology of aging	2007	84
16820298	348	Hatters DM	Apolipoprotein E structure: insights into function.	Trends in biochemical sciences	2006	143
17101822	348	Schaefer EJ	Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.	Archives of neurology	2006	111
17353377	348	Graff-Radford NR	Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.	Archives of neurology	2007	112
17515542	348	Bowman GL	Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.	Neurology	2007	55
18430999	348	Reger MA	Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.	Journal of Alzheimer's disease 	2008	106
18448847	348	Anstey KJ	Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis.	The American journal of geriatric psychiatry 	2008	88
19319544	348	Bell RD	Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.	Acta neuropathologica	2009	186
20155424	348	Grinberg LT	Vascular pathology in the aged human brain.	Acta neuropathologica	2010	61
20739649	348	Matsuzaki T	Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.	Neurology	2010	79
20837851	348	O'Bryant SE	A serum protein-based algorithm for the detection of Alzheimer disease.	Archives of neurology	2010	55
21245181	348	Yaffe K	Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.	JAMA	2011	54
21422459	348	Gupta VB	Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.	Neurology	2011	44
21779331	348	Han X	Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.	PloS one	2011	67
21969589	348	Johnson LV	Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration.	Proceedings of the National Academy of Sciences of the United States of America	2011	50
22095980	348	Averill MM	S100A8 and S100A9 in cardiovascular biology and disease.	Arteriosclerosis, thrombosis, and vascular biology	2012	34
22163278	348	O'Bryant SE	A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.	PloS one	2011	51
22213409	348	van Himbergen TM	Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.	Archives of neurology	2012	35
22339463	348	Panza F	Immunotherapy for Alzheimer's disease: from anti-Î²-amyloid to tau-based immunization strategies.	Immunotherapy	2012	39
22371413	348	Tan ZS	Red blood cell Ï-3 fatty acid levels and markers of accelerated brain aging.	Neurology	2012	39
22892585	348	Coric V	Safety and tolerability of the Î³-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.	Archives of neurology	2012	45
24041970	348	Whiley L	Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.	Neurobiology of aging	2014	31
24259049	348	Hudry E	Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain.	Science translational medicine	2013	26
24378418	348	Reed B	Associations between serum cholesterol levels and cerebral amyloidosis.	JAMA neurology	2014	30
24838203	348	Kim DH	Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.	Gene	2014	31
24910016	348	Bu XL	A study on the association between infectious burden and Alzheimer's disease.	European journal of neurology	2015	16
25349172	348	Cheng L	Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.	Molecular psychiatry	2015	21
26374897	348	Bailey CC	The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.	The Journal of biological chemistry	2015	21
1707140	354	Catalona WJ	Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.	The New England journal of medicine	1991	168
2442609	354	Stamey TA	Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.	The New England journal of medicine	1987	173
7506797	354	Epstein JI	Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.	JAMA	1994	210
7512659	354	Catalona WJ	Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.	The Journal of urology	1994	140
9605647	354	Kattan MW	A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.	Journal of the National Cancer Institute	1998	177
9605898	354	Catalona WJ	Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.	JAMA	1998	117
10984506	354	Mueller E	Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	2000	94
11016644	354	Butler LM	Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.	Cancer research	2000	138
11189684	354	Prorok PC	Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.	Controlled clinical trials	2000	259
11744442	354	Partin AW	Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.	Urology	2001	99
12086878	354	Singh D	Gene expression correlates of clinical prostate cancer behavior.	Cancer cell	2002	388
12699469	354	Duffield-Lillico AJ	Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.	BJU international	2003	108
12837834	354	Cooperberg MR	National practice patterns and time trends in androgen ablation for localized prostate cancer.	Journal of the National Cancer Institute	2003	80
15126525	354	Wang C	Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.	The Journal of clinical endocrinology and metabolism	2004	79
15169797	354	Papandreou CN	Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.	Journal of clinical oncology 	2004	103
15169800	354	Cooperberg MR	The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.	Journal of clinical oncology 	2004	103
15310996	354	Roehl KA	Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.	The Journal of urology	2004	123
15470213	354	Tannock IF	Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.	The New England journal of medicine	2004	945
15470214	354	Petrylak DP	Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.	The New England journal of medicine	2004	667
15474261	354	Madersbacher S	EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).	European urology	2004	83
15572415	354	Page ST	Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.	The Journal of clinical endocrinology and metabolism	2005	95
16177248	354	Wang X	Autoantibody signatures in prostate cancer.	The New England journal of medicine	2005	150
16627561	354	Groskopf J	APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer.	Clinical chemistry	2006	76
16705126	354	Stephenson AJ	Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.	Journal of the National Cancer Institute	2006	93
16818701	354	Pantuck AJ	Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.	Clinical cancer research 	2006	66
17077354	354	Carter HB	Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.	Journal of the National Cancer Institute	2006	67
17222629	354	Cookson MS	Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.	The Journal of urology	2007	101
17382159	354	Marks LS	PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.	Urology	2007	67
17652279	354	Vickers AJ	The surgical learning curve for prostate cancer control after radical prostatectomy.	Journal of the National Cancer Institute	2007	72
17785564	354	Hessels D	Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.	Clinical cancer research 	2007	77
18029831	354	BaÃ±ez LL	Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.	JAMA	2007	73
18036719	354	Nickel JC	The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.	European urology	2008	72
18056182	354	Danila DC	Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.	Clinical cancer research 	2007	153
18162772	354	Wang W	Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.	The American journal of surgical pathology	2008	53
18199855	354	Zheng SL	Cumulative association of five genetic variants with prostate cancer.	The New England journal of medicine	2008	221
18245462	354	Laxman B	A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.	Cancer research	2008	103
18295257	354	Deras IL	PCA3: a molecular urine assay for predicting prostate biopsy outcome.	The Journal of urology	2008	68
18824702	354	Tolcher AW	Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.	Journal of clinical oncology 	2008	59
19216571	354	Mani V	Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification.	ACS nano	2009	52
19359544	354	Tran C	Development of a second-generation antiandrogen for treatment of advanced prostate cancer.	Science	2009	438
19841273	354	Thaxton CS	Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
20103546	354	Lawrence MG	Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.	Endocrine reviews	2010	46
20159826	354	Zelefsky MJ	Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.	Journal of clinical oncology 	2010	50
20495550	354	Rissin DM	Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations.	Nature biotechnology	2010	136
20733135	354	Chi KN	Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.	Journal of clinical oncology 	2010	55
21044246	354	Nonomura N	Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer.	BJU international	2011	39
21115873	354	Cooperberg MR	Outcomes of active surveillance for men with intermediate-risk prostate cancer.	Journal of clinical oncology 	2011	48
21160077	354	Gudmundsson J	Genetic correction of PSA values using sequence variants associated with PSA levels.	Science translational medicine	2010	54
21195536	354	Dickinson L	Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.	European urology	2011	93
21419439	354	Catalona WJ	A multicenter study of -2pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.	The Journal of urology	2011	64
21537045	354	Hendrickson WK	Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.	Journal of clinical oncology 	2011	37
21632234	354	Chikkaveeraiah BV	Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum.	Biosensors and bioelectronics	2011	35
21934053	354	Alemozaffar M	Prediction of erectile function following treatment for prostate cancer.	JAMA	2011	42
22228146	354	Andriole GL	Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.	Journal of the National Cancer Institute	2012	201
22336380	354	Epstein JI	Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades.	European urology	2012	70
22476558	354	Brawley OW	Prostate cancer epidemiology in the United States.	World journal of urology	2012	60
22561842	354	Van Hemelrijck M	Cohort Profile: the National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0.	International journal of epidemiology	2013	28
22704366	354	SchrÃ¶der FH	Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).	European urology	2012	37
22998901	354	Crawford ED	Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases.	The Journal of urology	2012	31
23306100	354	Gravis G	Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2013	39
23375961	354	Lazzeri M	Serum isoform -2proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study.	European urology	2013	35
23395803	354	Pastuszak AW	Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.	The Journal of urology	2013	31
23856038	354	Heidenreich A	Early detection of prostate cancer: European Association of Urology recommendation.	European urology	2013	28
24177197	354	Dijkstra S	Clinical use of novel urine and blood based prostate cancer biomarkers: a review.	Clinical biochemistry	2014	25
24602293	354	Gacci M	Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.	BJU international	2015	19
24714754	354	Lin HM	Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.	British journal of cancer	2014	28
24727321	354	Beltran H	Aggressive variants of castration-resistant prostate cancer.	Clinical cancer research 	2014	47
25484141	354	van Soest RJ	Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer.	European urology	2015	17
25521481	354	Kachakova D	Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.	DNA and cell biology	2015	18
25568070	354	Schweizer MT	Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.	Science translational medicine	2015	27
25964175	354	Tomlins SA	Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.	European urology	2015	20
26537258	354	Romanel A	Plasma AR and abiraterone-resistant prostate cancer.	Science translational medicine	2015	37
26790878	354	Saini S	PSA and beyond: alternative prostate cancer biomarkers.	Cellular oncology	2016	10
27400947	354	Smith M	Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.	Journal of clinical oncology 	2016	10
17282996	361	Roemer SF	Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.	Brain 	2007	143
17449477	361	Takahashi T	Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.	Brain 	2007	109
18334978	361	Jarius S	Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.	Nature clinical practice. Neurology	2008	66
18434643	361	Matiello M	NMO-IgG predicts the outcome of recurrent optic neuritis.	Neurology	2008	58
18945724	361	Jarius S	Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.	Brain 	2008	84
19229993	361	Nicchia GP	Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.	Glia	2009	55
19938104	361	Bennett JL	Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.	Annals of neurology	2009	157
20639914	361	Jarius S	AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.	Nature reviews. Neurology	2010	100
20825655	361	Jarius S	Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.	Journal of neuroinflammation	2010	44
21454592	361	Crane JM	Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.	The Journal of biological chemistry	2011	67
21550068	361	Jarius S	Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.	Journal of the neurological sciences	2011	41
22302543	361	Waters PJ	Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.	Neurology	2012	88
22371853	361	Rostasy K	Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis.	Archives of neurology	2012	30
22914827	361	Kitley J	Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.	Neurology	2012	68
23257621	361	RostÃ¡sy K	Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.	Multiple sclerosis	2013	33
23658379	361	Marignier R	Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.	Neurology	2013	26
24118483	361	Jarius S	Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.	Brain pathology	2013	36
24425068	361	Kitley J	Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.	JAMA neurology	2014	54
24666204	361	Jarius S	Neuromyelitis optica: clinical features, immunopathogenesis and treatment.	Clinical and experimental immunology	2014	31
25112508	361	Papadopoulos MC	Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.	Nature reviews. Neurology	2014	40
25344373	361	HÃ¶ftberger R	Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.	Multiple sclerosis	2015	27
25821844	361	Waters P	MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.	Neurolog	2015	22
26092914	361	Wingerchuk DM	International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.	Neurology	2015	143
16269513	551	Morgenthaler NG	Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.	Clinical chemistry	2006	118
17384437	551	Konstam MA	Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.	JAMA	2007	171
22614056	551	EnhÃ¶rning S	Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective MalmÃ¶ Diet and Cancer Study cardiovascular cohort.	International journal of obesity	2013	25
22840551	551	Atzil S	Synchrony and specificity in the maternal and the paternal brain: relations to oxytocin and vasopressin.	Journal of the American Academy of Child and Adolescent Psychiatry	2012	31
8552144	567	O'Brien WA	Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.	The New England journal of medicine	1996	114
9182471	567	Mellors JW	Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.	Annals of internal medicine	1997	423
9358102	567	Liu Z	Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.	Journal of acquired immune deficiency syndromes and human retrovirology 	1997	191
9362426	567	Coleman RE	Skeletal complications of malignancy.	Cancer	1997	204
12490682	567	Eknoyan G	Effect of dialysis dose and membrane flux in maintenance hemodialysis.	The New England journal of medicine	2002	199
12528874	567	Kyle RA	Review of 1027 patients with newly diagnosed multiple myeloma.	Mayo Clinic proceedings	2003	255
14695409	567	Attal M	Single versus double autologous stem-cell transplantation for multiple myeloma.	The New England journal of medicine	2003	127
15809451	567	Greipp PR	International staging system for multiple myeloma.	Journal of clinical oncology 	2005	339
17209057	567	Avet-Loiseau H	Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du MyÃ©lome.	Blood	2007	159
18505783	567	Palumbo A	Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.	Blood	2008	61
19687334	567	Avet-Loiseau H	Prognostic significance of copy-number alterations in multiple myeloma.	Journal of clinical oncology 	2009	59
19832990	567	Sellam J	Increased levels of circulating microparticles in primary SjÃ¶gren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.	Arthritis research and therapy	2009	49
20528872	567	Romaguera JE	Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.	British journal of haematology	2010	43
11927139	627	Karege F	Decreased serum brain-derived neurotrophic factor levels in major depressed patients.	Psychiatry research	2002	183
12008958	627	Fujimura H	Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.	Thrombosis and haemostasis	2002	84
12842310	627	Shimizu E	Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.	Biological psychiatry	2003	168
12867502	627	Horton AC	Dual modes of endoplasmic reticulum-to-Golgi transport in dendrites revealed by live-cell imaging.	The Journal of neuroscience 	2003	89
15145621	627	Hashimoto K	Critical role of brain-derived neurotrophic factor in mood disorders.	Brain research. Brain research reviews	2004	76
15585351	627	Lommatzsch M	The impact of age, weight and gender on BDNF levels in human platelets and plasma.	Neurobiology of aging	2005	111
16458264	627	Kaufman J	Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children.	Biological psychiatry	2006	164
17130481	627	Gray J	Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene.	Diabetes	2006	105
17151862	627	Krabbe KS	Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.	Diabetologia	2007	88
17291990	627	Johnson JB	Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma.	Free radical biology and medicine	2007	104
17482146	627	Kim JM	Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.	Biological psychiatry	2007	73
18347599	627	Pezawas L	Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.	Molecular psychiatry	2008	68
18571629	627	Sen S	Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.	Biological psychiatry	2008	209
18707012	627	Komulainen P	BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study.	Neurobiology of learning and memory	2008	61
18753648	627	Han JC	Brain-derived neurotrophic factor and obesity in the WAGR syndrome.	The New England journal of medicine	2008	72
19368899	627	Vinogradov S	Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?	Biological psychiatry	2009	51
20194826	627	Keller S	Increased BDNF promoter methylation in the Wernicke area of suicide subjects.	Archives of general psychiatry	2010	63
20334574	627	Bocchio-Chiavetto L	Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.	The world journal of biological psychiatry 	2010	68
20392958	627	Erickson KI	Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume.	The Journal of neuroscience 	2010	79
20653908	627	Hashimoto K	Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.	Psychiatry and clinical neurosciences	2010	69
20702043	627	Bus BA	Determinants of serum brain-derived neurotrophic factor.	Psychoneuroendocrinology	2011	41
20726622	627	Knaepen K	Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects.	Sports medicine	2010	78
20733577	627	Green MJ	Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.	Molecular psychiatry	2011	68
20856249	627	Molendijk ML	Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment.	Molecular psychiatry	2011	56
21081796	627	Zoladz JA	The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies.	Journal of physiology and pharmacology 	2010	44
21253405	627	Lee BH	The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment.	Psychiatry investigation	2010	43
21531985	627	Erickson KI	The aging hippocampus: interactions between exercise, depression, and BDNF.	The Neuroscientist 	2012	56
21550050	627	Fernandes BS	Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.	Journal of psychiatric research	2011	52
21672499	627	Mondelli V	Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.	The Journal of clinical psychiatry	2011	38
22029953	627	Heyman E	Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.	Psychoneuroendocrinology	2012	32
22261206	627	Anderson-Hanley C	Exergaming and older adult cognition: a cluster randomized clinical trial.	American journal of preventive medicine	2012	46
22880079	627	Yoshida T	Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.	PloS one	2012	40
23422958	627	Perroud N	Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene.	Translational psychiatry	2013	40
23958957	627	Molendijk ML	Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).	Molecular psychiatry	2014	64
24103211	627	Haile CN	Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.	The international journal of neuropsychopharmacology	2014	27
24276217	627	Weinstein G	Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.	JAMA neurology	2014	22
25266124	627	Fernandes BS	Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.	Molecular psychiatry	2015	18
25553404	627	Polyakova M	BDNF as a biomarker for successful treatment of mood disorders: a systematic &amp;amp; quantitative meta-analysis.	Journal of affective disorders	2015	31
25772071	627	Young JE	Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells.	Cell stem cell	2015	18
25805886	627	Kimhy D	The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial.	Schizophrenia bulletin	2015	21
11120762	632	Falahati-Nini A	Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.	The Journal of clinical investigation	2000	116
18030310	632	Shea MK	Genetic and non-genetic correlates of vitamins K and D.	European journal of clinical nutrition	2009	58
18984661	632	Kanazawa I	Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2009	69
20164296	632	Finkelstein JS	Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis.	The Journal of clinical endocrinology and metabolism	2010	46
20165834	632	Kanazawa I	Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.	Osteoporosis international 	2011	43
23147574	632	Booth SL	The role of osteocalcin in human glucose metabolism: marker or mediator?	Nature reviews. Endocrinology	2013	33
2395859	920	Daar ES	High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates.	Proceedings of the National Academy of Sciences of the United States of America	1990	162
3107838	920	Stein BS	pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.	Cell	1987	235
3299090	920	Richman DD	The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.	The New England journal of medicine	1987	195
9217758	920	Cohen MS	Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.	Lancet	1997	181
9287227	920	Hammer SM	A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.	The New England journal of medicine	1997	394
9360926	920	Wong JK	Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.	Science	1997	528
9371822	920	Chun TW	Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	1997	463
9420212	920	Matano T	Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.	Journal of virology	1998	185
10196297	920	Mascola JR	Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.	Journal of virology	1999	336
10341272	920	Zhang L	Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.	The New England journal of medicine	1999	195
10419445	920	Lucas GM	Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.	Annals of internal medicine	1999	141
10607709	920	Hazenberg MD	T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).	Blood	2000	129
10837072	920	Pierson T	Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.	Annual review of immunology	2000	162
11192870	920	Marzolini C	Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.	AIDS	2001	150
11434728	920	Murphy EL	Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.	Annals of internal medicine	2001	121
11711588	920	Betts MR	Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.	Journal of virology	2001	251
11722271	920	Hogg RS	Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.	JAMA	2001	162
11748275	920	Kovacs JA	Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.	The Journal of experimental medicine	2001	85
11752161	920	Zhu T	Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.	Journal of virology	2002	115
11917238	920	Giorgi JV	Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.	Journal of acquired immune deficiency syndromes	2002	96
11953469	920	French N	Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.	AIDS	2002	100
12131186	920	Ling B	SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans.	AIDS	2002	89
12218162	920	Sousa AE	CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.	Journal of immunology	2002	154
12637625	920	Lalezari JP	Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.	The New England journal of medicine	2003	148
12693883	920	Palella FJ Jr	Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.	Annals of internal medicine	2003	109
12721933	920	Hunt PW	T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.	The Journal of infectious diseases	2003	296
12773645	920	Lazzarin A	Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia.	The New England journal of medicine	2003	102
14557216	920	Kaufmann GR	CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.	Archives of internal medicine	2003	85
14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
15117761	920	Deeks SG	Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.	Blood	2004	289
15210746	920	Matano T	Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.	The Journal of experimental medicine	2004	89
15247339	920	Jourdain G	Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.	The New England journal of medicine	2004	105
15280419	920	Kinter AL	CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.	The Journal of experimental medicine	2004	159
15577629	920	Buchacz K	Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections.	AIDS	2004	92
15840880	920	Strickler HD	Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.	Journal of the National Cancer Institute	2005	162
16182404	920	BrÃ¤u N	Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.	Journal of hepatology	2006	89
16631548	920	Battegay M	Immunological recovery and antiretroviral therapy in HIV-1 infection.	The Lancet. Infectious diseases	2006	61
16631912	920	Ferradini L	Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.	Lancet	2006	191
16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
16905788	920	Hammer SM	Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.	JAMA	2006	160
17035049	920	Chiang MC	3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry.	NeuroImage	2007	73
17135583	920	Strategies for Management of Antiretroviral Therapy (SMART) Study Group.	CD4+ count-guided interruption of antiretroviral treatment.	The New England journal of medicine	2006	629
17258731	920	von Hahn T	Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.	Gastroenterology	2007	144
17357054	920	Baeten JM	HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.	The Journal of infectious diseases	2007	81
17728240	920	Chen P	Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.	Journal of virology	2007	172
18171295	920	Hunt PW	Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.	The Journal of infectious diseases	2008	248
18195140	920	Letendre S	Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.	Archives of neurology	2008	229
18199042	920	Patel K	Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.	Clinical infectious diseases 	2008	67
18260759	920	Chun TW	Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.	The Journal of infectious diseases	2008	177
18480202	920	Riddler SA	Class-sparing regimens for initial treatment of HIV-1 infection.	The New England journal of medicine	2008	191
18525258	920	Archin NM	Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.	AIDS	2008	84
18677028	920	Hammer SM	Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.	JAMA	2008	294
18981777	920	Lima VD	Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.	AIDS	2008	54
19123865	920	Robbins GK	Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.	Clinical infectious diseases 	2009	73
19193107	920	Kelley CF	Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.	Clinical infectious diseases 	2009	99
19265479	920	Jiang W	Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.	The Journal of infectious diseases	2009	236
19440326	920	Zolopa A	Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.	PloS one	2009	123
19444075	920	Grabar S	Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.	AIDS	2009	50
19687491	920	Zhang F	Five-year outcomes of the China National Free Antiretroviral Treatment Program.	Annals of internal medicine	2009	93
19728788	920	French MA	Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.	The Journal of infectious diseases	2009	67
19818686	920	Guiguet M	Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.	The Lancet. Oncology	2009	140
19838127	920	Horberg M	Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients.	Journal of acquired immune deficiency syndromes	2010	41
19911963	920	Hoffmann CJ	Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa.	Clinical infectious diseases 	2009	53
20089951	920	Celum C	Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.	The New England journal of medicine	2010	216
20113183	920	Cohen RA	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.	Journal of neurovirology	2010	72
20153888	920	Lingappa JR	Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.	Lancet	2010	69
20170371	920	Euler Z	Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.	The Journal of infectious diseases	2010	66
20306555	920	Marinda ET	Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy.	Journal of acquired immune deficiency syndromes	2010	43
20457954	920	Ellis RJ	Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.	Archives of neurology	2010	84
20505494	920	Ford ES	Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.	AIDS	2010	73
20516524	920	Letendre SL	Neurologic complications of HIV disease and their treatment.	Topics in HIV medicine 	2010	84
20537376	920	Donnell D	Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.	Lancet	2010	343
20559035	920	Wallet MA	Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.	AIDS	2010	55
20597693	920	Meya DB	Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count &amp;lt; or = 100 cells/microL who start HIV therapy in resource-limited settings.	Clinical infectious diseases 	2010	78
20697368	920	Cutler C	Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.	Bone marrow transplantation	2011	38
20711481	920	Gandhi RT	The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial.	PLoS medicine	2010	119
20739646	920	Vivithanaporn P	Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study.	Neurology	2010	69
20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
21135382	920	Heaton RK	HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.	Neurology	2010	609
21217181	920	Crump JA	Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania.	Clinical infectious diseases 	2011	48
21249232	920	Mikell I	Characteristics of the earliest cross-neutralizing antibody response to HIV-1.	PLoS pathogens	2011	135
21325137	920	Ganesan A	High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.	The Journal of infectious diseases	2011	48
21367910	920	Anderson JA	Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.	Journal of virology	2011	38
21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
21471244	920	Xing S	Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.	Journal of virology	2011	79
21494598	920	Merlini E	Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.	PloS one	2011	42
21502083	920	Hunt PW	Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.	The Journal of infectious diseases	2011	98
21502920	920	Okulicz JF	Epidemiology and clinical characteristics of elite controllers.	Current opinion in HIV and AIDS	2011	37
21507924	920	Gandhi M	Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.	Clinical infectious diseases 	2011	41
21543722	920	Letvin NL	Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.	Science translational medicine	2011	109
21628667	920	Chun TW	Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.	The Journal of infectious diseases	2011	58
21690402	920	Josefsson L	Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.	Proceedings of the National Academy of Sciences of the United States of America	2011	75
21782230	920	Dixon AE	Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.	The Journal of allergy and clinical immunology	2011	66
21802367	920	Hamers RL	HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.	The Lancet. Infectious diseases	2011	99
21881481	920	Hunt PW	Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.	AIDS	2011	87
21890751	920	Mugavero MJ	Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.	Clinical infectious diseases 	2011	41
22240256	920	Witwer KW	Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.	Retrovirology	2012	49
22275402	920	Durand CM	HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.	The Journal of infectious diseases	2012	40
22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
22448150	920	Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.	CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.	PLoS medicine	2012	38
22614889	920	Peluso MJ	Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.	AIDS	2012	41
22716976	920	Violari A	Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.	The New England journal of medicine	2012	71
22745608	920	Cohen CR	Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.	PLoS medicine	2012	81
22824630	920	Kalayjian RC	Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.	AIDS	2012	36
22944874	920	Althoff KN	U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.	Annals of internal medicine	2012	46
22990012	920	Brenchley JM	Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.	Blood	2012	56
23206835	920	Jia Z	Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.	Lancet	2013	46
23283367	920	GarcÃ­a F	A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.	Science translational medicine	2013	46
23323898	920	Le T	Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.	The New England journal of medicine	2013	117
23698063	920	Rodger AJ	Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.	AIDS	2013	77
23818847	920	Josefsson L	Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.	PLoS pathogens	2013	33
24184682	920	Lindemans CA	Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome.	Blood	2014	23
24185941	920	Krishnan S	Evidence for innate immune system activation in HIV type 1-infected elite controllers.	The Journal of infectious diseases	2014	40
24204277	920	Wibmer CK	Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.	PLoS pathogens	2013	65
24352352	920	Ellis RJ	Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.	Clinical infectious diseases 	2014	23
24620025	920	Archin NM	HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.	The Journal of infectious diseases	2014	75
25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4âº memory T Cells.	Nature communications	2014	27
25594465	920	Ueno H	Pathophysiology of T follicular helper cells in humans and mice.	Nature immunology	2015	60
25706092	920	Sulkowski MS	Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.	JAMA	2015	65
25706232	920	Osinusi A	Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection.	JAMA	2015	41
25723975	920	Charurat ME	Uptake of treatment as prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria.	Journal of acquired immune deficiency syndromes	2015	16
25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
26130226	920	Lu W	CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.	Journal of the International AIDS Society	2015	17
26349551	920	Cao W	Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.	Clinical infectious diseases 	2016	13
26414912	920	Hendrix CW	Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066).	AIDS research and human retroviruses	2016	17
26633768	920	Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa.	Sustainable HIV treatment in Africa through viral-load-informed differentiated care.	Nature	2015	34
26858442	920	Simonetti FR	Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2016	40
27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and Î±4Î²7 antibody therapy.	Science	2016	20
9669788	966	PÃ©rez-Stable EJ	Nicotine metabolism and intake in black and white smokers.	JAMA	1998	162
11118008	966	Hundal RS	Mechanism by which metformin reduces glucose production in type 2 diabetes.	Diabetes	2000	159
12900431	966	Feig DI	Hyperuricemia in childhood primary hypertension.	Hypertension	2003	82
15781736	966	Sackner-Bernstein JD	Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.	Circulation	2005	92
16408129	966	Eriksen BO	The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.	Kidney international	2006	82
17309916	966	Briguori C	Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.	Circulation	2007	59
17414812	966	Ferris LT	The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function.	Medicine and science in sports and exercise	2007	98
18295053	966	Zhang L	Prevalence and factors associated with CKD: a population study from Beijing.	American journal of kidney diseases 	2008	55
18337481	966	Weiner DE	Uric acid and incident kidney disease in the community.	Journal of the American Society of Nephrology 	2008	75
19394734	966	Shah SN	Serum bicarbonate levels and the progression of kidney disease: a cohort study.	American journal of kidney diseases 	2009	50
20124537	966	Hemmelgarn BR	Relation between kidney function, proteinuria, and adverse outcomes.	JAMA	2010	201
20138414	966	White SL	Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.	American journal of kidney diseases 	2010	56
20170948	966	Bakris GL	Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.	Lancet	2010	50
20371664	966	Donga E	A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects.	The Journal of clinical endocrinology and metabolism	2010	73
20385436	966	Bellomo G	Association of uric acid with change in kidney function in healthy normotensive individuals.	American journal of kidney diseases 	2010	42
20557989	966	Stevens LA	Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.	American journal of kidney diseases 	2010	105
21059968	966	Rosansky SJ	Early start of hemodialysis may be harmful.	Archives of internal medicine	2011	41
21482743	966	Tangri N	A predictive model for progression of chronic kidney disease to kidney failure.	JAMA	2011	136
21656330	966	Lim EL	Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.	Diabetologia	2011	121
22028277	966	Zoppini G	Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.	Diabetes care	2012	33
22194591	966	Udy AA	Subtherapeutic initial Î²-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.	Chest	2012	44
22206742	966	Jotwani V	Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.	American journal of kidney diseases 	2012	31
22770927	966	Roshanravan B	A prospective study of frailty in nephrology-referred patients with CKD.	American journal of kidney diseases 	2012	46
22889713	966	Kilbride HS	Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly.	American journal of kidney diseases 	2013	30
22936784	966	Alexander RT	Kidney stones and kidney function loss: a cohort study.	BMJ	2012	37
23489677	966	Dobre M	Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.	American journal of kidney diseases 	2013	33
24042021	966	Bose B	Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.	Nephrology, dialysis, transplantation 	2014	32
24067879	966	Gane EJ	Telbivudine improves renal function in patients with chronic hepatitis B.	Gastroenterology	2014	27
25795794	966	Germain DP	Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.	Journal of medical genetics	2015	20
26906014	966	Billings FT 4th	High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.	JAMA	2016	21
14559957	1071	Barzilai N	Unique lipoprotein phenotype and genotype associated with exceptional longevity.	JAMA	2003	157
15925013	1071	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	78
16365197	1071	Naik SU	Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.	Circulation	2006	87
17984165	1071	Barter PJ	Effects of torcetrapib in patients at high risk for coronary events.	The New England journal of medicine	2007	476
18536749	1071	Forrest MJ	Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone.	British journal of pharmacology	2008	57
19640950	1071	Qin Y	Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects.	The American journal of clinical nutrition	2009	48
20400780	1071	Musunuru K	Candidate gene association resource (CARe): design, methods, and proof of concept.	Circulation. Cardiovascular genetics	2010	89
20694148	1071	Zabaneh D	A genome-wide association study of the metabolic syndrome in Indian Asian men.	PloS one	2010	40
12685552	1084	Terada T	Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth.	Pathology international	2002	96
15201323	1084	Kalin NH	The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate.	The Journal of neuroscience 	2004	120
15613691	1084	Marshall JL	Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas.	Journal of clinical oncology 	2005	83
18818422	1084	Abd Hamid UM	A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.	Glycobiology	2008	59
20103634	1084	Galanis E	Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.	Cancer research	2010	98
21325298	1084	Brand RE	Serum biomarker panels for the detection of pancreatic cancer.	Clinical cancer research 	2011	65
23315099	1084	Haas M	Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.	Journal of cancer research and clinical oncology	2013	29
23572188	1084	Shimada H	Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.	Gastric cancer 	2014	32
23649003	1084	Aparicio AM	Platinum-based chemotherapy for variant castrate-resistant prostate cancer.	Clinical cancer research 	2013	38
23672279	1084	He CZ	Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.	BMC gastroenterology	2013	29
24709885	1084	Wang J	Identification of a circulating microRNA signature for colorectal cancer detection.	PloS one	2014	35
25273947	1084	Liu L	A preoperative serum signature of CEA+/CA125+/CA19-9ââ¥â1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer.	International journal of cancer	2015	19
25851626	1084	Tie J	Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.	Annals of oncology 	2015	38
16007257	1113	Mahapatra NR	Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.	The Journal of clinical investigation	2005	88
16253899	1113	Oberg K	Endocrine tumours of the pancreas.	Best practice and research. Clinical gastroenterology	2005	69
17505000	1113	Ekeblad S	Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.	Clinical cancer research 	2007	62
18703061	1113	Metz DC	Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.	Gastroenterology	2008	103
20159983	1113	Sobczak K	Structural diversity of triplet repeat RNAs.	The Journal of biological chemistry	2010	41
23845449	1113	VÃ©layoudom-CÃ©phise FL	Are G3 ENETS neuroendocrine neoplasms heterogeneous?	Endocrine-related cancer	2013	26
25646366	1113	Caplin ME	Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.	Annals of oncology 	2015	21
16142722	1116	Hueber W	Antigen microarray profiling of autoantibodies in rheumatoid arthritis.	Arthritis and rheumatism	2005	75
18003958	1116	Chupp GL	A chitinase-like protein in the lung and circulation of patients with severe asthma.	The New England journal of medicine	2007	143
18403759	1116	Ober C	Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.	The New England journal of medicine	2008	151
18802121	1116	LÃ©tuvÃ© S	YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.	Journal of immunology	2008	64
19767768	1116	Shao R	YKL-40, a secreted glycoprotein, promotes tumor angiogenesis.	Oncogene	2009	71
21054166	1116	Lee CG	Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.	Annual review of physiology	2011	153
22056877	1116	Kawada M	Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer.	Oncogene	2012	32
23641933	1116	Cassol E	Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.	BMC infectious diseases	2013	28
27068280	1116	Olsson B	CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.	The Lancet. Neurology	2016	38
10068581	1234	Giorgi JV	Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.	The Journal of infectious diseases	1999	379
11317000	1234	Chakraborty H	Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.	AIDS	2001	86
11588058	1234	Donaghy H	Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.	Blood	2001	111
11809184	1234	Fellay J	Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.	Lancet	2002	82
15995960	1234	Brumme ZL	Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.	The Journal of infectious diseases	2005	86
16973562	1234	Sagar M	Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity.	Journal of virology	2006	133
17116663	1234	Whitcomb JM	Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.	Antimicrobial agents and chemotherapy	2007	120
17132723	1234	Zhang L	HIV-1 infection and pathogenesis in a novel humanized mouse model.	Blood	2007	71
17243065	1234	Wilkin TJ	HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.	Clinical infectious diseases 	2007	61
17570119	1234	Gulick RM	Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.	The Journal of infectious diseases	2007	74
18753930	1234	Raymond S	Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.	AIDS	2008	51
19012957	1234	McElrath MJ	HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.	Lancet	2008	334
19487424	1234	Salazar-Gonzalez JF	Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.	The Journal of experimental medicine	2009	343
19997090	1234	Kim SS	RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.	Molecular therapy 	2010	67
20371483	1234	Butler DM	The origins of sexually transmitted HIV among men who have sex with men.	Science translational medicine	2010	42
21288824	1234	Swenson LC	Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.	The Journal of infectious diseases	2011	58
21587341	1234	Vandamme AM	European recommendations for the clinical use of HIV drug resistance testing: 2011 update.	AIDS reviews	2011	36
22190722	1234	Ochsenbauer C	Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.	Journal of virology	2012	129
22784116	1234	Reshef R	Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.	The New England journal of medicine	2012	58
23043157	1234	Shaw GM	HIV transmission.	Cold Spring Harbor perspectives in medicine	2012	57
23460751	1234	Henrich TJ	Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.	The Journal of infectious diseases	2013	84
24813472	1234	Wilson EM	Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.	The Journal of infectious diseases	2014	25
6286115	1356	Nakabayashi H	Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.	Cancer research	1982	423
11729749	1356	KmieÄ Z	Cooperation of liver cells in health and disease.	Advances in anatomy, embryology, and cell biology	2001	99
23549081	1356	Roth AJ	Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.	The Journal of clinical investigation	2013	32
25496901	1356	Bandmann O	Wilson's disease and other neurological copper disorders.	The Lancet. Neurology	2015	25
10618417	1392	Wong ML	Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.	Proceedings of the National Academy of Sciences of the United States of America	2000	106
11238541	1392	Rask E	Tissue-specific dysregulation of cortisol metabolism in human obesity.	The Journal of clinical endocrinology and metabolism	2001	94
11282691	1392	Heim C	Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.	The American journal of psychiatry	2001	131
11689280	1392	Weinstock M	Alterations induced by gestational stress in brain morphology and behaviour of the offspring.	Progress in neurobiology	2001	102
12079865	1392	JÃ©quier E	Leptin signaling, adiposity, and energy balance.	Annals of the New York Academy of Sciences	2002	119
12832253	1392	Capuron L	Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.	The American journal of psychiatry	2003	76
15507922	1392	Wadhwa PD	Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.	American journal of obstetrics and gynecology	2004	81
15944068	1392	Weinstock M	The potential influence of maternal stress hormones on development and mental health of the offspring.	Brain, behavior, and immunity	2005	109
15996533	1392	Swaab DF	The stress system in the human brain in depression and neurodegeneration.	Ageing research reviews	2005	133
16309788	1392	Sandman CA	Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock.	Peptides	2006	80
16472586	1392	Dinan TG	Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?	Gastroenterology	2006	111
17825799	1392	Heim C	The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.	Biological psychiatry	2008	64
18334580	1392	Nieman LK	The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2008	148
19363098	1392	Kramer MS	Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones.	American journal of epidemiology	2009	64
7880233	1401	Liuzzo G	The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.	The New England journal of medicine	1994	169
7934491	1401	Elliott MJ	Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.	Lancet	1994	216
8250987	1401	Elliott MJ	Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.	Arthritis and rheumatism	1993	134
9077376	1401	Ridker PM	Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.	The New England journal of medicine	1997	538
9490235	1401	Ridker PM	Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.	Circulation	1998	108
9655393	1401	Staels B	Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.	Nature	1998	144
9738637	1401	Ridker PM	Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.	Circulation	1998	109
9892589	1401	Koenig W	C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.	Circulation	1999	209
9987089	1401	Zimmermann J	Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.	Kidney international	1999	125
10231453	1401	Stenvinkel P	Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.	Kidney international	1999	158
10335721	1401	Harris TB	Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.	The American journal of medicine	1999	307
10368284	1401	Thompson D	The physiological structure of human C-reactive protein and its complex with phosphocholine.	Structure	1999	107
10411845	1401	Ridker PM	Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.	Circulation	1999	119
10525563	1401	Seaton A	Particulate air pollution and the blood.	Thorax	1999	98
10591334	1401	Visser M	Elevated C-reactive protein levels in overweight and obese adults.	JAMA	1999	334
10733371	1401	Ridker PM	C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.	The New England journal of medicine	2000	789
10769275	1401	Ridker PM	Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.	Circulation	2000	363
10903648	1401	Danesh J	Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses.	BMJ	2000	214
10999830	1401	Bastard JP	Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.	The Journal of clinical endocrinology and metabolism	2000	129
11056086	1401	Pasceri V	Direct proinflammatory effect of C-reactive protein on human endothelial cells.	Circulation	2000	195
11063384	1401	Loos BG	Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients.	Journal of periodontology	2000	101
11368701	1401	Ridker PM	Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.	JAMA	2001	159
11434828	1401	Albert MA	Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.	JAMA	2001	174
11440492	1401	Peters A	Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study.	European heart journal	2001	103
11577954	1401	Noack B	Periodontal infections contribute to elevated systemic C-reactive protein level.	Journal of periodontology	2001	91
11692019	1401	Rost NS	Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study.	Stroke	2001	105
11728958	1401	Kalantar-Zadeh K	A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.	American journal of kidney diseases 	2001	96
11744348	1401	Das UN	Is obesity an inflammatory condition?	Nutrition	2001	122
11748099	1401	Wallace AM	Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).	Circulation	2001	123
11864854	1401	Liu S	Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.	The American journal of clinical nutrition	2002	95
11916939	1401	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	94
11978661	1401	Freeman DJ	C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.	Diabetes	2002	122
12021247	1401	Hundal RS	Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.	The Journal of clinical investigation	2002	144
12034649	1401	Shamsuzzaman AS	Elevated C-reactive protein in patients with obstructive sleep apnea.	Circulation	2002	138
12163427	1401	Haffner SM	Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.	Circulation	2002	90
12190368	1401	Pradhan AD	Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.	JAMA	2002	98
12210786	1401	Schmidt R	Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.	Annals of neurology	2002	132
12366601	1401	Blake GJ	Inflammatory bio-markers and cardiovascular risk prediction.	Journal of internal medicine	2002	90
12438290	1401	Brunner EJ	Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study.	Circulation	2002	86
12515748	1401	Shlipak MG	Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.	Circulation	2003	125
12615790	1401	Yokoe T	Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.	Circulation	2003	134
12654604	1401	Vasan RS	Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.	Circulation	2003	103
12684358	1401	Esposito K	Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.	JAMA	2003	222
12752838	1401	Rantanen T	Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism.	Journal of the American Geriatrics Society	2003	105
12821543	1401	Pischon T	Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women.	Circulation	2003	94
12829649	1401	Duncan BB	Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.	Diabetes	2003	200
12847160	1401	Yaffe K	Inflammatory markers and cognition in well-functioning African-American and white elders.	Neurology	2003	159
12905467	1401	Cambridge G	Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.	Arthritis and rheumatism	2003	78
12943870	1401	Cesari M	Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition Health ABC Study).	The American journal of cardiology	2003	80
12946885	1401	Penninx BW	Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.	Biological psychiatry	2003	108
14573731	1401	Brennan ML	Prognostic value of myeloperoxidase in patients with chest pain.	The New England journal of medicine	2003	140
14665655	1401	Sesso HD	C-reactive protein and the risk of developing hypertension.	JAMA	2003	141
14725719	1401	Smith CJ	Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.	BMC neurology	2004	84
14747502	1401	Liu Y	Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.	JAMA	2004	107
14762037	1401	Erlinger TP	C-reactive protein and the risk of incident colorectal cancer.	JAMA	2004	112
14871421	1401	Oberg BP	Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.	Kidney international	2004	127
14871914	1401	Jiang R	Body iron stores in relation to risk of type 2 diabetes in apparently healthy women.	JAMA	2004	99
15031308	1401	Cesari M	Inflammatory markers and physical performance in older persons: the InCHIANTI study.	The journals of gerontology. Series A, Biological sciences and medical sciences	2004	160
15031312	1401	Tilvis RS	Predictors of cognitive decline and mortality of aged people over a 10-year period.	The journals of gerontology. Series A, Biological sciences and medical sciences	2004	90
15048997	1401	Kuhn E	Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards.	Proteomics	2004	85
15070788	1401	Danesh J	C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.	The New England journal of medicine	2004	437
15082700	1401	Pischon T	Plasma adiponectin levels and risk of myocardial infarction in men.	JAMA	2004	303
15086475	1401	Simmons EM	Plasma cytokine levels predict mortality in patients with acute renal failure.	Kidney international	2004	83
15096581	1401	Fontana L	Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans.	Proceedings of the National Academy of Sciences of the United States of America	2004	200
15173056	1401	Willerson JT	Inflammation as a cardiovascular risk factor.	Circulation	2004	159
15175438	1401	Weiss R	Obesity and the metabolic syndrome in children and adolescents.	The New England journal of medicine	2004	476
15201411	1401	Klein S	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.	The New England journal of medicine	2004	113
15209648	1401	Penninx BW	Inflammatory markers and incident mobility limitation in the elderly.	Journal of the American Geriatrics Society	2004	83
15234425	1401	Chrysohoou C	Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.	Journal of the American College of Cardiology	2004	90
15241098	1401	Wong CH	The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections.	Critical care medicine	2004	93
15307030	1401	Simon L	Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.	Clinical infectious diseases 	2004	183
15337754	1401	Black S	C-reactive Protein.	The Journal of biological chemistry	2004	186
15447916	1401	Lopez-Garcia E	Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2004	141
15472670	1401	Daperno M	Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.	Gastrointestinal endoscopy	2004	108
15477419	1401	Latini R	Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.	Circulation	2004	80
15536110	1401	Yaffe K	The metabolic syndrome, inflammation, and risk of cognitive decline.	JAMA	2004	197
15602020	1401	Pai JK	Inflammatory markers and the risk of coronary heart disease in men and women.	The New England journal of medicine	2004	233
15710760	1401	Reilly MP	Resistin is an inflammatory marker of atherosclerosis in humans.	Circulation	2005	144
15817606	1401	Wannamethee SG	Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.	European heart journal	2005	69
15855252	1401	Karelis AD	The metabolically healthy but obese individual presents a favorable inflammation profile.	The Journal of clinical endocrinology and metabolism	2005	115
15897982	1401	Carlson CS	Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.	American journal of human genetics	2005	89
15941879	1401	Noakes M	Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women.	The American journal of clinical nutrition	2005	66
16002815	1401	Fung TT	Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2005	118
16055618	1401	Broekhuizen R	Raised CRP levels mark metabolic and functional impairment in advanced COPD.	Thorax	2006	74
16087797	1401	Tzoulaki I	C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.	Circulation	2005	79
16143583	1401	Pinto-Plata VM	C-reactive protein in patients with COPD, control smokers and non-smokers.	Thorax	2006	95
16219884	1401	Fibrinogen Studies Collaboration.	Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.	JAMA	2005	201
16234304	1401	Ferrucci L	Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.	The Journal of clinical endocrinology and metabolism	2006	121
16251237	1401	Kang DH	Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.	Journal of the American Society of Nephrology 	2005	147
16267155	1401	Shlipak MG	Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.	Journal of the American Society of Nephrology 	2006	66
16277583	1401	Loos BG	Systemic markers of inflammation in periodontitis.	Journal of periodontology	2005	79
16325697	1401	Timpson NJ	C-reactive protein and its role in metabolic syndrome: mendelian randomisation study.	Lancet	2005	79
16377395	1401	Honda H	Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.	American journal of kidney diseases 	2006	72
16412867	1401	Meyer TE	Long-term caloric restriction ameliorates the decline in diastolic function in humans.	Journal of the American College of Cardiology	2006	79
16489056	1401	Gunter MJ	A prospective study of serum C-reactive protein and colorectal cancer risk in men.	Cancer research	2006	63
16505242	1401	Devaraj S	Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.	Diabetes	2006	84
16534530	1401	Kim CS	Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.	International journal of obesity	2006	70
16582918	1401	Chen K	Induction of leptin resistance through direct interaction of C-reactive protein with leptin.	Nature medicine	2006	73
16595481	1401	Bauer TW	Diagnosis of periprosthetic infection.	The Journal of bone and joint surgery. American volume	2006	64
16600925	1401	Ma Y	Association between dietary fiber and serum C-reactive protein.	The American journal of clinical nutrition	2006	65
16618517	1401	Haukeland JW	Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.	Journal of hepatology	2006	89
16715031	1401	Uzzan B	Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.	Critical care medicine	2006	117
16735679	1401	Kobayashi T	Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.	Circulation	2006	66
16738034	1401	Man SF	C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.	Thorax	2006	74
16799074	1401	Hurst JR	Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2006	79
16818923	1401	Estruch R	Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.	Annals of internal medicine	2006	198
16894037	1401	Sattar N	Adiponectin and coronary heart disease: a prospective study and meta-analysis.	Circulation	2006	82
16901505	1401	von KÃ¤nel R	Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder.	Journal of psychiatric research	2007	84
16926254	1401	Vega GL	Influence of body fat content and distribution on variation in metabolic risk.	The Journal of clinical endocrinology and metabolism	2006	76
16931170	1401	Maser EA	Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.	Clinical gastroenterology and hepatology 	2006	82
16980117	1401	Agranoff D	Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum.	Lancet	2006	62
17011077	1401	Ravaglia G	Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.	Neurobiology of aging	2007	57
17027526	1401	Fain JN	Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.	Vitamins and hormones	2006	124
17040956	1401	Wang Y	Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.	Clinical chemistry	2007	91
17053205	1401	Dahl M	C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2007	86
17101857	1401	Crawford DC	Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey.	Circulation	2006	60
17107990	1401	Perera WR	Inflammatory changes, recovery and recurrence at COPD exacerbation.	The European respiratory journal	2007	63
17157039	1401	Pearle AD	Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis.	Osteoarthritis and cartilage	2007	61
17158434	1401	Esmaillzadeh A	Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome.	The American journal of clinical nutrition	2006	81
17164456	1401	Lange LA	Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.	JAMA	2006	65
17192290	1401	Stewart FM	Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers.	The Journal of clinical endocrinology and metabolism	2007	59
17228047	1401	McAdams MA	Comparison of self-reported and measured BMI as correlates of disease markers in US adults.	Obesity	2007	117
17242319	1401	Ranjit N	Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis.	Archives of internal medicine	2007	66
17245566	1401	McMillan DC	Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.	International journal of colorectal disease	2007	64
17277040	1401	Pittas AG	The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.	Diabetes care	2007	141
17310862	1401	Punjabi NM	C-reactive protein is associated with sleep disordered breathing independent of adiposity.	Sleep	2007	59
17329698	1401	Tonetti MS	Treatment of periodontitis and endothelial function.	The New England journal of medicine	2007	166
17341558	1401	Balagopal P	Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.	The Journal of clinical endocrinology and metabolism	2007	61
17389710	1401	Fontana L	Calorie restriction or exercise: effects on coronary heart disease risk factors. A randomized, controlled trial.	American journal of physiology. Endocrinology and metabolism	2007	65
17429083	1401	Larsen CM	Interleukin-1-receptor antagonist in type 2 diabetes mellitus.	The New England journal of medicine	2007	415
17452738	1401	Uribarri J	Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2007	82
17466231	1401	Ye X	Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people.	Journal of the American College of Cardiology	2007	56
17470699	1401	Ford ES	Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents.	Circulation	2007	90
17494805	1401	Yanbaeva DG	Systemic effects of smoking.	Chest	2007	152
17502528	1401	Dhingra R	Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.	Archives of internal medicine	2007	171
17524614	1401	Frey DJ	The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults.	Brain, behavior, and immunity	2007	71
17536046	1401	Tan ZS	Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.	Neurology	2007	116
17541022	1401	Kiechl S	Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.	Arteriosclerosis, thrombosis, and vascular biology	2007	62
17587156	1401	Chun HY	Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.	Journal of clinical immunology	2007	68
17701281	1401	Kanbay M	Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.	International urology and nephrology	2007	71
17702268	1401	Taheri S	Correlates of serum C-reactive protein (CRP)--no association with sleep duration or sleep disordered breathing.	Sleep	2007	60
17716746	1401	Bremmer MA	Inflammatory markers in late-life depression: results from a population-based study.	Journal of affective disorders	2008	66
17878249	1401	Qi Q	Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.	The Journal of clinical endocrinology and metabolism	2007	56
17890755	1401	Chen H	Peripheral inflammatory biomarkers and risk of Parkinson's disease.	American journal of epidemiology	2008	64
17910386	1401	Haack M	Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers.	Sleep	2007	114
17911176	1401	Laughlin GA	Low serum testosterone and mortality in older men.	The Journal of clinical endocrinology and metabolism	2008	119
17916108	1401	Langhorst J	Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.	The American journal of gastroenterology	2008	96
17919270	1401	Kajander K	Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.	Alimentary pharmacology and therapeutics	2008	52
17997848	1401	Armah HB	Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children.	Malaria journal	2007	76
18006902	1401	Shea MK	Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.	American journal of epidemiology	2008	58
18022866	1401	Sipponen T	Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.	Inflammatory bowel diseases	2008	65
18172326	1401	Kim S	Circulating levels of inflammatory cytokines and risk of colorectal adenomas.	Cancer research	2008	71
18175744	1401	Wolever TM	The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.	The American journal of clinical nutrition	2008	51
18240558	1401	Ridker PM	Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.	Nutrition reviews	2007	59
18256376	1401	Szeto CC	Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients.	Clinical journal of the American Society of Nephrology 	2008	52
18276939	1401	Gozal D	Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children.	American journal of respiratory and critical care medicine	2008	99
18285417	1401	Ding C	Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.	The Journal of clinical endocrinology and metabolism	2008	54
18294231	1401	Paraskevas S	A systematic review and meta-analyses on C-reactive protein in relation to periodontitis.	Journal of clinical periodontology	2008	77
18385206	1401	Astor BC	Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.	American journal of epidemiology	2008	72
18402527	1401	Engels EA	Inflammation in the development of lung cancer: epidemiological evidence.	Expert review of anticancer therapy	2008	89
18413553	1401	Fung TT	Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.	Archives of internal medicine	2008	170
18439548	1401	Ridker PM	Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.	American journal of human genetics	2008	114
18452641	1401	McMillan DC	An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer.	The Proceedings of the Nutrition Society	2008	66
18452784	1401	Bahrami H	Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.	Journal of the American College of Cardiology	2008	84
18533059	1401	Gimeno D	Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study.	Psychological medicine	2009	81
18574092	1401	Dobnig H	Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality.	Archives of internal medicine	2008	271
18625666	1401	Dorkova Z	Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome.	Chest	2008	64
18629312	1401	Delfino RJ	Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease.	Environmental health perspectives	2008	95
18695075	1401	Wildman RP	The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).	Archives of internal medicine	2008	307
18723437	1401	Seemungal TA	Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.	American journal of respiratory and critical care medicine	2008	62
18765397	1401	Serruys PW	Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.	Circulation	2008	89
18843258	1401	Ravani P	Vitamin D levels and patient outcome in chronic kidney disease.	Kidney international	2009	85
18942885	1401	Kuller LH	Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.	PLoS medicine	2008	516
19011614	1401	Lu J	Structural recognition and functional activation of FcgammaR by innate pentraxins.	Nature	2008	67
19016938	1401	Nicklas BJ	Exercise training and plasma C-reactive protein and interleukin-6 in elderly people.	Journal of the American Geriatrics Society	2008	52
19070949	1401	Rambod M	Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.	American journal of kidney diseases 	2009	53
19088165	1401	Pittas AG	Association between serum osteocalcin and markers of metabolic phenotype.	The Journal of clinical endocrinology and metabolism	2009	88
19131384	1401	de Ruijter W	Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.	BMJ	2009	70
19165157	1401	Beasley LE	Inflammation and race and gender differences in computerized tomography-measured adipose depots.	Obesity	2009	54
19171901	1401	Witte AV	Caloric restriction improves memory in elderly humans.	Proceedings of the National Academy of Sciences of the United States of America	2009	108
19217002	1401	Merkin SS	Neighborhoods and cumulative biological risk profiles by race/ethnicity in a national sample of U.S. adults: NHANES III.	Annals of epidemiology	2009	52
19240794	1401	van Leeuwen WM	Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.	PloS one	2009	82
19289618	1401	Allin KH	Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.	Journal of clinical oncology 	2009	80
19318937	1401	McMillan DC	Systemic inflammation, nutritional status and survival in patients with cancer.	Current opinion in clinical nutrition and metabolic care	2009	123
19324974	1401	Shyamsundar M	Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.	American journal of respiratory and critical care medicine	2009	56
19406957	1401	Zaritsky J	Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2009	53
19416750	1401	Stewart JC	A prospective evaluation of the directionality of the depression-inflammation relationship.	Brain, behavior, and immunity	2009	65
19470939	1401	Pierce BL	Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.	Journal of clinical oncology 	2009	147
19477372	1401	Zakynthinos E	Inflammatory biomarkers in coronary artery disease.	Journal of cardiology	2009	47
19520972	1401	Eisenhardt SU	Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.	Circulation research	2009	46
19565477	1401	Livshits G	Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study.	Arthritis and rheumatism	2009	52
19567438	1401	Elliott P	Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.	JAMA	2009	146
19584191	1401	Nadeau KJ	Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.	The Journal of clinical endocrinology and metabolism	2009	46
19622801	1401	Schaap LA	Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength.	The journals of gerontology. Series A, Biological sciences and medical sciences	2009	89
20016471	1401	Barreto DV	Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease.	Kidney international	2010	51
20031199	1401	Emerging Risk Factors Collaboration.	C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.	Lancet	2010	368
20064902	1401	Kiecolt-Glaser JK	Stress, inflammation, and yoga practice.	Psychosomatic medicine	2010	44
20181810	1401	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	42
20203163	1401	Matias PJ	Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.	Clinical journal of the American Society of Nephrology 	2010	43
20205737	1401	Park JS	Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans.	Nutrition and metabolism	2010	43
20397003	1401	MÃ¥rtensson J	Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury.	Intensive care medicine	2010	62
20421535	1401	Chaturvedi AK	C-reactive protein and risk of lung cancer.	Journal of clinical oncology 	2010	54
20497981	1401	Blankenberg S	Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project.	Circulation	2010	60
20500811	1401	Garcia-Rio F	Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.	Respiratory research	2010	50
20538833	1401	Goicoechea M	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.	Clinical journal of the American Society of Nephrology 	2010	124
20610634	1401	Thurnham DI	Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis.	The American journal of clinical nutrition	2010	82
20664401	1401	Wei SQ	Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review.	Obstetrics and gynecology	2010	52
20682604	1401	Upadhyay A	Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.	Nephrology, dialysis, transplantation 	2011	38
20718771	1401	Kalinchenko SY	Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.	Clinical endocrinology	2010	65
20810860	1401	Berbari E	Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis.	The Journal of bone and joint surgery. American volume	2010	41
20870757	1401	Craig TR	A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase inhibition for acute lung injury (The HARP Study).	American journal of respiratory and critical care medicine	2011	44
20876676	1401	Yu M	Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.	Clinical journal of the American Society of Nephrology 	2011	41
20952596	1401	Sun Q	Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors.	American journal of epidemiology	2010	47
21047923	1401	Stanley TL	TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2011	52
21062445	1401	Hagau N	Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.	Critical care	2010	57
21115010	1401	Chan AT	Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.	Gastroenterology	2011	49
21168133	1401	Escobar-Morreale HF	Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.	Fertility and sterility	2011	51
21216812	1401	Myasoedova E	Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.	Annals of the rheumatic diseases	2011	61
21252259	1401	Sandler NG	Plasma levels of soluble CD14 independently predict mortality in HIV infection.	The Journal of infectious diseases	2011	346
21253011	1401	Boulware DR	Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.	PLoS medicine	2010	85
21266974	1401	Proctor MJ	An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.	British journal of cancer	2011	66
21324198	1401	Koch A	Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.	Critical care	2011	50
21349201	1401	Su G	Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.	Cardiovascular diabetology	2011	41
21364762	1401	Erdman LK	Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study.	PloS one	2011	48
21411617	1401	Reid D	The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty.	The American journal of clinical nutrition	2011	45
21525259	1401	Azadbakht L	The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.	The Journal of nutrition	2011	40
21527524	1401	Galesloot TE	Serum hepcidin: reference ranges and biochemical correlates in the general population.	Blood	2011	45
21645639	1401	Wu BU	Lactated Ringer's solution reduces systemic inflammation compared with saline in patients with acute pancreatitis.	Clinical gastroenterology and hepatology 	2011	45
21680719	1401	Tan ZS	Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study.	Diabetes care	2011	42
21685357	1401	Pine SR	Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.	Journal of the National Cancer Institute	2011	81
21718915	1401	Al Mheid I	Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.	Journal of the American College of Cardiology	2011	62
21848462	1401	Marrakchi S	Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.	The New England journal of medicine	2011	87
22035340	1401	Allin KH	Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.	Critical reviews in clinical laboratory sciences	2011	66
22158726	1401	Duncan A	Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements.	The American journal of clinical nutrition	2012	34
22237992	1401	Satoh M	Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.	Arthritis and rheumatism	2012	50
22345378	1401	Wood LG	The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma.	Chest	2012	46
22412070	1401	de Koning L	Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men.	Circulation	2012	76
22427534	1401	Celli BR	Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2012	72
22549948	1401	Imayama I	Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial.	Cancer research	2012	49
22658574	1401	Anderson AH	Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2012	63
22708923	1401	Bartlett DB	The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection.	Aging cell	2012	31
22730366	1401	Genovese MC	Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.	Annals of the rheumatic diseases	2013	58
22749178	1401	Bogdanski P	Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.	Nutrition research	2012	36
22809118	1401	Su L	Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.	BMC infectious diseases	2012	41
22810411	1401	Parvizi J	Management of periprosthetic joint infection: the current knowledge: AAOS exhibit selection.	The Journal of bone and joint surgery. American volume	2012	35
22855860	1401	Hu WT	Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.	Neurology	2012	62
22891048	1401	Hamer M	Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study.	Circulation	2012	34
22915618	1401	Hughes-Austin JM	Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA).	Annals of the rheumatic diseases	2013	26
22933030	1401	Niraula S	Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study.	Breast cancer research and treatment	2012	62
23216550	1401	Fujimoto T	Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.	Journal of gastroenterology and hepatology	2013	28
23266538	1401	Wium-Andersen MK	Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals.	JAMA psychiatry	2013	42
23432640	1401	Voorhees PM	A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.	British journal of haematology	2013	33
23454726	1401	Waldron JL	Vitamin D: a negative acute phase reactant.	Journal of clinical pathology	2013	29
23526699	1401	Verdam FJ	Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.	Obesity	2013	51
23591192	1401	Song M	A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.	British journal of cancer	2013	25
23633005	1401	van Vugt SF	Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study.	BMJ	2013	36
23637781	1401	De Groote MA	Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment.	PloS one	2013	34
23689826	1401	Varadhan R	Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults.	The journals of gerontology. Series A, Biological sciences and medical sciences	2014	26
23820256	1401	Ishizuka M	Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer.	British journal of cancer	2013	29
23842110	1401	Groeger D	Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.	Gut microbes	2013	28
23979951	1401	Phillips CM	Does inflammation determine metabolic health status in obese and nonobese adults?	The Journal of clinical endocrinology and metabolism	2013	36
24107546	1401	Shivappa N	A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS).	Public health nutrition	2014	75
24201751	1401	Szkandera J	Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.	British journal of cancer	2014	25
24284436	1401	Ley SH	Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women.	The American journal of clinical nutrition	2014	22
24363360	1401	Jin X	Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis.	Annals of the rheumatic diseases	2015	22
24389297	1401	Poddubnyy D	Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).	Annals of the rheumatic diseases	2014	28
24429405	1401	Sinha A	Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.	Kidney international	2014	21
24443059	1401	Aleksandrova K	Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.	Hepatology	2014	29
24474383	1401	Cornillie F	Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.	Gut	2014	37
24481424	1401	Klein R	Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.	JAMA ophthalmology	2014	31
24553386	1401	Davila ML	Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.	Science translational medicine	2014	297
24558364	1401	Prendergast AJ	Stunting is characterized by chronic inflammation in Zimbabwean infants.	PloS one	2014	41
24559495	1401	Dogan MV	The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women.	BMC genomics	2014	53
24576974	1401	Eraly SA	Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk.	JAMA psychiatry	2014	36
24592925	1401	Rogers GB	A novel microbiota stratification system predicts future exacerbations in bronchiectasis.	Annals of the American Thoracic Society	2014	28
24606079	1401	Laird E	Vitamin D deficiency is associated with inflammation in older Irish adults.	The Journal of clinical endocrinology and metabolism	2014	21
24661739	1401	Amrein K	Vitamin D status and its association with season, hospital and sepsis mortality in critical illness.	Critical care	2014	26
24819981	1401	Semba RD	Resveratrol levels and all-cause mortality in older community-dwelling adults.	JAMA internal medicine	2014	22
24918371	1401	Chirinos JA	CPAP, weight loss, or both for obstructive sleep apnea.	The New England journal of medicine	2014	48
25017001	1401	Uher R	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.	The American journal of psychiatry	2014	34
25082648	1401	Christian LM	Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index.	Cytokine	2014	27
25128861	1401	Young JJ	A review of the relationship between proinflammatory cytokines and major depressive disorder.	Journal of affective disorders	2014	34
25133871	1401	Khandaker GM	Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.	JAMA psychiatry	2014	49
25274000	1401	Xanthakis V	Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study.	Circulation	2014	24
25447616	1401	Parthasarathy S	Persistent insomnia is associated with mortality risk.	The American journal of medicine	2015	21
25527668	1401	Karakochuk CD	Genetic hemoglobin disorders rather than iron deficiency are a major predictor of hemoglobin concentration in women of reproductive age in rural prey Veng, Cambodia.	The Journal of nutrition	2015	16
25589616	1401	Rossi JF	Interleukin-6 as a therapeutic target.	Clinical cancer research 	2015	38
25620670	1401	Wright EK	Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.	Gastroenterology	2015	20
25640603	1401	Wright KP Jr	Influence of sleep deprivation and circadian misalignment on cortisol, inflammatory markers, and cytokine balance.	Brain, behavior, and immunity	2015	15
25710246	1401	Hajat A	Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA).	Epidemiology	2015	21
25761863	1401	Michelena J	Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.	Hepatology	2015	26
25779987	1401	Otvos JD	GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation.	Clinical chemistry	2015	22
25827033	1401	Michopoulos V	Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma.	The American journal of psychiatry	2015	23
25934640	1401	Wei XL	A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.	BMC cancer	2015	20
26063409	1401	Zhang WW	Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.	Tumour biology 	2015	19
26084991	1401	Zhou T	Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.	Scientific reports	2015	18
26169974	1401	Fernandes BS	C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.	Molecular psychiatry	2016	17
26271406	1401	Hunt L	Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study.	The Lancet. Infectious diseases	2015	32
26351344	1401	Hurwitz HI	Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.	Journal of clinical oncology 	2015	26
26390126	1401	Xu XL	A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.	PloS one	2015	20
26467665	1401	Tang LQ	Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.	Journal of the National Cancer Institute	2016	16
26494833	1401	Besarab A	Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.	Journal of the American Society of Nephrology 	2016	13
26530445	1401	Ishizuka M	Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.	Annals of surgical oncology	2016	13
26552591	1401	Felger JC	Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.	Molecular psychiatry	2016	26
26754953	1401	Haroon E	Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.	Molecular psychiatry	2016	11
26837745	1401	Ridker PM	From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.	Circulation research	2016	23
27338587	1401	Giloteaux L	Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.	Microbiome	2016	14
8274730	1437	Tilg H	Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.	Blood	1994	127
8841451	1437	Bender A	Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.	Journal of immunological methods	1996	112
9712065	1437	Luft T	Type I IFNs enhance the terminal differentiation of dendritic cells.	Journal of immunology	1998	123
10389921	1437	Chen Z	Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.	Clinical cancer research 	1999	112
12473579	1437	Giaccone G	A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.	Clinical cancer research 	2002	124
16783192	1437	Finnerty CC	Cytokine expression profile over time in severely burned pediatric patients.	Shock	2006	72
17483528	1437	Sharkey DJ	Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells.	Molecular human reproduction	2007	61
17577033	1437	Filipazzi P	Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.	Journal of clinical oncology 	2007	230
18202348	1437	Inoue Y	Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.	American journal of respiratory and critical care medicine	2008	50
18332343	1437	Nagel MA	The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.	Neurology	2008	74
18495536	1437	Park BH	Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.	The Lancet. Oncology	2008	135
18578883	1437	Bozza FA	Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity.	BMC infectious diseases	2008	93
18646045	1437	Higano CS	Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.	Cancer	2008	55
19319993	1437	Hoge EA	Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder.	Depression and anxiety	2009	57
19890632	1437	Gulley JL	Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.	Cancer immunology, immunotherapy 	2010	109
20179677	1437	Morgan RA	Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.	Molecular therapy 	2010	397
20224308	1437	Roberts L	Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.	AIDS	2010	66
20484626	1437	Emmanouilidou E	Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival.	The Journal of neuroscience 	2010	237
20817712	1437	Tadokera R	Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.	The European respiratory journal	2011	47
22822024	1437	Leentjens J	Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study.	American journal of respiratory and critical care medicine	2012	32
22913682	1437	Browne SK	Adult-onset immunodeficiency in Thailand and Taiwan.	The New England journal of medicine	2012	73
23075808	1437	Gleason MK	Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.	Molecular cancer therapeutics	2012	38
23088985	1437	Burke JM	A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer.	The Journal of urology	2012	38
23509356	1437	Rosen LB	Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.	Journal of immunology	2013	40
23677592	1437	Kim MK	Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans.	Science translational medicine	2013	36
24643864	1437	Saijo T	Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.	mBio	2014	30
26554728	1437	De Mattos-Arruda L	Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.	Nature communications	2015	20
10206092	1471	Erlandsen EJ	Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.	Scandinavian journal of clinical and laboratory investigation	1999	103
15327406	1471	Herget-Rosenthal S	Early detection of acute renal failure by serum cystatin C.	Kidney international	2004	155
15607309	1471	Filler G	Cystatin C as a marker of GFR--history, indications, and future research.	Clinical biochemistry	2005	111
15788478	1471	Perkins BA	Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.	Journal of the American Society of Nephrology 	2005	89
15809461	1471	Sarnak MJ	Cystatin C concentration as a risk factor for heart failure in older adults.	Annals of internal medicine	2005	94
15901858	1471	Shlipak MG	Cystatin C and the risk of death and cardiovascular events among elderly persons.	The New England journal of medicine	2005	289
15961546	1471	Grubb A	Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.	Clinical chemistry	2005	72
16408133	1471	Rule AD	Glomerular filtration rate estimated by cystatin C among different clinical presentations.	Kidney international	2006	72
16908914	1471	Shlipak MG	Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.	Annals of internal medicine	2006	141
17190862	1471	Ix JH	Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.	Circulation	2007	74
17329575	1471	Perkins BA	Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.	Journal of the American Society of Nephrology 	2007	105
17464129	1471	Devarajan P	Emerging biomarkers of acute kidney injury.	Contributions to nephrology	2007	58
17699320	1471	Furth SL	Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.	Clinical journal of the American Society of Nephrology 	2006	104
18094679	1471	Coca SG	Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.	Kidney international	2008	141
18235143	1471	Baxmann AC	Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.	Clinical journal of the American Society of Nephrology 	2008	74
18295055	1471	Stevens LA	Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.	American journal of kidney diseases 	2008	337
18650797	1471	Koyner JL	Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery.	Kidney international	2008	75
19001197	1471	Rifkin DE	Rapid kidney function decline and mortality risk in older adults.	Archives of internal medicine	2008	99
19114878	1471	Haase-Fielitz A	Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.	Critical care medicine	2009	71
19119287	1471	Stevens LA	Factors other than glomerular filtration rate affect serum cystatin C levels.	Kidney international	2009	113
19158356	1471	Schwartz GJ	New equations to estimate GFR in children with CKD.	Journal of the American Society of Nephrology 	2009	343
19820136	1471	Schwartz GJ	Measurement and estimation of GFR in children and adolescents.	Clinical journal of the American Society of Nephrology 	2009	71
20332356	1471	Ficociello LH	High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.	Diabetes care	2010	43
20445497	1471	Mahajan A	Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy.	Kidney international	2010	56
20709438	1471	Choi A	Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.	American journal of kidney diseases 	2010	43
20798258	1471	Koyner JL	Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.	Clinical journal of the American Society of Nephrology 	2010	87
21601330	1471	Zhang Z	Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis.	American journal of kidney diseases 	2011	43
22240130	1471	Nickolas TL	Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.	Journal of the American College of Cardiology	2012	66
22305758	1471	Astor BC	Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.	American journal of kidney diseases 	2012	48
22418979	1471	Nejat M	Some biomarkers of acute kidney injury are increased in pre-renal acute injury.	Kidney international	2012	38
22622496	1471	Schwartz GJ	Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C.	Kidney international	2012	49
22626821	1471	Duranton F	Normal and pathologic concentrations of uremic toxins.	Journal of the American Society of Nephrology 	2012	84
22762315	1471	Inker LA	Estimating glomerular filtration rate from serum creatinine and cystatin C.	The New England journal of medicine	2012	450
23024164	1471	Gupta J	Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.	Clinical journal of the American Society of Nephrology 	2012	47
23027318	1471	Schaeffner ES	Two novel equations to estimate kidney function in persons aged 70 years or older.	Annals of internal medicine	2012	68
23273292	1471	Metra M	Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.	Journal of the American College of Cardiology	2013	58
23393104	1471	Goraya N	A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.	Clinical journal of the American Society of Nephrology 	2013	40
23423253	1471	Rule AD	Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.	Kidney international	2013	30
23619125	1471	Grams ME	Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.	American journal of kidney diseases 	2013	28
24004120	1471	Shlipak MG	Cystatin C versus creatinine in determining risk based on kidney function.	The New England journal of medicine	2013	122
24247300	1471	Chen HH	Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.	JAMA	2013	54
24485147	1471	Levey AS	GFR estimation: from physiology to public health.	American journal of kidney diseases 	2014	37
24694986	1471	Goraya N	Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.	Kidney international	2014	22
25195004	1471	Wasung ME	Biomarkers of renal function, which and when?	Clinica chimica acta; international journal of clinical chemistry	2015	24
25554404	1471	Raman SV	Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.	The Lancet. Neurology	2015	26
25599331	1471	Tang WH	Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.	Circulation research	2015	78
16122278	1576	Peng B	Clinical pharmacokinetics of imatinib.	Clinical pharmacokinetics	2005	67
16914578	1576	Wen PY	Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.	Clinical cancer research 	2006	92
17215845	1576	Glaeser H	Intestinal drug transporter expression and the impact of grapefruit juice in humans.	Clinical pharmacology and therapeutics	2007	64
18288078	1576	Hebert MF	Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study.	Clinical pharmacology and therapeutics	2008	52
18309947	1576	Rudin CM	Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.	Journal of clinical oncology 	2008	55
19228077	1576	Keating GM	Sorafenib: a review of its use in advanced hepatocellular carcinoma.	Drugs	2009	70
19483103	1576	Waxman DJ	Sex differences in the expression of hepatic drug metabolizing enzymes.	Molecular pharmacology	2009	123
22748591	1576	Sax PE	Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.	Lancet	2012	83
1328889	1636	Cambien F	Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.	Nature	1992	151
8413456	1636	Lewis EJ	The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.	The New England journal of medicine	1993	490
8596594	1636	Maschio G	Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.	The New England journal of medicine	1996	125
9769304	1636	Nolan J	Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).	Circulation	1998	137
10969042	1636	Donoghue M	A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.	Circulation research	2000	242
11260414	1636	Kambham N	Obesity-related glomerulopathy: an emerging epidemic.	Kidney international	2001	156
11453706	1636	Jafar TH	Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.	Annals of internal medicine	2001	100
12531578	1636	Nakao N	Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.	Lancet	2003	78
12965979	1636	Jafar TH	Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.	Annals of internal medicine	2003	133
14769700	1636	McAlister FA	Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.	Circulation	2004	92
15516696	1636	Barnett AH	Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.	The New England journal of medicine	2004	109
15897343	1636	Ferrario CM	Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.	Circulation	2005	70
18707986	1636	Mann JF	Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.	Lancet	2008	243
19926893	1636	Mehdi UF	Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.	Journal of the American Society of Nephrology 	2009	69
22124756	1636	Agarwal D	Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR.	Basic research in cardiology	2011	36
22158026	1636	Shiina S	Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.	The American journal of gastroenterology	2012	89
25260312	1636	Rich N	Hepatocellular carcinoma tumour markers: current role and expectations.	Best practice and research. Clinical gastroenterology	2014	24
25340798	1636	Kauwe JS	Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.	PLoS genetics	2014	23
8100523	1803	Mentlein R	Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.	European journal of biochemistry	1993	135
12892317	1803	Lambeir AM	Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.	Critical reviews in clinical laboratory sciences	2003	110
16816950	1803	Matikainen N	Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.	Diabetologia	2006	60
16912128	1803	Herman GA	Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2006	81
17130196	1803	Aschner P	Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.	Diabetes care	2006	152
17130197	1803	Charbonnel B	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.	Diabetes care	2006	122
17157112	1803	Rosenstock J	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.	Clinical therapeutics	2006	91
17277036	1803	Bosi E	Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.	Diabetes care	2007	77
17300595	1803	Nauck MA	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.	Diabetes, obesity and metabolism	2007	117
17593236	1803	Hermansen K	Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.	Diabetes, obesity and metabolism	2007	102
17933414	1803	Nonaka K	Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes.	Diabetes research and clinical practice	2008	59
18786605	1803	Holst JJ	The incretin system and its role in type 2 diabetes mellitus.	Molecular and cellular endocrinology	2009	75
19557413	1803	Cordero OJ	On the origin of serum CD26 and its altered concentration in cancer patients.	Cancer immunology, immunotherapy 	2009	52
20075143	1803	Read PA	DPP-4 inhibition by sitagliptin improves the myocardial response to dobutamine stress and mitigates stunning in a pilot study of patients with coronary artery disease.	Circulation. Cardiovascular imaging	2010	42
20357375	1803	Fadini GP	The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.	Diabetes care	2010	63
20580422	1803	Bergenstal RM	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.	Lancet	2010	126
21114605	1803	Taskinen MR	Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.	Diabetes, obesity and metabolism	2011	63
21205122	1803	Del Prato S	Effect of linagliptin monotherapy on glycaemic control and markers of Î²-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.	Diabetes, obesity and metabolism	2011	69
21208359	1803	Madsbad S	An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.	Diabetes, obesity and metabolism	2011	36
21593202	1803	Lamers D	Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.	Diabetes	2011	94
21672124	1803	Graefe-Mody U	Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*).	Diabetes, obesity and metabolism	2011	39
21781152	1803	Owens DR	Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.	Diabetic medicine 	2011	52
21824266	1803	D'Alessio D	The role of dysregulated glucagon secretion in type 2 diabetes.	Diabetes, obesity and metabolism	2011	48
22215383	1803	Monami M	DPP-4 inhibitors and lipids: systematic review and meta-analysis.	Advances in therapy	2012	38
22745245	1803	Makdissi A	Sitagliptin exerts an antinflammatory action.	The Journal of clinical endocrinology and metabolism	2012	43
23344728	1803	Kim YG	Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis.	Diabetologia	2013	53
23653460	1803	Aroor AR	Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.	Endocrinology	2013	38
23715753	1803	Gough SC	Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.	Diabetes care	2013	28
23894014	1803	dos Santos L	Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.	Circulation. Heart failure	2013	26
24144654	1803	Jabbour SA	Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.	Diabetes care	2014	42
24225429	1803	Fujita H	DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1Î± in type 2 diabetic patients with incipient nephropathy.	Endocrine journal	2014	22
26063450	1803	Ferrannini E	Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.	European heart journal	2015	17
26489970	1803	Nauck M	Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.	Diabetes, obesity and metabolism	2016	14
14990351	1906	Gladwin MT	The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation.	Free radical biology and medicine	2004	73
17242275	1906	Silver AE	Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress.	Circulation	2007	56
18261470	1906	Wood KC	Sickle cell disease vasculopathy: a state of nitric oxide resistance.	Free radical biology and medicine	2008	53
18629317	1906	Peretz A	Diesel exhaust inhalation elicits acute vasoconstriction in vivo.	Environmental health perspectives	2008	59
20026766	1906	Murphy SR	Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.	Hypertension	2010	54
21683931	1906	D'haeseleer M	Vascular aspects of multiple sclerosis.	The Lancet. Neurology	2011	37
22409294	1906	Zhou J	Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.	Current eye research	2012	33
23742177	1906	Flammer J	The primary vascular dysregulation syndrome: implications for eye diseases.	The EPMA journal	2013	42
24046434	1906	Jaguszewski M	A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction.	European heart journal	2014	22
25075228	1906	Konieczka K	Flammer syndrome.	The EPMA journal	2014	25
6157683	1956	Ushiro H	Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes.	The Journal of biological chemistry	1980	190
9831867	1956	Ross JS	The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.	Stem cells	1998	109
11897506	1956	Filardo EJ	Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.	The Journal of steroid biochemistry and molecular biology	2002	91
12429632	1956	Di Lorenzo G	Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.	Clinical cancer research 	2002	88
15738541	1956	Mitsudomi T	Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.	Journal of clinical oncology 	2005	175
15955900	1956	Burris HA 3rd	Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas.	Journal of clinical oncology 	2005	123
15994331	1956	Clayton AH	Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis.	The Journal of biological chemistry	2005	82
16818687	1956	Kimura H	Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.	Clinical cancer research 	2006	67
17050876	1956	Dragovich T	Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.	Journal of clinical oncology 	2006	75
17082756	1956	Chonchol M	25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey.	Kidney international	2007	63
17551144	1956	Taguchi F	Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.	Journal of the National Cancer Institute	2007	68
18188694	1956	Cameron D	A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.	Breast cancer research and treatment	2008	143
18211286	1956	Vazquez-Martin A	Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.	Cell proliferation	2008	54
18425114	1956	Al-Nedawi K	Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.	Nature cell biology	2008	350
18596266	1956	Maheswaran S	Detection of mutations in EGFR in circulating lung-cancer cells.	The New England journal of medicine	2008	402
18782861	1956	Tao RH	All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells.	Journal of cell science	2008	69
18981003	1956	Costa DB	Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.	Clinical cancer research 	2008	54
19047149	1956	Saxena NK	Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor.	Cancer research	2008	65
19058255	1956	Xia W	Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer.	Molecular carcinogenesis	2009	67
19201650	1956	Cohen EE	Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.	The Lancet. Oncology	2009	52
19276259	1956	Yung TK	Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.	Clinical cancer research 	2009	99
19351754	1956	Kuang Y	Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer.	Clinical cancer research 	2009	65
19414683	1956	Bai H	Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.	Journal of clinical oncology 	2009	84
19429932	1956	Mirza MA	Relationship between circulating FGF23 and total body atherosclerosis in the community.	Nephrology, dialysis, transplantation 	2009	51
19692684	1956	Rosell R	Screening for epidermal growth factor receptor mutations in lung cancer.	The New England journal of medicine	2009	452
19861462	1956	Wang SC	Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors.	Clinical cancer research 	2009	63
19949019	1956	Hanrahan EO	Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.	Journal of clinical oncology 	2010	52
20065189	1956	Wells SA Jr	Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.	Journal of clinical oncology 	2010	95
20142592	1956	Haura EB	Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.	Journal of clinical oncology 	2010	57
20150372	1956	Raizer JJ	A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.	Neuro-oncology	2010	56
20189275	1956	Matsushita K	Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.	American journal of kidney diseases 	2010	64
20855820	1956	Johnson FM	Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.	Journal of clinical oncology 	2010	53
21189092	1956	de Boer RA	Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.	Annals of medicine	2011	74
21471286	1956	Hegi ME	Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial.	Molecular cancer therapeutics	2011	35
21900837	1956	Goto K	Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.	Journal of thoracic oncology 	2012	51
21976538	1956	Taniguchi K	Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas.	Clinical cancer research 	2011	75
22261334	1956	Han W	Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.	Cancer letters	2012	64
22414764	1956	Blivet-Van EggelpoÃ«l MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	37
22440336	1956	Scagliotti GV	Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer.	Clinical lung cancer	2012	44
22520625	1956	Wang YN	Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family.	Cell and bioscience	2012	32
22605616	1956	Goldman JW	Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib.	Cancer	2012	35
22649089	1956	Forshew T	Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.	Science translational medicine	2012	209
22797485	1956	Zhao X	Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.	Respiration; international review of thoracic diseases	2013	30
22801742	1956	Doecke JD	Blood-based protein biomarkers for diagnosis of Alzheimer disease.	Archives of neurology	2012	65
22806307	1956	Togashi Y	Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer.	Cancer chemotherapy and pharmacology	2012	34
22826274	1956	Bai H	Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer.	Journal of clinical oncology 	2012	60
22898037	1956	Argiris A	Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.	Annals of oncology 	2013	34
23123196	1956	Yang W	EGFR-induced and PKCÎµ monoubiquitylation-dependent NF-ÎºB activation upregulates PKM2 expression and promotes tumorigenesis.	Molecular cell	2012	55
23563269	1956	Murtaza M	Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.	Nature	2013	259
23687356	1956	Rhee EP	A combined epidemiologic and metabolomic approach improves CKD prediction.	Journal of the American Society of Nephrology 	2013	40
23888061	1956	Liu X	The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies.	Journal of clinical pathology	2013	29
24263064	1956	Douillard JY	First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study.	British journal of cancer	2014	33
24429397	1956	Niewczas MA	Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.	Kidney international	2014	27
24429876	1956	Oxnard GR	Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.	Clinical cancer research 	2014	111
24553387	1956	Misale S	Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer.	Science translational medicine	2014	58
24652789	1956	Lu JL	Association of body mass index with outcomes in patients with CKD.	Journal of the American Society of Nephrology 	2014	33
24687921	1956	Koeppen H	Biomarker analyses from a placebo-controlled phase II study evaluating erlotinibÂ±onartuzumab in advanced non-small cell lung cancer: MET expression levels are predictive of patient benefit.	Clinical cancer research 	2014	26
24747441	1956	Seguin L	An integrin Î²â-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.	Nature cell biology	2014	58
24773774	1956	Weber B	Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays.	BMC cancer	2014	25
24831979	1956	Gregorc V	Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.	The Lancet. Oncology	2014	39
25013125	1956	Couraud S	Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.	Clinical cancer research 	2014	40
25103305	1956	Sorensen BS	Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced non-small cell lung cancer during treatment with erlotinib.	Cancer	2014	32
25122430	1956	Douillard JY	Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status.	Journal of thoracic oncology 	2014	62
25405807	1956	Wang Z	Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC.	PloS one	2014	31
25409146	1956	Cheng CJ	MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.	Nature	2015	97
25594178	1956	Tan X	A kinase-independent role for EGF receptor in autophagy initiation.	Cell	2015	35
25614492	1956	Brown MA	CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life.	Clinical journal of the American Society of Nephrology 	2015	17
25628445	1956	Morelli MP	Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment.	Annals of oncology 	2015	22
25726255	1956	Higuchi C	Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.	Metabolism	2015	20
25769900	1956	Zhu G	Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer.	The Journal of molecular diagnostics 	2015	22
25934077	1956	Piotrowska Z	Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.	Cancer discovery	2015	55
26181014	1956	Karachaliou N	Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.	JAMA oncology	2015	38
26184520	1956	Tabernero J	Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.	The Lancet. Oncology	2015	37
26206882	1956	Uchida J	Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.	Clinical chemistry	2015	25
26227959	1956	Sun W	Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer.	Journal of hematology and oncology	2015	25
26229137	1956	Stubbs JR	Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.	Journal of the American Society of Nephrology 	2016	27
26295376	1956	Marchetti A	Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.	Journal of thoracic oncology 	2015	25
26459174	1956	Paweletz CP	Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients.	Clinical cancer research 	2016	19
26494259	1956	Thress KS	EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.	Lung cancer	2015	39
26577492	1956	Sueoka-Aragane N	Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.	Cancer science	2016	13
26582655	1956	Xu S	Circulating tumor DNA identified by targeted sequencing in advanced-stage non-small cell lung cancer patients.	Cancer letters	2016	12
26747242	1956	Karlovich C	Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686).	Clinical cancer research 	2016	15
26755650	1956	Lee JY	Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02).	Oncotarget	2016	16
26799287	1956	Del Re M	Contribution of KRAS mutations and c.2369C &amp;gt; T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA.	Oncotarget	2017	9
26867973	1956	Zheng D	Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance.	Scientific reports	2016	29
26898616	1956	Tan CS	Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer.	Lung cancer	2016	17
26912543	1956	Torres VE	Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.	Clinical journal of the American Society of Nephrology 	2016	10
26968708	1956	Feng K	Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.	Science China. Life sciences	2016	14
27354477	1956	Oxnard GR	Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer.	Journal of clinical oncology 	2016	31
10936180	2026	Encinas M	Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells.	Journal of neurochemistry	2000	122
16864809	2026	Wijdicks EF	Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.	Neurology	2006	151
20680517	2026	Samaniego EA	Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia.	Neurocritical care	2011	36
24463859	2026	Oddo M	Early multimodal outcome prediction after cardiac arrest in patients treated with hypothermia.	Critical care medicine	2014	22
24627036	2026	Shahim P	Blood biomarkers for brain injury in concussed professional ice hockey players.	JAMA neurology	2014	45
11844847	2056	Casadevall N	Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.	The New England journal of medicine	2002	103
12435860	2056	Ehrenreich H	Erythropoietin therapy for acute stroke is both safe and beneficial.	Molecular medicine	2002	162
15284297	2056	Sharples EJ	Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.	Journal of the American Society of Nephrology 	2004	81
17267740	2056	Coyne DW	Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.	Journal of the American Society of Nephrology 	2007	64
17267743	2056	Inaba M	Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.	Journal of the American Society of Nephrology 	2007	75
17488680	2056	Origa R	Liver iron concentrations and urinary hepcidin in beta-thalassemia.	Haematologica	2007	81
19212416	2056	Ashby DR	Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease.	Kidney international	2009	50
19833632	2056	Ashby DR	Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.	Haematologica	2010	46
20164823	2056	Endre ZH	Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).	Kidney international	2010	67
21115615	2056	Bernhardt WM	Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD.	Journal of the American Society of Nephrology 	2010	65
21900080	2056	Sachdev V	Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.	Circulation	2011	36
23008465	2056	Wu YW	Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.	Pediatrics	2012	46
23669289	2056	HÃ©zode C	Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.	Journal of hepatology	2013	96
23695894	2056	Tefferi A	Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.	American journal of hematology	2013	29
24366362	2056	Rumi E	JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.	Blood	2014	63
24645943	2056	Kamar N	Ribavirin for chronic hepatitis E virus infection in transplant recipients.	The New England journal of medicine	2014	44
25611051	2056	Tefferi A	Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.	American journal of hematology	2015	22
26976799	2056	Pockros PJ	Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.	Gastroenterology	2016	18
1741036	2147	Bock LC	Selection of single-stranded DNA molecules that bind and inhibit human thrombin.	Nature	1992	281
8916933	2147	Poort SR	A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.	Blood	1996	212
10648405	2147	Nieuwland R	Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.	Blood	2000	93
11341498	2147	Berckmans RJ	Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.	Thrombosis and haemostasis	2001	94
14643116	2147	Olsson SB	Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.	Lancet	2003	82
15701910	2147	Albers GW	Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.	JAMA	2005	72
17306706	2147	Leroyer AS	Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques.	Journal of the American College of Cardiology	2007	66
17506785	2147	Stangier J	The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.	British journal of clinical pharmacology	2007	104
17671515	2147	Man MQ	Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.	The Journal of investigative dermatology	2008	52
17950801	2147	Ezekowitz MD	Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).	The American journal of cardiology	2007	56
18006647	2147	Blech S	The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.	Drug metabolism and disposition	2008	82
18399711	2147	Stangier J	Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.	Clinical pharmacokinetics	2008	88
18574264	2147	Hirsh J	Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).	Chest	2008	77
19667878	2147	Park MS	Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.	The Journal of trauma	2009	50
19696042	2147	Stangier J	Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.	Clinical and applied thrombosis/hemostasis 	2009	46
19815831	2147	van Beers EJ	Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.	Haematologica	2009	46
20214409	2147	Stangier J	Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.	Clinical pharmacokinetics	2010	91
20870944	2147	Amara U	Molecular intercommunication between the complement and coagulation systems.	Journal of immunology	2010	109
21972820	2147	Liesenfeld KH	Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.	Journal of thrombosis and haemostasis 	2011	36
21976677	2147	Choi SH	Polyphosphate is a cofactor for the activation of factor XI by thrombin.	Blood	2011	49
22227958	2147	Stangier J	Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran.	Blood coagulation and fibrinolysis 	2012	42
22315264	2147	Garcia DA	Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.	Chest	2012	62
22438031	2147	Douxfils J	Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.	Thrombosis and haemostasis	2012	39
23220847	2147	Siegal DM	Acute management of bleeding in patients on novel oral anticoagulants.	European heart journal	2013	28
23991661	2147	Eikelboom JW	Dabigatran versus warfarin in patients with mechanical heart valves.	The New England journal of medicine	2013	75
25012129	2147	Gould TJ	Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms.	Arteriosclerosis, thrombosis, and vascular biology	2014	39
25660055	2147	Stakos DA	Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction.	European heart journal	2015	23
27919911	2147	Noubouossie DF	In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps.	Blood	2017	5
12805058	2152	Shet AS	Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.	Blood	2003	125
21368657	2152	Gando S	Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature.	Annals of surgery	2011	35
25647528	2152	Zidar DA	Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.	Journal of acquired immune deficiency syndromes	2015	25
20231535	2157	Smith NL	Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.	Circulation	2010	87
22223821	2157	Powell JS	Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.	Blood	2012	31
1402682	2244	Brown LF	Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.	The Journal of experimental medicine	1992	151
7807658	2244	-	Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.	JAMA	1995	131
8035924	2244	Breteler MM	Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.	Neurology	1994	133
8353913	2244	Newman AB	Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.	Circulation	1993	156
10187889	2244	Ebrahim S	Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study.	Stroke	1999	100
10657556	2244	Yudkin JS	Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?	Atherosclerosis	2000	214
11719299	2244	Seemungal T	Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2001	174
15840727	2244	Steptoe A	Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes.	Proceedings of the National Academy of Sciences of the United States of America	2005	109
16723443	2244	Wong TY	Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).	Investigative ophthalmology and visual science	2006	92
17457176	2244	Brohi K	Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?	Annals of surgery	2007	123
17463411	2244	Chuang KJ	The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults.	American journal of respiratory and critical care medicine	2007	139
17846344	2244	Kloner RA	To drink or not to drink? That is the question.	Circulation	2007	58
19296670	2244	Kollman JM	Crystal structure of human fibrinogen.	Biochemistry	2009	58
20439481	2244	Thompson S	Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.	International journal of epidemiology	2010	41
20943795	2244	Mozaffarian D	Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.	The American journal of clinical nutrition	2010	43
21131036	2244	Krug U	Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.	Lancet	2010	43
21375741	2244	SchÃ¶chl H	Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.	Critical care	2011	50
21437585	2244	Bellia A	Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects.	Internal and emergency medicine	2013	34
21799891	2244	Bonetto A	STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.	PloS one	2011	58
21970887	2244	GÃ¶rlinger K	First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.	Anesthesiology	2011	43
22144540	2244	Zhang YZ	Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome.	Clinical infectious diseases 	2012	52
22385985	2244	Adinolfi LE	Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.	Atherosclerosis	2012	35
23249928	2244	Rahe-Meyer N	Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.	Anesthesiology	2013	31
23755138	2244	Menzaghi C	Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.	PloS one	2014	21
24368514	2244	McInnes IB	Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.	Annals of the rheumatic diseases	2015	32
25695403	2244	Rennard SI	CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.	American journal of respiratory and critical care medicine	2015	18
9626049	2247	Nissen NN	Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.	The American journal of pathology	1998	116
12203386	2247	Ignatova TN	Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro.	Glia	2002	250
15887229	2247	Doucet C	Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications.	Journal of cellular physiology	2005	93
15998317	2247	Nickel W	Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells.	Traffic	2005	99
16109759	2247	Sotiropoulou PA	Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.	Stem cells	2006	108
16179608	2247	Vallier L	Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.	Journal of cell science	2005	231
16360975	2247	Bremnes RM	Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.	Lung cancer	2006	67
16388305	2247	Ludwig TE	Derivation of human embryonic stem cells in defined conditions.	Nature biotechnology	2006	257
16697959	2247	Lee J	Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.	Cancer cell	2006	670
17426693	2247	Jiang W	In vitro derivation of functional insulin-producing cells from human embryonic stem cells.	Cell research	2007	86
18316562	2247	Dowlati A	Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study.	Clinical cancer research 	2008	74
18323556	2247	Yao JC	Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.	Journal of clinical oncology 	2008	79
19026649	2247	Basma H	Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.	Gastroenterology	2009	139
19232461	2247	Qiang L	Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.	Cancer letters	2009	55
19614919	2247	Lee EY	Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF.	Wound repair and regeneration 	2009	87
20186512	2247	International Stem Cell Initiative Consortium.	Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.	In vitro cellular and developmental biology. Animal	2010	46
21494607	2247	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	120
21572306	2247	Keating SM	The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.	AIDS	2011	37
21855631	2247	Xu X	Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells.	Mechanisms of development	2011	37
22296115	2247	Fekete N	Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.	Cytotherapy	2012	53
24960162	2247	Bertero T	Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.	The Journal of clinical investigation	2014	43
25241748	2247	Shelton M	Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells.	Stem cell reports	2014	25
25884704	2247	Li CY	Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy.	Stem cell research and therapy	2015	22
2445780	2335	Nathan CF	Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.	The Journal of clinical investigation	1987	164
8127021	2335	Ryan MJ	HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney.	Kidney international	1994	155
9214622	2335	Watanabe N	p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin.	The EMBO journal	1997	208
10508858	2335	Aguirre Ghiso JA	Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.	The Journal of cell biology	1999	115
11588036	2335	Campagnoli C	Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.	Blood	2001	230
11675329	2335	Reyes M	Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells.	Blood	2001	140
14627547	2335	Amit M	Feeder layer- and serum-free culture of human embryonic stem cells.	Biology of reproduction	2004	92
15173316	2335	D'Ippolito G	Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential.	Journal of cell science	2004	134
17914904	2335	Smith ML	Force-induced unfolding of fibronectin in the extracellular matrix of living cells.	PLoS biology	2007	107
18673086	2335	Winer JP	Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli.	Tissue engineering. Part A	2009	66
19940066	2335	Pattabiraman PP	Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells.	American journal of physiology. Cell physiology	2010	45
21126355	2335	Szarka A	Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array.	BMC immunology	2010	86
22153870	2335	Cheng NC	The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities.	Biomaterials	2012	36
17023693	2638	Houghton LA	The case against ergocalciferol (vitamin D2) as a vitamin supplement.	The American journal of clinical nutrition	2006	79
22398410	2638	Bhan I	Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients.	Kidney international	2012	58
26161453	2638	Aloia J	Free 25(OH)D and the Vitamin D Paradox in African Americans.	The Journal of clinical endocrinology and metabolism	2015	18
26453697	2638	Henderson CM	Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites.	Clinical chemistry	2016	17
8405741	2641	Nauck MA	Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.	Diabetologia	1993	130
8423228	2641	Nauck MA	Preserved incretin activity of glucagon-like peptide 1 7-36 amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.	The Journal of clinical investigation	1993	212
9449682	2641	Flint A	Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.	The Journal of clinical investigation	1998	156
10794683	2641	Knudsen LB	Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.	Journal of medicinal chemistry	2000	102
11246881	2641	VilsbÃ¸ll T	Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.	Diabetes	2001	139
11502801	2641	Toft-Nielsen MB	Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.	The Journal of clinical endocrinology and metabolism	2001	135
11897280	2641	Zander M	Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.	Lancet	2002	188
12788877	2641	VilsbÃ¸ll T	Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2003	89
15111485	2641	Degn KB	One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.	Diabetes	2004	71
16219666	2641	Theodorakis MJ	Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.	American journal of physiology. Endocrinology and metabolism	2006	72
18057091	2641	Vollmer K	Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.	Diabetes	2008	74
18239636	2641	Rodieux F	Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.	Obesity	2008	69
18782641	2641	Drucker DJ	Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study.	Lancet	2008	200
19037628	2641	HÃ¸jberg PV	Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.	Diabetologia	2009	45
19289857	2641	Zinman B	Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).	Diabetes care	2009	182
19515413	2641	Buse JB	Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).	Lancet	2009	299
19570554	2641	Nakatani H	Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.	Metabolism	2009	49
19638921	2641	Peterli R	Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.	Annals of surgery	2009	88
19776140	2641	Cani PD	Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal.	The American journal of clinical nutrition	2009	103
20130660	2641	Tarini J	The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects.	Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme	2010	45
20215461	2641	Buse JB	DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.	Diabetes care	2010	56
20595511	2641	Wild D	Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.	Journal of nuclear medicine 	2010	42
21205128	2641	Garber A	Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.	Diabetes, obesity and metabolism	2011	39
21209033	2641	HegedÃ¼s L	GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide.	The Journal of clinical endocrinology and metabolism	2011	38
21307137	2641	Blevins T	DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes.	The Journal of clinical endocrinology and metabolism	2011	71
21868791	2641	Salehi M	Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans.	Diabetes	2011	67
22354457	2641	Peterli R	Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.	Obesity surgery	2012	65
23187122	2641	Bradley D	Gastric bypass and banding equally improve insulin sensitivity and Î² cell function.	The Journal of clinical investigation	2012	52
23377698	2641	Calanna S	Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.	Diabetologia	2013	29
24161075	2641	Drucker DJ	Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.	Annual review of physiology	2014	24
24988476	2641	Napolitano A	Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.	PloS one	2014	28
25190523	2641	Gough SC	Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.	The lancet. Diabetes and endocrinology	2014	35
25500202	2641	Chambers ES	Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults.	Gut	2015	48
26394161	2641	Armstrong MJ	Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.	Journal of hepatology	2016	13
9441573	2688	Papanicolaou DA	The pathophysiologic roles of interleukin-6 in human disease.	Annals of internal medicine	1998	132
10203281	2688	Ma J	Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.	Journal of the National Cancer Institute	1999	183
12543931	2688	Adkins JN	Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry.	Molecular and cellular proteomics 	2002	116
12764120	2688	Benedetti F	Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses.	The Journal of neuroscience 	2003	93
16616726	2688	Munro CA	Sex differences in striatal dopamine release in healthy adults.	Biological psychiatry	2006	81
18256394	2688	Merideth MA	Phenotype and course of Hutchinson-Gilford progeria syndrome.	The New England journal of medicine	2008	138
19409844	2688	Boyd N	Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study.	The Lancet. Oncology	2009	49
20584998	2688	Tong J	Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.	Diabetes	2010	77
23418415	2688	Munch EM	Transcriptome profiling of microRNA by Next-Gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast milk.	PloS one	2013	37
9819447	2875	Davis GL	Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.	The New England journal of medicine	1998	152
10210705	2875	Kenny-Walsh E	Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.	The New England journal of medicine	1999	144
10632283	2875	Sulkowski MS	Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.	JAMA	2000	119
11716091	2875	Durbin AP	Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.	The American journal of tropical medicine and hygiene	2001	86
12093239	2875	Prati D	Updated definitions of healthy ranges for serum alanine aminotransferase levels.	Annals of internal medicine	2002	219
12512031	2875	Ruhl CE	Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.	Gastroenterology	2003	118
12606734	2875	Hadziyannis SJ	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.	The New England journal of medicine	2003	131
12891527	2875	Angus P	Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.	Gastroenterology	2003	95
14512888	2875	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	99
14699491	2875	Peters MG	Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.	Gastroenterology	2004	90
14960526	2875	Hickman IJ	Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.	Gut	2004	72
15639293	2875	Janssen HL	Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.	Lancet	2005	150
15867021	2875	Schwimmer JB	Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.	Pediatrics	2005	81
16391218	2875	Chen CJ	Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.	JAMA	2006	452
16729316	2875	Lee YS	Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.	Hepatology	2006	68
16820551	2875	Watkins PB	Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.	JAMA	2006	74
17087951	2875	Hadziyannis SJ	Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.	Gastroenterology	2006	145
17439526	2875	Coco B	Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases.	Journal of viral hepatitis	2007	108
17595248	2875	Kotronen A	Liver fat in the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2007	70
17983800	2875	Gish RG	Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.	Gastroenterology	2007	57
18094378	2875	Lai CL	Telbivudine versus lamivudine in patients with chronic hepatitis B.	The New England journal of medicine	2007	144
18302293	2875	Hsu C	A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.	Hepatology	2008	53
18384521	2875	Leite NC	Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.	Liver international 	2009	76
18421281	2875	Larson-Meyer DE	Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.	Obesity	2008	53
18624899	2875	Banas A	Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.	Journal of gastroenterology and hepatology	2009	63
18752331	2875	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	95
18945255	2875	Loomba R	Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.	Alimentary pharmacology and therapeutics	2009	48
19585618	2875	Feldstein AE	Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.	Hepatology	2009	123
19877169	2875	Ratziu V	Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.	Hepatology	2010	52
21109302	2875	Athyros VG	Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.	Lancet	2010	95
21126940	2875	Cave M	Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003-2004.	Environmental health perspectives	2010	45
21139063	2875	Thomson EC	Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.	Gut	2011	38
21145828	2875	Ratziu V	A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.	Journal of hepatology	2011	48
21323729	2875	Chen CJ	Natural history of chronic hepatitis B REVEALed.	Journal of gastroenterology and hepatology	2011	39
21423260	2875	Kwon H	Hepatitis B therapy.	Nature reviews. Gastroenterology and hepatology	2011	66
21497551	2875	Yang HI	Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.	The Lancet. Oncology	2011	67
21505361	2875	Vajro P	Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease.	Journal of pediatric gastroenterology and nutrition	2011	47
21602530	2875	Wong VW	Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.	Gut	2011	38
21688282	2875	Bhala N	The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.	Hepatology	2011	78
21953442	2875	Kowdley KV	Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2012	65
22183689	2875	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	52
22266604	2875	Antoine DJ	Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.	Journal of hepatology	2012	103
22941922	2875	Tseng TC	Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.	Hepatology	2013	32
23355498	2875	Loomba R	Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.	American journal of epidemiology	2013	25
23696515	2875	Noureddin M	Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.	Hepatology	2013	53
24107395	2875	Gordon SC	Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.	Clinical gastroenterology and hepatology 	2014	25
24316260	2875	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	63
25092309	2875	Ward J	Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25212606	2875	Puzanov I	A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors.	Clinical cancer research 	2015	22
25311610	2875	Faghihzadeh F	Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.	Nutrition research	2014	24
25482832	2875	Loomba R	Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial).	Hepatology	2015	36
25776943	2875	Guo K	Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.	Obesity	2015	15
25873639	2875	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	13
26667191	2875	Ballestri S	Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.	Journal of gastroenterology and hepatology	2016	25
15163532	3075	RodrÃ­guez de CÃ³rdoba S	The human complement factor H: functional roles, genetic variations and disease associations.	Molecular immunology	2004	117
15590760	3075	Dragon-Durey MA	Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.	Journal of the American Society of Nephrology 	2005	76
15800116	3075	Appel GB	Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.	Journal of the American Society of Nephrology 	2005	72
16621965	3075	Caprioli J	Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.	Blood	2006	128
16849663	3075	Despriet DD	Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.	JAMA	2006	77
17132743	3075	Chung KM	West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.	Proceedings of the National Academy of Sciences of the United States of America	2006	74
17599974	3075	Sellier-Leclerc AL	Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.	Journal of the American Society of Nephrology 	2007	69
18081690	3075	de CÃ³rdoba SR	Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.	Clinical and experimental immunology	2008	75
18419542	3075	Welsch JA	Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.	The Journal of infectious diseases	2008	60
18596911	3075	Scholl HP	Systemic complement activation in age-related macular degeneration.	PloS one	2008	96
18684951	3075	Schmidt CQ	A new map of glycosaminoglycan and C3b binding sites on factor H.	Journal of immunology	2008	71
20595690	3075	Noris M	Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.	Clinical journal of the American Society of Nephrology 	2010	127
20619376	3075	Jiang HQ	Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.	Vaccine	2010	52
21325619	3075	Beernink PT	A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.	Journal of immunology	2011	57
22403278	3075	Bomback AS	Eculizumab for dense deposit disease and C3 glomerulonephritis.	Clinical journal of the American Society of Nephrology 	2012	57
22875704	3075	Shaw PX	Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids.	Proceedings of the National Academy of Sciences of the United States of America	2012	34
23431077	3075	Bresin E	Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.	Journal of the American Society of Nephrology 	2013	46
24088957	3075	Sinha A	Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.	Kidney international	2014	21
25161192	3075	Costa I	Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.	mBio	2014	22
25402769	3075	Blaum BS	Structural basis for sialic acid-mediated self-recognition by complement factor H.	Nature chemical biology	2015	36
25859752	3075	Loirat C	An international consensus approach to the management of atypical hemolytic uremic syndrome in children.	Pediatric nephrology	2016	24
12620891	3146	Park JS	Activation of gene expression in human neutrophils by high mobility group box 1 protein.	American journal of physiology. Cell physiology	2003	102
15502843	3146	Wang H	Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.	Nature medicine	2004	249
15753748	3146	SundÃ©n-Cullberg J	Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.	Critical care medicine	2005	111
15944249	3146	Dumitriu IE	Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.	Journal of immunology	2005	127
16721263	3146	Goldstein RS	Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia.	Shock	2006	60
17334246	3146	Angus DC	Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis.	Critical care medicine	2007	58
19064698	3146	Urbonaviciute V	Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.	The Journal of experimental medicine	2008	154
19533845	3146	Peltz ED	HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans.	Shock	2009	59
19887013	3146	Cohen MJ	Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion.	Critical care	2009	78
20530955	3146	de Jong HK	The systemic pro-inflammatory response in sepsis.	Journal of innate immunity	2010	44
22700877	3146	Suzuki Y	Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.	Cancer research	2012	44
23390034	3146	Antoine DJ	Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.	Hepatology	2013	79
24464016	3146	Jia L	Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia.	Blood	2014	27
25636263	3146	Woolbright BL	Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.	Toxicology and applied pharmacology	2015	29
25941621	3146	Kepp O	Consensus guidelines for the detection of immunogenic cell death.	Oncoimmunology	2014	89
21214223	3240	Arnold JN	Novel glycan biomarkers for the detection of lung cancer.	Journal of proteome research	2011	49
22021369	3240	Hod EA	Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron.	Blood	2011	64
22922649	3240	Andersen CB	Structure of the haptoglobin-haemoglobin complex.	Nature	2012	44
23264591	3240	Schaer DJ	Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.	Blood	2013	97
23965626	3240	Uzureau P	Mechanism of Trypanosoma brucei gambiense resistance to human serum.	Nature	2013	36
1361507	3383	Ades EW	HMEC-1: establishment of an immortalized human microvascular endothelial cell line.	The Journal of investigative dermatology	1992	283
9416885	3383	Hwang SJ	Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.	Circulation	1997	188
9439492	3383	Ridker PM	Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.	Lancet	1998	137
11566912	3383	Chae CU	Blood pressure and inflammation in apparently healthy men.	Hypertension	2001	102
11923038	3383	Nappo F	Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.	Journal of the American College of Cardiology	2002	90
15113816	3383	Meigs JB	Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.	JAMA	2004	128
16429128	3383	MillÃ¡n J	Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains.	Nature cell biology	2006	104
17182639	3383	O'Neill MS	Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility.	Occupational and environmental medicine	2007	77
17944012	3383	Calfee CS	Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders.	Critical care medicine	2007	63
19307690	3383	Lawson C	ICAM-1 signaling in endothelial cells.	Pharmacological reports 	2009	133
19560161	3383	Steppan J	Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix.	The Journal of surgical research	2011	38
19858233	3383	Ware LB	Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.	Chest	2010	78
19910332	3383	Sauvet F	Effect of acute sleep deprivation on vascular function in healthy subjects.	Journal of applied physiology	2010	43
21399646	3383	Flach TL	Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity.	Nature medicine	2011	83
22016448	3383	Richards TJ	Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.	American journal of respiratory and critical care medicine	2012	75
22744718	3383	Chalmers JD	Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis.	American journal of respiratory and critical care medicine	2012	30
23524845	3383	Skibsted S	Biomarkers of endothelial cell activation in early sepsis.	Shock	2013	25
24739658	3383	Amable PR	Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton's jelly.	Stem cell research and therapy	2014	27
11199920	3439	Bengtsson AA	Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.	Lupus	2000	102
11711679	3439	Blanco P	Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.	Science	2001	304
12707322	3439	Kerkmann M	Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.	Journal of immunology	2003	91
12960254	3439	Izaguirre A	Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells.	Journal of leukocyte biology	2003	112
15070685	3439	Poeck H	Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.	Blood	2004	83
15593221	3439	Kirou KA	Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.	Arthritis and rheumatism	2004	96
15998792	3439	Nestle FO	Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.	The Journal of experimental medicine	2005	173
16632604	3439	Herbeuval JP	Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.	Proceedings of the National Academy of Sciences of the United States of America	2006	86
17326216	3439	Bruno S	Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study.	Hepatology	2007	119
17581626	3439	Niewold TB	High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.	Genes and immunity	2007	134
17678633	3439	Felger JC	Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.	Biological psychiatry	2007	58
18521089	3439	Raison CL	Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.	Molecular psychiatry	2010	69
18797453	3439	KarikÃ³ K	Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.	Molecular therapy 	2008	67
18801471	3439	Raison CL	Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.	Biological psychiatry	2009	96
19339987	3439	Kariuki SN	Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.	Genes and immunity	2009	46
19648060	3439	Belderbos ME	Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.	Clinical immunology	2009	56
19790071	3439	Bauer JW	Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.	Arthritis and rheumatism	2009	81
20112359	3439	Salloum R	Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.	Arthritis and rheumatism	2010	55
20145197	3439	Fitzgerald-Bocarsly P	Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.	Journal of leukocyte biology	2010	59
20844193	3439	Santer DM	C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.	Journal of immunology	2010	42
21604071	3439	Mundy-Bosse BL	Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4âº T cells from patients with GI malignancy.	Cancer immunology, immunotherapy 	2011	46
21923413	3439	Niewold TB	Interferon alpha as a primary pathogenic factor in human lupus.	Journal of interferon and cytokine research 	2011	48
22981791	3439	Baraldo S	Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma.	The Journal of allergy and clinical immunology	2012	33
23046671	3439	Micco L	Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.	Journal of hepatology	2013	35
23072726	3439	Felger JC	Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.	Brain, behavior, and immunity	2013	28
23400715	3439	Petri M	Sifalimumab, a human anti-interferon-Î± monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.	Arthritis and rheumatism	2013	47
25733157	3439	Gane EJ	The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection.	Journal of hepatology	2015	25
25754160	3439	Serti E	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.	Gastroenterology	2015	19
9428763	3458	Wilson SB	Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.	Nature	1998	126
9464798	3458	Jonuleit H	Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions.	European journal of immunology	1997	226
10226067	3458	Baldini M	A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.	American journal of respiratory cell and molecular biology	1999	125
10479160	3458	Day NP	The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria.	The Journal of infectious diseases	1999	99
12001037	3458	Libraty DH	Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.	The Journal of infectious diseases	2002	160
12147537	3458	Adrie C	Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome.	Circulation	2002	113
12750172	3458	Dufour C	TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.	Blood	2003	82
12898444	3458	Wang SM	Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema.	The Journal of infectious diseases	2003	75
14512316	3458	Nieda M	Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.	Blood	2004	86
15709009	3458	Lindesmith L	Cellular and humoral immunity following Snow Mountain virus challenge.	Journal of virology	2005	79
16258194	3458	Arican O	Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.	Mediators of inflammation	2005	91
16785573	3458	Xu D	Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.	Journal of immunology	2006	101
17255300	3458	Ochoa AC	Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.	Clinical cancer research 	2007	133
17671215	3458	Dieli F	Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.	Cancer research	2007	115
17689290	3458	NylÃ©n S	Interleukin-10 and the pathogenesis of human visceral leishmaniasis.	Trends in immunology	2007	102
17916356	3458	Dolganiuc A	Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.	Gastroenterology	2007	65
18005941	3458	Potvin S	Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.	Biological psychiatry	2008	171
18275276	3458	Pereyra F	Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.	The Journal of infectious diseases	2008	244
18359186	3458	Witek-Janusek L	Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.	Brain, behavior, and immunity	2008	75
18448618	3458	Forrest BD	Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.	Clinical and vaccine immunology 	2008	62
18684007	3458	Cranage M	Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.	PLoS medicine	2008	72
18722511	3458	Klehmet J	Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial.	Neuroscience	2009	51
19064561	3458	Wong HL	Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons.	Cancer epidemiology, biomarkers and prevention 	2008	54
19251324	3458	Brietzke E	Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.	Journal of affective disorders	2009	46
19255340	3458	Eid RE	Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.	Circulation	2009	111
19287090	3458	Levy Y	Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.	The Journal of clinical investigation	2009	114
19577283	3458	Jones SM	Clinical efficacy and immune regulation with peanut oral immunotherapy.	The Journal of allergy and clinical immunology	2009	135
19675671	3458	Smolders J	Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.	PloS one	2009	53
19909538	3458	Fletcher MA	Plasma cytokines in women with chronic fatigue syndrome.	Journal of translational medicine	2009	55
20003352	3458	Bermejo-Martin JF	Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.	Critical care	2009	91
20019339	3458	Chen X	Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells.	American journal of respiratory and critical care medicine	2010	48
20112361	3458	Kokkonen H	Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis.	Arthritis and rheumatism	2010	94
20713898	3458	Soon E	Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.	Circulation	2010	98
20725040	3458	Berry MP	An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.	Nature	2010	449
21628665	3458	Wauquier N	The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation.	The Journal of infectious diseases	2011	39
21998409	3458	Fabri M	Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.	Science translational medicine	2011	135
22084578	3458	Chen Y	Kynurenine pathway metabolites in humans: disease and healthy States.	International journal of tryptophan research 	2009	76
22289511	3458	McElhaney JE	The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.	Vaccine	2012	48
22485125	3458	Zhang L	Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis.	PloS one	2012	36
22569268	3458	Kamat A	Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.	Journal of acquired immune deficiency syndromes	2012	61
22592608	3458	Klinger M	Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.	Blood	2012	74
22662108	3458	Sokolove J	Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis.	PloS one	2012	88
22700860	3458	Meintjes G	Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome.	American journal of respiratory and critical care medicine	2012	30
23144328	3458	Kartalija M	Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.	American journal of respiratory and critical care medicine	2013	31
23331510	3458	Salahuddin N	Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study Supplementary Cholecalciferol in recovery from tuberculosis. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'.	BMC infectious diseases	2013	36
24219905	3458	Zimmermann JA	Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.	Cytotherapy	2014	26
24655295	3458	Lowes MA	Immunology of psoriasis.	Annual review of immunology	2014	88
24704219	3458	Upthegrove R	Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis.	Schizophrenia research	2014	36
24934179	3458	Masi A	Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.	Molecular psychiatry	2015	34
25210141	3458	Jensen KJ	Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.	The Journal of infectious diseases	2015	19
25244096	3458	Kirabo A	DC isoketal-modified proteins activate T cells and promote hypertension.	The Journal of clinical investigation	2014	60
25416807	3458	Huss DJ	In vivo maintenance of human regulatory T cells during CD25 blockade.	Journal of immunology	2015	15
25647269	3458	Talaat RM	Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.	Cytokine	2015	23
8156941	3479	Thissen JP	Nutritional regulation of the insulin-like growth factors.	Endocrine reviews	1994	133
9438850	3479	Chan JM	Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.	Science	1998	265
9593409	3479	Hankinson SE	Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.	Lancet	1998	250
9923856	3479	Yu H	Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.	Journal of the National Cancer Institute	1999	109
11018095	3479	Kaaks R	Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.	Journal of the National Cancer Institute	2000	136
11310428	3479	Kaaks R	Energy balance and cancer: the role of insulin and insulin-like growth factor-I.	The Proceedings of the Nutrition Society	2001	109
11832363	3479	Ferrando AA	Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.	American journal of physiology. Endocrinology and metabolism	2002	85
12050121	3479	Riggs BL	Sex steroids and the construction and conservation of the adult skeleton.	Endocrine reviews	2002	296
12122101	3479	Chan JM	Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.	Journal of the National Cancer Institute	2002	88
12373602	3479	Boyd NF	The association of breast mitogens with mammographic densities.	British journal of cancer	2002	83
12843179	3479	BonafÃ¨ M	Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control.	The Journal of clinical endocrinology and metabolism	2003	84
12941837	3479	Maloney EK	An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.	Cancer research	2003	80
14563498	3479	Roubenoff R	Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study.	The American journal of medicine	2003	82
15069117	3479	Ma J	A prospective study of plasma C-peptide and colorectal cancer risk in men.	Journal of the National Cancer Institute	2004	78
15509939	3479	Eppley BL	Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing.	Plastic and reconstructive surgery	2004	126
16002437	3479	Miller BF	Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise.	The Journal of physiology	2005	102
16537681	3479	IbÃ¡Ã±ez L	Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children.	The Journal of clinical endocrinology and metabolism	2006	72
16702379	3479	Missmer SA	Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period.	Cancer epidemiology, biomarkers and prevention 	2006	65
16772322	3479	Petrella JK	Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women.	American journal of physiology. Endocrinology and metabolism	2006	64
17332988	3479	Chen J	Retinopathy of prematurity.	Angiogenesis	2007	123
17617058	3479	Geraghty KM	Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR.	The Biochemical journal	2007	56
18003755	3479	HyppÃ¶nen E	25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort.	Diabetes	2008	88
18172327	3479	Gunter MJ	Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.	Cancer research	2008	66
18316725	3479	Suh Y	Functionally significant insulin-like growth factor I receptor mutations in centenarians.	Proceedings of the National Academy of Sciences of the United States of America	2008	227
18398032	3479	Gunter MJ	A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.	Cancer epidemiology, biomarkers and prevention 	2008	63
18591391	3479	Forouhi NG	Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.	Diabetes	2008	134
18838726	3479	Roddam AW	Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.	Annals of internal medicine	2008	76
18843793	3479	Fontana L	Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans.	Aging cell	2008	82
19064975	3479	Wolpin BM	Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.	Journal of clinical oncology 	2009	56
19116382	3479	Gunter MJ	Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.	Journal of the National Cancer Institute	2009	129
19366899	3479	Beltran PJ	AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells.	Molecular cancer therapeutics	2009	49
19786654	3479	Tolcher AW	Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.	Journal of clinical oncology 	2009	103
19810099	3479	Rinaldi S	Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.	International journal of cancer	2010	44
19904628	3479	Fontana L	Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production.	Age	2010	56
20065132	3479	Baker LD	Effects of aerobic exercise on mild cognitive impairment: a controlled trial.	Archives of neurology	2010	199
20197302	3479	Perrini S	The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.	The Journal of endocrinology	2010	62
20371689	3479	Kurzrock R	A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors.	Clinical cancer research 	2010	67
20621847	3479	Boas M	Childhood exposure to phthalates: associations with thyroid function, insulin-like growth factor I, and growth.	Environmental health perspectives	2010	48
20843485	3479	Gonzalez CA	Diet and cancer prevention: Contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.	European journal of cancer	2010	52
21403984	3479	Fortier LA	The role of growth factors in cartilage repair.	Clinical orthopaedics and related research	2011	81
21641545	3479	Kunkel SD	mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass.	Cell metabolism	2011	50
21722657	3479	Griffin ÃW	Aerobic exercise improves hippocampal function and increases BDNF in the serum of young adult males.	Physiology and behavior	2011	56
21741057	3479	Sienkiewicz E	Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women.	Metabolism	2011	41
21911725	3479	Kaseb AO	Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.	Journal of clinical oncology 	2011	39
22025154	3479	Juergens H	Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.	Journal of clinical oncology 	2011	57
22184397	3479	Malempati S	Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.	Journal of clinical oncology 	2012	56
22840388	3479	Fine EJ	Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients.	Nutrition	2012	32
23123199	3479	Voss MW	Neurobiological markers of exercise-related brain plasticity in older adults.	Brain, behavior, and immunity	2013	62
23956055	3479	Weigel B	Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.	Pediatric blood and cancer	2014	26
25208878	3479	Jones RL	Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors.	Clinical cancer research 	2015	21
2835680	3553	Michie HR	Detection of circulating tumor necrosis factor after endotoxin administration.	The New England journal of medicine	1988	218
8787820	3553	Blum-Degen D	Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.	Neuroscience letters	1995	120
9141509	3553	Vgontzas AN	Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.	The Journal of clinical endocrinology and metabolism	1997	141
9925898	3553	Ostrowski K	Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans.	The Journal of physiology	1999	105
10404912	3553	Ranieri VM	Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.	JAMA	1999	224
10608764	3553	Gogos CA	Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.	The Journal of infectious diseases	2000	116
11058758	3553	Fournier T	Alpha-1-acid glycoprotein.	Biochimica et biophysica acta	2000	114
11982604	3553	Baize S	Inflammatory responses in Ebola virus-infected patients.	Clinical and experimental immunology	2002	95
12235117	3553	Maedler K	Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.	The Journal of clinical investigation	2002	229
12606524	3553	Spranger J	Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.	Diabetes	2003	249
12957433	3553	Gielen S	Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure.	Journal of the American College of Cardiology	2003	81
14581396	3553	Mazurek T	Human epicardial adipose tissue is a source of inflammatory mediators.	Circulation	2003	266
16284605	3553	Demircan N	Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.	Eye	2006	76
16330726	3553	Kiecolt-Glaser JK	Hostile marital interactions, proinflammatory cytokine production, and wound healing.	Archives of general psychiatry	2005	121
17475444	3553	Steptoe A	The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis.	Brain, behavior, and immunity	2007	228
18262644	3553	Challier JC	Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta.	Placenta	2008	129
18385818	3553	Prasad AS	Zinc in human health: effect of zinc on immune cells.	Molecular medicine	2008	64
18484740	3553	Fichorova RN	Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study.	Analytical chemistry	2008	56
19156204	3553	Ng LF	IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.	PloS one	2009	65
19364880	3553	Lachmann HJ	In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes.	The Journal of experimental medicine	2009	68
19542207	3553	Larsen CM	Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.	Diabetes care	2009	87
19692116	3553	Richette P	Gout.	Lancet	2010	95
19706826	3553	Bower JE	Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer.	Clinical cancer research 	2009	80
19842207	3553	Zhang JY	Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.	Hepatology	2010	89
20398920	3553	Hastie AT	Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes.	The Journal of allergy and clinical immunology	2010	88
20705131	3553	Ashwood P	Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.	Brain, behavior, and immunity	2011	120
21159789	3553	Skulas-Ray AC	Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.	The American journal of clinical nutrition	2011	51
21297467	3553	Boden G	Obesity, insulin resistance and free fatty acids.	Current opinion in endocrinology, diabetes, and obesity	2011	127
21796103	3553	Hannestad J	The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis.	Neuropsychopharmacology 	2011	100
21906753	3553	Pandey GN	Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims.	Journal of psychiatric research	2012	46
22195044	3553	Mitroulis I	Neutrophil extracellular trap formation is associated with IL-1Î² and autophagy-related signaling in gout.	PloS one	2011	58
22521247	3553	Philbin VJ	Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.	The Journal of allergy and clinical immunology	2012	32
22699305	3553	Gullestad L	Inflammatory cytokines in heart failure: mediators and markers.	Cardiology	2012	38
22925832	3553	Rethorst CD	Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.	Molecular psychiatry	2013	29
22993202	3553	Duboc H	Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.	Gut	2013	61
23110185	3553	Keshari RS	Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition.	PloS one	2012	31
23360282	3553	Gola H	Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells.	BMC psychiatry	2013	33
23436686	3553	Pallet N	A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells.	Proteomics	2013	26
23557933	3553	TomÃ©-Carneiro J	One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.	Pharmacological research	2013	38
23904163	3553	Farrera C	Macrophage clearance of neutrophil extracellular traps is a silent process.	Journal of immunology	2013	51
24497828	3553	Sereti I	Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.	PLoS pathogens	2014	32
24634448	3553	Braun HJ	The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy.	The American journal of sports medicine	2014	24
24845688	3553	Ferguson KK	Urinary phthalate metabolite associations with biomarkers of inflammation and oxidative stress across pregnancy in Puerto Rico.	Environmental science and technology	2014	23
24901329	3553	Kumar RG	Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury.	The Journal of head trauma rehabilitation	2015	27
24978137	3553	Ye SB	Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.	Oncotarget	2014	44
25057045	3553	Dinh DM	Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.	The Journal of infectious diseases	2015	56
25649144	3553	CriÈan TO	Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra.	Annals of the rheumatic diseases	2016	13
2444978	3569	Gauldie J	Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.	Proceedings of the National Academy of Sciences of the United States of America	1987	261
8609343	3569	Torre-Amione G	Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).	Journal of the American College of Cardiology	1996	134
9041933	3569	Tak PP	Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity.	Arthritis and rheumatism	1997	115
9389420	3569	Pickup JC	NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.	Diabetologia	1997	150
9398739	3569	Mohamed-Ali V	Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.	The Journal of clinical endocrinology and metabolism	1997	276
9506738	3569	Fried SK	Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.	The Journal of clinical endocrinology and metabolism	1998	272
9704787	3569	Gomez R	The fetal inflammatory response syndrome.	American journal of obstetrics and gynecology	1998	161
9769329	3569	Fishman D	The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.	The Journal of clinical investigation	1998	297
10366160	3569	Ferrucci L	Serum IL-6 level and the development of disability in older persons.	Journal of the American Geriatrics Society	1999	177
10720054	3569	Vgontzas AN	Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.	The Journal of clinical endocrinology and metabolism	2000	180
10815894	3569	Almand B	Clinical significance of defective dendritic cell differentiation in cancer.	Clinical cancer research 	2000	144
11022058	3569	Vila N	Proinflammatory cytokines and early neurological worsening in ischemic stroke.	Stroke	2000	103
11080265	3569	Steensberg A	Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6.	The Journal of physiology	2000	120
11287357	3569	Kern PA	Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2001	280
11445664	3569	Vozarova B	Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.	Obesity research	2001	86
11983728	3569	Visser M	Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study.	The journals of gerontology. Series A, Biological sciences and medical sciences	2002	178
11994345	3569	Bastard JP	Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.	The Journal of clinical endocrinology and metabolism	2002	90
12177370	3569	Weaver JD	Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.	Neurology	2002	114
12379575	3569	Esposito K	Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.	Circulation	2002	268
12393667	3569	Silliman CC	Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.	Blood	2003	94
12473005	3569	Ferrucci L	Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels.	Journal of the American Geriatrics Society	2002	123
12626436	3569	Starkie R	Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans.	FASEB journal 	2003	96
12857678	3569	Steensberg A	IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.	American journal of physiology. Endocrinology and metabolism	2003	107
12872236	3569	Pieper R	The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins.	Proteomics	2003	79
12883485	3569	Kugelmas M	Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.	Hepatology	2003	82
12932356	3569	Jego G	Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.	Immunity	2003	263
14567964	3569	Raper SE	Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.	Molecular genetics and metabolism	2003	272
14960743	3569	Petersen KF	Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.	The New England journal of medicine	2004	463
15057738	3569	Ito H	A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.	Gastroenterology	2004	96
15150588	3569	Michalaki V	Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer.	British journal of cancer	2004	73
15229336	3569	Vendrell J	Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.	Obesity research	2004	78
15313862	3569	St John MA	Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.	Archives of otolaryngology--head and neck surgery	2004	80
15356039	3569	Vgontzas AN	Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist.	The Journal of clinical endocrinology and metabolism	2004	79
15644641	3569	Parsons PE	Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.	Critical care medicine	2005	155
15705924	3569	Alesci S	Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications.	The Journal of clinical endocrinology and metabolism	2005	67
15886319	3569	Kemna E	Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.	Blood	2005	105
15893251	3569	Vgontzas AN	Sleep apnea is a manifestation of the metabolic syndrome.	Sleep medicine reviews	2005	68
15942443	3569	Loguercio C	Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.	Journal of clinical gastroenterology	2005	87
16046295	3569	Di Gregorio GB	Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.	Diabetes	2005	111
16052591	3569	Roelofs MF	The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.	Arthritis and rheumatism	2005	72
16120716	3569	Minoguchi K	Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.	American journal of respiratory and critical care medicine	2005	85
16236847	3569	Donaldson GC	Airway and systemic inflammation and decline in lung function in patients with COPD.	Chest	2005	86
16412224	3569	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	121
16613757	3569	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	383
16737350	3569	Yang RZ	Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.	PLoS medicine	2006	69
16849509	3569	Levy O	The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.	Journal of immunology	2006	71
16864705	3569	Angelone DF	Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.	Pediatric research	2006	61
16870211	3569	O'Brien SM	Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.	Journal of psychiatric research	2007	62
16927176	3569	KnÃ¼pfer H	Significance of interleukin-6 (IL-6) in breast cancer (review).	Breast cancer research and treatment	2007	108
16946190	3569	Pace TW	Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.	The American journal of psychiatry	2006	172
16949415	3569	Andrews WW	The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants.	American journal of obstetrics and gynecology	2006	64
17003332	3569	Carey AL	Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.	Diabetes	2006	134
17090751	3569	Creely SJ	Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.	American journal of physiology. Endocrinology and metabolism	2007	160
17114290	3569	Petersen KF	Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.	Proceedings of the National Academy of Sciences of the United States of America	2006	82
17170049	3569	de Jager W	Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.	Annals of the rheumatic diseases	2007	62
17287468	3569	Fontana L	Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.	Diabetes	2007	203
17446340	3569	TÃ¶rnqvist H	Persistent endothelial dysfunction in humans after diesel exhaust inhalation.	American journal of respiratory and critical care medicine	2007	94
17698689	3569	Kellum JA	Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.	Archives of internal medicine	2007	172
17716366	3569	Jeschke MG	Burn size determines the inflammatory and hypermetabolic response.	Critical care	2007	58
17825619	3569	Gozal D	Systemic inflammation in non-obese children with obstructive sleep apnea.	Sleep medicine	2008	51
18235097	3569	Grigoryev DN	The local and systemic inflammatory transcriptome after acute kidney injury.	Journal of the American Society of Nephrology 	2008	70
18458677	3569	Bull SJ	Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.	Molecular psychiatry	2009	73
18536030	3569	Duffy SA	Interleukin-6 predicts recurrence and survival among head and neck cancer patients.	Cancer	2008	83
18628464	3569	Dhillon N	Phase II trial of curcumin in patients with advanced pancreatic cancer.	Clinical cancer research 	2008	197
18633101	3569	Reyna SM	Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.	Diabetes	2008	90
18689695	3569	Balkau B	Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).	Diabetes care	2008	55
18728182	3569	Pichiorri F	MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2008	184
18753925	3569	Strategies for Management of Anti-Retroviral Therapy/INSIGHT.	Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.	AIDS	2008	81
18771602	3569	Kauer-Sant'Anna M	Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.	The international journal of neuropsychopharmacology	2009	49
18784373	3569	Nishimoto N	Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease.	Blood	2008	80
18791359	3569	Jeschke MG	Pathophysiologic response to severe burn injury.	Annals of surgery	2008	137
18926322	3569	Martin SS	Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease.	Journal of the American College of Cardiology	2008	92
18975322	3569	Weinblatt ME	Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial.	Arthritis and rheumatism	2008	77
19018268	3569	Suzuki S	Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects.	Journal of cerebral blood flow and metabolism 	2009	53
19118018	3569	Ara T	Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.	Cancer research	2009	51
19126626	3569	Lee CG	Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study.	The Journal of clinical endocrinology and metabolism	2009	50
19259271	3569	KlÃ¶ting N	MicroRNA expression in human omental and subcutaneous adipose tissue.	PloS one	2009	69
19267406	3569	Wong VW	High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.	International journal of cancer	2009	57
19268915	3569	Lindqvist D	Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.	Biological psychiatry	2009	93
19318968	3569	Tarantino G	Could inflammatory markers help diagnose nonalcoholic steatohepatitis?	European journal of gastroenterology and hepatology	2009	46
19470921	3569	Willett CG	Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.	Journal of clinical oncology 	2009	144
19497986	3569	Lehrke M	Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.	European journal of endocrinology	2009	48
19581928	3569	Sullivan NJ	Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.	Oncogene	2009	166
19585655	3569	Marra F	Adipokines in liver diseases.	Hepatology	2009	93
19650110	3569	Pricola KL	Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism.	Journal of cellular biochemistry	2009	53
19678756	3569	Rodger AJ	Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.	The Journal of infectious diseases	2009	63
19781428	3569	FÃ¶rhÃ©cz Z	Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.	American heart journal	2009	76
19828697	3569	Funderburg NT	Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.	Blood	2010	89
19833726	3569	Roca H	CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization.	The Journal of biological chemistry	2009	128
19898853	3569	KnÃ¼pfer H	Serum interleukin-6 levels in colorectal cancer patients--a summary of published results.	International journal of colorectal disease	2010	56
20055989	3569	Determann RM	Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial.	Critical care	2010	92
20112381	3569	Illei GG	Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.	Arthritis and rheumatism	2010	78
20176930	3569	Cole SW	Computational identification of gene-social environment interaction at the human IL6 locus.	Proceedings of the National Academy of Sciences of the United States of America	2010	91
20215499	3569	Germano G	Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.	Cancer research	2010	52
20335016	3569	Ara T	Interleukin-6 in bone metastasis and cancer progression.	European journal of cancer	2010	80
20353817	3569	Wang XS	Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.	Brain, behavior, and immunity	2010	49
20435656	3569	Stapleton RD	The association between BMI and plasma cytokine levels in patients with acute lung injury.	Chest	2010	41
20446847	3569	Kalayjian RC	Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.	The Journal of infectious diseases	2010	56
20581244	3569	Wong VW	Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.	Gut	2010	87
20583924	3569	Uldrick TS	An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.	Clinical infectious diseases 	2010	59
20629534	3569	Cassol E	Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.	The Journal of infectious diseases	2010	73
20644113	3569	Song SN	Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.	Blood	2010	41
20664016	3569	Brown TT	Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.	Diabetes care	2010	60
20816981	3569	Stannus O	Circulating levels of IL-6 and TNF-Î± are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults.	Osteoarthritis and cartilage	2010	45
21042596	3569	Bertola A	Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.	PloS one	2010	47
21185346	3569	Maes M	The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.	Progress in neuro-psychopharmacology and biological psychiatry	2011	62
21245574	3569	Hassman LM	KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.	The Journal of clinical investigation	2011	36
21248066	3569	Hung IF	Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.	Clinical infectious diseases 	2011	37
21321193	3569	Chihara N	Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21343371	3569	Anglesio MS	IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.	Clinical cancer research 	2011	55
21414532	3569	Silvain J	Composition of coronary thrombus in acute myocardial infarction.	Journal of the American College of Cardiology	2011	43
21505312	3569	Marchetti G	Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.	AIDS	2011	64
21576701	3569	Piconi S	Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.	Blood	2011	50
21619709	3569	Lane D	Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients.	BMC cancer	2011	37
21726511	3569	Sandler NG	Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.	Gastroenterology	2011	90
21784145	3569	Kiecolt-Glaser JK	Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial.	Brain, behavior, and immunity	2011	41
21795409	3569	Coward J	Interleukin-6 as a therapeutic target in human ovarian cancer.	Clinical cancer research 	2011	90
21801431	3569	Chen DY	Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-Î± therapy.	Arthritis research and therapy	2011	36
21809006	3569	Niu Q	Disturbed Th17/Treg balance in patients with rheumatoid arthritis.	Rheumatology international	2012	33
21873546	3569	Armitage AE	Hepcidin regulation by innate immune and infectious stimuli.	Blood	2011	69
21964948	3569	Zeng C	The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.	Journal of molecular medicine	2012	36
22022504	3569	Lee N	Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.	PloS one	2011	41
22159018	3569	Takai Y	Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract.	Investigative ophthalmology and visual science	2012	34
22197776	3569	Andaluz-Ojeda D	A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis.	Cytokine	2012	31
22334567	3569	Antoniades CG	Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans.	Hepatology	2012	46
22416101	3569	Bakker OJ	Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial.	JAMA	2012	50
22511581	3569	Ho GY	Adipokines linking obesity with colorectal cancer risk in postmenopausal women.	Cancer research	2012	37
22527592	3569	IllÃ¡n-GÃ³mez F	Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery.	Obesity surgery	2012	31
22651903	3569	Guo Y	Interleukin-6 signaling pathway in targeted therapy for cancer.	Cancer treatment reviews	2012	135
22687336	3569	Hiles SA	A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity.	Brain, behavior, and immunity	2012	35
22698992	3569	Kesler S	Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors.	Brain, behavior, and immunity	2013	54
22743373	3569	Ostrowski SR	Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.	The journal of trauma and acute care surgery	2012	36
23034965	3569	Itariu BK	Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.	The American journal of clinical nutrition	2012	38
23038174	3569	MartÃ­nez I	Gut microbiome composition is linked to whole grain-induced immunological improvements.	The ISME journal	2013	54
23065151	3569	Funderburg NT	Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.	Blood	2012	73
23178647	3569	FÃ¼lster S	Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).	European heart journal	2013	30
23332012	3569	Longenecker CT	Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.	HIV medicine	2013	52
23348980	3569	Kruger P	A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.	American journal of respiratory and critical care medicine	2013	32
23390498	3569	Panchapakesan U	Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?	PloS one	2013	29
23407306	3569	Belenchia AM	Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial.	The American journal of clinical nutrition	2013	46
23482247	3569	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	44
23559466	3569	Erlandson KM	Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.	The Journal of infectious diseases	2013	46
23874201	3569	Chugh PE	Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.	PLoS pathogens	2013	29
24053309	3569	Nguyen DP	Inflammation and prostate cancer: the role of interleukin 6 (IL-6).	BJU international	2014	32
24065013	3569	Messier SP	Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial.	JAMA	2013	80
24117923	3569	Xiao S	A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.	FEMS microbiology ecology	2014	36
24346288	3569	Nagasaki T	Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.	British journal of cancer	2014	46
24370923	3569	Daniele G	The inflammatory status score including IL-6, TNF-Î±, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.	Acta diabetologica	2014	21
24378753	3569	Noel N	Elevated IP10 levels are associated with immune activation and low CD4âº T-cell counts in HIV controller patients.	AIDS	2014	28
24567119	3569	Brosseron F	Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.	Molecular neurobiology	2014	29
24618232	3569	Serra R	Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines.	International wound journal	2016	10
24622327	3569	Fajgenbaum DC	HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.	Blood	2014	34
24622416	3569	Gitelman SE	Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.	The lancet. Diabetes and endocrinology	2013	29
24708472	3569	Zheng G	Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.	Respiratory research	2014	29
24751614	3569	Pal M	From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation.	Immunology and cell biology	2014	30
24795473	3569	Tenorio AR	Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.	The Journal of infectious diseases	2014	99
24828436	3569	Bala S	Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.	PloS one	2014	38
25084831	3569	Darcy CJ	Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients.	Critical care	2014	20
25174587	3569	Wang QS	Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.	Molecular therapy 	2015	28
25196086	3569	Muniraj N	Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease.	International journal of rheumatic diseases	2017	7
25341798	3569	McLaughlin T	T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	31
25352269	3569	MichaÃ«lsson K	Milk intake and risk of mortality and fractures in women and men: cohort studies.	BMJ	2014	31
25387317	3569	Somsouk M	Gut epithelial barrier and systemic inflammation during chronic HIV infection.	AIDS	2015	26
25583168	3569	Hileman CO	Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.	The Journal of infectious diseases	2015	16
25593123	3569	Catoire M	The search for exercise factors in humans.	FASEB journal 	2015	16
25787249	3569	Puthanveetil P	Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.	Journal of cellular and molecular medicine	2015	18
25868978	3569	Deshmukh SK	Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation.	Oncotarget	2015	17
26121490	3569	Scicluna BP	A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission.	American journal of respiratory and critical care medicine	2015	16
26428501	3569	Kim CJ	Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.	American journal of obstetrics and gynecology	2015	26
26435067	3569	Wang D	The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.	Cellular and molecular immunology	2017	9
26858430	3569	Morris CJ	Circadian misalignment increases cardiovascular disease risk factors in humans.	Proceedings of the National Academy of Sciences of the United States of America	2016	16
26891037	3569	GutiÃ©rrez C	Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy.	AIDS	2016	15
27070405	3569	Coughlin JM	In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using (11)CDPA-713 PET and analysis of CSF and plasma.	Translational psychiatry	2016	14
27076371	3569	Teachey DT	Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.	Cancer discovery	2016	23
1551497	3630	Van Cauter E	Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.	Diabetes	1992	148
1671422	3630	McKeigue PM	Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians.	Lancet	1991	260
1954451	3630	Hales CN	Fetal and infant growth and impaired glucose tolerance at age 64.	BMJ	1991	360
2044434	3630	DeFronzo RA	Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.	Diabetes care	1991	373
2403659	3630	Shulman GI	Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.	The New England journal of medicine	1990	193
3056758	3630	Reaven GM	Banting lecture 1988. Role of insulin resistance in human disease.	Diabetes	1988	1192
3899825	3630	Matthews DR	Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.	Diabetologia	1985	4427
7624391	3630	Reaven GM	Pathophysiology of insulin resistance in human disease.	Physiological reviews	1995	131
7677463	3630	Pories WJ	Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.	Annals of surgery	1995	248
7738205	3630	Hotamisligil GS	Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.	The Journal of clinical investigation	1995	471
7935656	3630	Nolan JJ	Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.	The New England journal of medicine	1994	126
8247074	3630	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	204
8675698	3630	Roden M	Mechanism of free fatty acid-induced insulin resistance in humans.	The Journal of clinical investigation	1996	227
9303923	3630	Ferrannini E	Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).	The Journal of clinical investigation	1997	116
9509261	3630	Goodyear LJ	Exercise, glucose transport, and insulin sensitivity.	Annual review of medicine	1998	149
9920074	3630	Banerji MA	Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.	The Journal of clinical endocrinology and metabolism	1999	100
10189543	3630	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	180
10645822	3630	Hanson RL	Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.	American journal of epidemiology	2000	97
10896648	3630	Ross R	Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial.	Annals of internal medicine	2000	199
11289033	3630	Ryan EA	Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.	Diabetes	2001	90
11826410	3630	Pagano G	Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.	Hepatology	2002	105
11861436	3630	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2002	122
11872682	3630	Mayerson AB	The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.	Diabetes	2002	98
12086926	3630	Itani SI	Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.	Diabetes	2002	277
12136392	3630	Cryer PE	Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.	Diabetologia	2002	160
12196473	3630	Buchanan TA	Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.	Diabetes	2002	184
12399260	3630	Elliott SS	Fructose, weight gain, and the insulin resistance syndrome.	The American journal of clinical nutrition	2002	170
12540621	3630	Garvey WT	Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.	Diabetes	2003	93
12562574	3630	Ryan MC	Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.	The American journal of psychiatry	2003	104
12766131	3630	Cryer PE	Hypoglycemia in diabetes.	Diabetes care	2003	183
12953019	3630	Masuo K	Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.	Hypertension	2003	79
14623617	3630	McLaughlin T	Use of metabolic markers to identify overweight individuals who are insulin resistant.	Annals of internal medicine	2003	151
14633821	3630	Ascaso JF	Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.	Diabetes care	2003	82
14752837	3630	Promrat K	A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.	Hepatology	2004	112
14985484	3630	Bhargava SK	Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood.	The New England journal of medicine	2004	186
15161770	3630	Heise T	Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.	Diabetes	2004	76
15288712	3630	Benedict C	Intranasal insulin improves memory in humans.	Psychoneuroendocrinology	2004	106
15483088	3630	Korner J	Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin.	The Journal of clinical endocrinology and metabolism	2005	75
15564314	3630	Gershengorn MC	Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.	Science	2004	100
15602591	3630	Taheri S	Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index.	PLoS medicine	2004	428
15623819	3630	Apridonidze T	Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.	The Journal of clinical endocrinology and metabolism	2005	88
15630069	3630	Henderson DC	Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.	Archives of general psychiatry	2005	67
15734833	3630	Petersen KF	Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.	Diabetes	2005	183
15747110	3630	Bugianesi E	Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.	Diabetologia	2005	109
15951550	3630	Fartoux L	Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.	Gut	2005	73
16030278	3630	Ingelsson E	Insulin resistance and risk of congestive heart failure.	JAMA	2005	110
16155268	3630	Robertson MD	Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism.	The American journal of clinical nutrition	2005	69
16230722	3630	Heine RJ	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.	Annals of internal medicine	2005	142
16352795	3630	Stolzenberg-Solomon RZ	Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.	JAMA	2005	104
16371598	3630	Kiens B	Skeletal muscle lipid metabolism in exercise and insulin resistance.	Physiological reviews	2006	76
16388523	3630	Basaria S	Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy.	Cancer	2006	65
16434464	3630	Smith MR	Insulin sensitivity during combined androgen blockade for prostate cancer.	The Journal of clinical endocrinology and metabolism	2006	98
16456680	3630	Yki-JÃ¤rvinen H	Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.	Diabetologia	2006	83
16556766	3630	Wiederkehr A	Minireview: implication of mitochondria in insulin secretion and action.	Endocrinology	2006	69
16644702	3630	Clerk LH	Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.	Diabetes	2006	80
17145742	3630	Kahn SE	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.	The New England journal of medicine	2006	516
17158419	3630	LÃª KA	A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans.	The American journal of clinical nutrition	2006	76
17204604	3630	McLean AB	Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.	Stem cells	2007	124
17326548	3630	Jennings JR	Self-reported sleep quality is associated with the metabolic syndrome.	Sleep	2007	70
17507704	3630	Hovi P	Glucose regulation in young adults with very low birth weight.	The New England journal of medicine	2007	78
18158075	3630	Barnett AH	Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.	Clinical therapeutics	2007	62
18197184	3630	Trapp EG	The effects of high-intensity intermittent exercise training on fat loss and fasting insulin levels of young women.	International journal of obesity	2008	57
18285809	3630	Farrant HJ	Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size.	European journal of clinical nutrition	2009	48
18423592	3630	Weinstock M	The long-term behavioural consequences of prenatal stress.	Neuroscience and biobehavioral reviews	2008	167
18434349	3630	Macfarlane DP	Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.	The Journal of endocrinology	2008	64
18474251	3630	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	52
18502299	3630	Weng J	Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.	Lancet	2008	134
18682704	3630	Shaham O	Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity.	Molecular systems biology	2008	114
18769702	3630	Vos MB	Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.	Medscape journal of medicine	2008	90
18835745	3630	Ma J	Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.	The Lancet. Oncology	2008	106
18854399	3630	FernÃ¡ndez-Real JM	The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training.	The Journal of clinical endocrinology and metabolism	2009	51
19008343	3630	Haus JM	Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.	Diabetes	2009	104
19088155	3630	Cryer PE	Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.	The Journal of clinical endocrinology and metabolism	2009	102
19141606	3630	Maratou E	Studies of insulin resistance in patients with clinical and subclinical hypothyroidism.	European journal of endocrinology	2009	49
19175906	3630	Babraj JA	Extremely short duration high intensity interval training substantially improves insulin action in young healthy males.	BMC endocrine disorders	2009	61
19208729	3630	Teff KL	Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses.	The Journal of clinical endocrinology and metabolism	2009	78
19332493	3630	BrÃ¸ns C	Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.	The Journal of physiology	2009	50
19470610	3630	Helmerhorst HJ	Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity.	Diabetes	2009	65
19528367	3630	Wilding JP	A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.	Diabetes care	2009	80
19637289	3630	Johnson NA	Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.	Hepatology	2009	88
19712802	3630	Caminiti G	Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.	Journal of the American College of Cardiology	2009	56
19781131	3630	von Hurst PR	Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial.	The British journal of nutrition	2010	124
19915016	3630	Nadeau KJ	Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.	The Journal of clinical endocrinology and metabolism	2010	71
20123614	3630	Nelson JW	Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population.	Environmental health perspectives	2010	44
20357360	3630	Wentworth JM	Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity.	Diabetes	2010	106
20484490	3630	Preis SR	Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study.	The Journal of clinical endocrinology and metabolism	2010	62
21067784	3630	Stephens BR	Effects of 1 day of inactivity on insulin action in healthy men and women: interaction with energy intake.	Metabolism	2011	39
21115858	3630	Duggan C	Associations of insulin resistance and adiponectin with mortality in women with breast cancer.	Journal of clinical oncology 	2011	60
21159388	3630	Tiganis T	Reactive oxygen species and insulin resistance: the good, the bad and the ugly.	Trends in pharmacological sciences	2011	44
21170321	3630	Fiehn O	Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women.	PloS one	2010	83
21216854	3630	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	36
21270174	3630	Birkeland KI	Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.	Diabetes care	2011	40
21298090	3630	Lee DH	Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes.	PloS one	2011	78
21367930	3630	Steil GM	The effect of insulin feedback on closed loop glucose control.	The Journal of clinical endocrinology and metabolism	2011	49
21403394	3630	Rhee EP	Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.	The Journal of clinical investigation	2011	117
21614570	3630	Camastra S	Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.	Diabetologia	2011	37
21617108	3630	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Diabetes care	2011	65
21617152	3630	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2011	56
21930939	3630	Kumashiro N	Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.	Proceedings of the National Academy of Sciences of the United States of America	2011	104
22065088	3630	Shah SH	Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss.	Diabetologia	2012	66
22124462	3630	Yu L	Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay.	Diabetes	2012	32
22431673	3630	Wilding JP	Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.	Annals of internal medicine	2012	81
22496545	3630	Buxton OM	Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption.	Science translational medicine	2012	138
22521071	3630	Heller S	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	72
22521072	3630	Garber AJ	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	70
22974438	3630	Rorsman P	Regulation of insulin secretion in human pancreatic islets.	Annual review of physiology	2013	74
23043166	3630	Zinman B	Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).	Diabetes care	2012	62
23166346	3630	Ho M	Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis.	Pediatrics	2012	62
23223406	3630	Pisprasert V	Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.	Diabetes care	2013	28
23274890	3630	Gao H	Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study.	Diabetes	2013	25
23359039	3630	Haidar A	Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.	CMAJ 	2013	34
23368510	3630	Kapitza C	Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin.	Diabetes, obesity and metabolism	2013	31
23393185	3630	Mathieu C	Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.	The Journal of clinical endocrinology and metabolism	2013	38
23594269	3630	Baudrand R	High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome.	Clinical endocrinology	2014	22
23847240	3630	Wolpin BM	Hyperglycemia, insulin resistance, impaired pancreatic Î²-cell function, and risk of pancreatic cancer.	Journal of the National Cancer Institute	2013	30
23897112	3630	Thambisetty M	Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.	JAMA neurology	2013	31
24172179	3630	Scherer J	Issues in hypertriglyceridemic pancreatitis: an update.	Journal of clinical gastroenterology	2014	27
24316517	3630	Vrieze A	Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.	Journal of hepatology	2014	48
24463448	3630	Merovci A	Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.	The Journal of clinical investigation	2014	93
24519298	3630	Wang G	Preterm birth and random plasma insulin levels at birth and in early childhood.	JAMA	2014	23
25002497	3630	Davies SK	Effect of sleep deprivation on the human metabolome.	Proceedings of the National Academy of Sciences of the United States of America	2014	46
25056438	3630	Chondronikola M	Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans.	Diabetes	2014	93
25114296	3630	Buse JB	Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).	Diabetes care	2014	27
25303484	3630	Chen X	Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance.	The Journal of clinical endocrinology and metabolism	2015	26
25754552	3630	Cederberg H	Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.	Diabetologia	2015	35
26706022	3630	Akkasheh G	Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.	Nutrition	2016	18
27409811	3630	Pedersen HK	Human gut microbes impact host serum metabolome and insulin sensitivity.	Nature	2016	31
16528543	3934	Mishra J	Kidney NGAL is a novel early marker of acute injury following transplantation.	Pediatric nephrology	2006	73
17874137	3934	Hirsch R	NGAL is an early predictive biomarker of contrast-induced nephropathy in children.	Pediatric nephrology	2007	100
18070344	3934	Dent CL	Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study.	Critical care	2007	114
18337554	3934	Bennett M	Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study.	Clinical journal of the American Society of Nephrology 	2008	159
18379258	3934	Wheeler DS	Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.	Critical care medicine	2008	76
18649981	3934	Wagener G	Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery.	American journal of kidney diseases 	2008	53
19176795	3934	Bolignano D	Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2009	104
19850388	3934	Haase M	Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.	American journal of kidney diseases 	2009	231
19956924	3934	Bagshaw SM	Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness.	Intensive care medicine	2010	87
19956925	3934	Cruz DN	Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.	Intensive care medicine	2010	62
20056755	3934	McIlroy DR	Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.	Clinical journal of the American Society of Nephrology 	2010	44
20123318	3934	Aghel A	Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.	Journal of cardiac failure	2010	54
20406069	3934	Devarajan P	Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.	Biomarkers in medicine	2010	54
20458050	3934	Batchelor TT	Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.	Journal of clinical oncology 	2010	136
20609093	3934	Devarajan P	Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury.	Nephrology	2010	66
20935115	3934	de Geus HR	Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.	American journal of respiratory and critical care medicine	2011	60
21300375	3934	Krawczeski CD	Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass.	The Journal of pediatrics	2011	42
21511111	3934	Haase M	The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.	Journal of the American College of Cardiology	2011	133
21576334	3934	Bachman MA	Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.	Infection and immunity	2011	51
21791540	3934	Maisel AS	Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.	European journal of heart failure	2011	41
22580944	3934	Chowdhury AH	A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyteÂ® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.	Annals of surgery	2012	72
23375078	3934	Singer E	Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications.	Acta physiologica	2013	28
24518531	3934	Haase-Fielitz A	Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status.	Annals of clinical biochemistry	2014	38
25311702	3934	Liu KD	Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.	American journal of kidney diseases 	2015	18
26880194	3934	Zhang A	Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis.	Critical care	2016	14
27209269	3934	Zarbock A	Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.	JAMA	2016	35
8616722	3952	Schwartz MW	Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans.	Nature medicine	1996	117
8684156	3952	Caro JF	Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance.	Lancet	1996	126
9202122	3952	Montague CT	Congenital leptin deficiency is associated with severe early-onset obesity in humans.	Nature	1997	361
9288733	3952	Masuzaki H	Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans.	Nature medicine	1997	116
10546697	3952	Heymsfield SB	Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.	JAMA	1999	203
11124751	3952	Fung TT	Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk.	The American journal of clinical nutrition	2001	121
11342529	3952	Yamagishi SI	Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A.	The Journal of biological chemistry	2001	97
11856796	3952	Oral EA	Leptin-replacement therapy for lipodystrophy.	The New England journal of medicine	2002	197
12393845	3952	Farooqi IS	Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.	The Journal of clinical investigation	2002	281
12727933	3952	Chan JL	The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men.	The Journal of clinical investigation	2003	102
14514348	3952	Silha JV	Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.	European journal of endocrinology	2003	88
14709639	3952	Chan KC	Size distributions of maternal and fetal DNA in maternal plasma.	Clinical chemistry	2004	74
15181085	3952	Teff KL	Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.	The Journal of clinical endocrinology and metabolism	2004	139
15583226	3952	Spiegel K	Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite.	Annals of internal medicine	2004	457
16445991	3952	Uher R	Cerebral processing of food-related stimuli: effects of fasting and gender.	Behavioural brain research	2006	64
17228054	3952	Chaput JP	Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study.	Obesity	2007	99
18564298	3952	Schmid SM	A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men.	Journal of sleep research	2008	63
19166821	3952	Greco SJ	Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.	Biochemical and biophysical research communications	2009	54
19223908	3952	Wu MH	Circulating levels of leptin, adiposity and breast cancer risk.	British journal of cancer	2009	56
19910504	3952	Li H	A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.	Clinical chemistry	2010	40
20009056	3952	Lieb W	Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.	JAMA	2009	93
20413520	3952	Mente A	Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance.	Diabetes care	2010	44
20453022	3952	Simpson NS	Sleep restriction is associated with increased morning plasma leptin concentrations, especially in women.	Biological research for nursing	2010	42
21471283	3952	Benedict C	Acute sleep deprivation reduces energy expenditure in healthy men.	The American journal of clinical nutrition	2011	50
21494606	3952	Mueller K	Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging.	PloS one	2011	41
22040697	3952	Procaccini C	Leptin as an immunomodulator.	Molecular aspects of medicine	2012	57
22595228	3952	de Boer TN	Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage.	Osteoarthritis and cartilage	2012	39
22935803	3952	Coppari R	Leptin revisited: its mechanism of action and potential for treating diabetes.	Nature reviews. Drug discovery	2012	65
23266767	3952	Yadav A	Role of leptin and adiponectin in insulin resistance.	Clinica chimica acta; international journal of clinical chemistry	2013	41
10639434	4153	Neth O	Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.	Infection and immunity	2000	100
16395391	4153	Garred P	Mannose-binding lectin and its genetic variants.	Genes and immunity	2006	80
18357343	4153	MacLennan CA	The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children.	The Journal of clinical investigation	2008	75
8018341	4353	Stolk J	Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol.	American journal of respiratory cell and molecular biology	1994	152
12952835	4353	Baldus S	Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.	Circulation	2003	145
17850484	4353	Nauseef WM	How human neutrophils kill and degrade microbes: an integrated view.	Immunological reviews	2007	186
19726691	4353	Undurti A	Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.	The Journal of biological chemistry	2009	50
20595643	4353	Basu A	Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.	Journal of the American College of Nutrition	2010	45
22158016	4353	Papakostas GI	Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.	Molecular psychiatry	2013	29
22267330	4353	Charles-Schoeman C	Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.	Annals of the rheumatic diseases	2012	34
22647055	4353	Zhao H	Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.	BMC gastroenterology	2012	36
23818485	4353	Borissoff JI	Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state.	Arteriosclerosis, thrombosis, and vascular biology	2013	36
25547404	4353	Mangold A	Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size.	Circulation research	2015	19
27036091	4353	Thieblemont N	Human neutrophils in auto-immunity.	Seminars in immunology	2016	12
7647779	4524	Frosst P	A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.	Nature genetics	1995	633
8616944	4524	Jacques PF	Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.	Circulation	1996	143
9067278	4524	Ma J	Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.	Cancer research	1997	106
9545395	4524	van der Put NM	A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?	American journal of human genetics	1998	194
10448523	4524	Selhub J	Homocysteine metabolism.	Annual review of nutrition	1999	168
12387655	4524	Klerk M	MTHFR 677C--&amp;gt;T polymorphism and risk of coronary heart disease: a meta-analysis.	JAMA	2002	125
15652605	4524	Casas JP	Homocysteine and stroke: evidence on a causal link from mendelian randomisation.	Lancet	2005	75
20446114	4524	Ueland PM	Choline and betaine in health and disease.	Journal of inherited metabolic disease	2011	52
20808944	4524	Devlin AM	Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth.	PloS one	2010	61
26689889	4524	Hainsworth AH	Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID).	Biochimica et biophysica acta	2016	10
17848650	4709	Jamison RL	Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.	JAMA	2007	88
17851649	4709	Yajnik CS	Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study.	Diabetologia	2008	91
19920236	4709	Ebbing M	Cancer incidence and mortality after treatment with folic acid and vitamin B12.	JAMA	2009	65
24398331	4709	Price S	Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.	Blood	2014	23
27431367	4709	Smith AD	Homocysteine, B Vitamins, and Cognitive Impairment.	Annual review of nutrition	2016	12
10791374	4879	Troughton RW	Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.	Lancet	2000	128
12225726	4879	Redfield MM	Plasma brain natriuretic peptide concentration: impact of age and gender.	Journal of the American College of Cardiology	2002	105
12628948	4879	Anand IS	Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).	Circulation	2003	83
14769680	4879	Wang TJ	Impact of obesity on plasma natriuretic peptide levels.	Circulation	2004	124
15716560	4879	Kragelund C	N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.	The New England journal of medicine	2005	73
17448376	4879	Jourdain P	Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.	Journal of the American College of Cardiology	2007	67
18760965	4879	Maisel A	State of the art: using natriuretic peptide levels in clinical practice.	European journal of heart failure	2008	87
25424852	4879	Rodon J	First-in-human dose study of the novel transforming growth factor-Î² receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma.	Clinical cancer research 	2015	31
25444145	4879	Tang WH	Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.	Journal of the American College of Cardiology	2014	50
25881932	4879	Cheng ML	Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics.	Journal of the American College of Cardiology	2015	19
15564564	4982	Collin-Osdoby P	Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin.	Circulation research	2004	76
9513736	5020	Modahl C	Plasma oxytocin levels in autistic children.	Biological psychiatry	1998	133
16046364	5020	Grewen KM	Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact.	Psychosomatic medicine	2005	71
17958710	5020	Feldman R	Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding.	Psychological science	2007	115
19632787	5020	Domes G	Effects of intranasal oxytocin on emotional face processing in women.	Psychoneuroendocrinology	2010	120
20153585	5020	Feldman R	Natural variations in maternal and paternal care are associated with systematic changes in oxytocin following parent-infant contact.	Psychoneuroendocrinology	2010	83
20424014	5020	Taylor SE	Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?	Psychological science	2010	43
20947304	5020	Rubin LH	Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.	Schizophrenia research	2010	47
21562482	5020	Skrundz M	Plasma oxytocin concentration during pregnancy is associated with development of postpartum depression.	Neuropsychopharmacology 	2011	48
21636661	5020	Szeto A	Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin.	Psychosomatic medicine	2011	47
21676095	5020	Feldman R	Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding.	Developmental science	2011	62
21881566	5020	Atzil S	Specifying the neurobiological basis of human attachment: brain, hormones, and behavior in synchronous and intrusive mothers.	Neuropsychopharmacology 	2011	50
22336563	5020	Feldman R	Sensitive parenting is associated with plasma oxytocin and polymorphisms in the OXTR and CD38 genes.	Biological psychiatry	2012	70
22999263	5020	Weisman O	Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety.	Psychoneuroendocrinology	2013	25
23325323	5020	Feldman R	Parental oxytocin and early caregiving jointly shape children's oxytocin response and social reciprocity.	Neuropsychopharmacology 	2013	34
23413037	5020	Miller M	Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms.	Autism research 	2013	28
23665533	5020	McCullough ME	Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?	Neuroscience and biobehavioral reviews	2013	57
24845176	5020	Modi ME	Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.	Psychoneuroendocrinology	2014	30
25092315	5020	Parker KJ	Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.	Proceedings of the National Academy of Sciences of the United States of America	2014	31
25349162	5020	Carson DS	Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.	Molecular psychiatry	2015	23
12515680	5091	Longnecker MP	Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment.	Environmental health perspectives	2003	76
16002372	5091	Schisterman EF	Lipid adjustment in the analysis of environmental contaminants and human health risks.	Environmental health perspectives	2005	113
19320182	5091	Patterson DG Jr	Levels in the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements.	Environmental science and technology	2009	51
19558692	5091	Fan TW	Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM).	Molecular cancer	2009	101
19654916	5091	Turyk M	Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers.	Environmental health perspectives	2009	45
21997443	5091	Govarts E	Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a meta-analysis within 12 European Birth Cohorts.	Environmental health perspectives	2012	60
23151773	5091	Buck Louis GM	Persistent environmental pollutants and couple fecundity: the LIFE study.	Environmental health perspectives	2013	37
14764795	5228	Thadhani R	First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.	The Journal of clinical endocrinology and metabolism	2004	84
14764923	5228	Levine RJ	Circulating angiogenic factors and the risk of preeclampsia.	The New England journal of medicine	2004	529
18669461	5228	Rini BI	Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.	Journal of clinical oncology 	2008	110
19850276	5228	Verlohren S	An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.	American journal of obstetrics and gynecology	2010	55
22000672	5228	Verlohren S	The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.	American journal of obstetrics and gynecology	2012	35
22261192	5228	Rana S	Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.	Circulation	2012	58
22433027	5228	Kleinrouweler CE	Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.	BJOG 	2012	32
22495259	5228	Andraweera PH	The vascular endothelial growth factor family in adverse pregnancy outcomes.	Human reproduction update	2012	30
26735990	5228	Zeisler H	Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.	The New England journal of medicine	2016	19
11502812	5443	Vgontzas AN	Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.	The Journal of clinical endocrinology and metabolism	2001	108
12764219	5443	Schommer NC	Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress.	Psychosomatic medicine	2003	76
15039002	5443	Barr CS	Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques.	Biological psychiatry	2004	111
17408865	5443	Wilhelm I	Is the cortisol awakening rise a response to awakening?	Psychoneuroendocrinology	2007	64
17662255	5443	Carpenter LL	Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment.	Biological psychiatry	2007	115
15835926	5444	Khersonsky O	Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.	Biochemistry	2005	69
18349088	5444	Bhattacharyya T	Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.	JAMA	2008	119
7658481	5617	Hankinson SE	Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women.	Journal of the National Cancer Institute	1995	140
11071707	5617	Rothman RB	Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.	Synapse	2001	213
16489055	5617	Tworoger SS	Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.	Cancer research	2006	70
23783576	5617	Tworoger SS	A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.	Cancer research	2013	35
24677189	5617	Peuskens J	The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.	CNS drugs	2014	21
9661593	5741	Khosla S	Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.	The Journal of clinical endocrinology and metabolism	1998	146
11238511	5741	Lips P	A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.	The Journal of clinical endocrinology and metabolism	2001	91
11297596	5741	Pfeifer M	Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.	The Journal of clinical endocrinology and metabolism	2001	112
11493580	5741	Lips P	Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.	Endocrine reviews	2001	254
12081584	5741	Chertow GM	Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.	Kidney international	2002	183
12456735	5741	Iannuzzi-Sucich M	Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.	The journals of gerontology. Series A, Biological sciences and medical sciences	2002	107
14500805	5741	Finkelstein JS	The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.	The New England journal of medicine	2003	109
14671166	5741	Visser M	Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.	The Journal of clinical endocrinology and metabolism	2003	120
15001609	5741	Parikh SJ	The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults.	The Journal of clinical endocrinology and metabolism	2004	116
15176987	5741	Bekker PJ	A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.	Journal of bone and mineral research 	2004	113
15284307	5741	Block GA	Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.	Journal of the American Society of Nephrology 	2004	404
15698460	5741	Young EW	Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.	Kidney international	2005	115
15769903	5741	Hodsman AB	Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.	Endocrine reviews	2005	98
15797954	5741	Holick MF	Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.	The Journal of clinical endocrinology and metabolism	2005	151
15855256	5741	Snijder MB	Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women.	The Journal of clinical endocrinology and metabolism	2005	116
16278362	5741	Steingrimsdottir L	Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.	JAMA	2005	76
16563471	5741	Lips P	Vitamin D physiology.	Progress in biophysics and molecular biology	2006	166
16600341	5741	Zittermann A	Vitamin D and disease prevention with special reference to cardiovascular disease.	Progress in biophysics and molecular biology	2006	79
16738536	5741	Melamed ML	Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.	Kidney international	2006	78
17091124	5741	Levin A	Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.	Kidney international	2007	242
17339618	5741	Greenspan SL	Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.	Annals of internal medicine	2007	67
17452740	5741	Houston DK	Association between vitamin D status and physical performance: the InCHIANTI study.	The journals of gerontology. Series A, Biological sciences and medical sciences	2007	60
17805238	5741	Russo D	The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.	Kidney international	2007	66
18088161	5741	Cranney A	Effectiveness and safety of vitamin D in relation to bone health.	Evidence report/technology assessment	2007	106
18458202	5741	Hoogendijk WJ	Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults.	Archives of general psychiatry	2008	59
18492750	5741	Romagnoli E	Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.	The Journal of clinical endocrinology and metabolism	2008	54
18667733	5741	Regidor DL	Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.	Journal of the American Society of Nephrology 	2008	53
18689399	5741	Aloia JF	African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox.	The American journal of clinical nutrition	2008	57
18838623	5741	Forman JP	Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women.	Hypertension	2008	86
19451355	5741	HagstrÃ¶m E	Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.	Circulation	2009	82
19594303	5741	Priemel M	Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients.	Journal of bone and mineral research 	2010	56
19965540	5741	Oliveira RB	Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?	Clinical journal of the American Society of Nephrology 	2010	94
20139235	5741	Viljakainen HT	Maternal vitamin D status determines bone variables in the newborn.	The Journal of clinical endocrinology and metabolism	2010	46
20593414	5741	JÃ¼ppner H	FGF-23: More than a regulator of renal phosphate handling?	Journal of bone and mineral research 	2010	44
20614473	5741	Kalantar-Zadeh K	Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.	Journal of bone and mineral research 	2010	46
20631407	5741	Isakova T	Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.	Nephrology, dialysis, transplantation 	2011	44
20814967	5741	Cosman F	Effects of intravenous zoledronic acid plus subcutaneous teriparatide rhPTH(1-34) in postmenopausal osteoporosis.	Journal of bone and mineral research 	2011	43
20848081	5741	GutiÃ©rrez OM	Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey.	Osteoporosis international 	2011	68
20861820	5741	Wesseling-Perry K	Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.	Kidney international	2011	47
20950166	5741	Bashutski JD	Teriparatide and osseous regeneration in the oral cavity.	The New England journal of medicine	2010	46
21159838	5741	Sai AJ	Relationship between vitamin D, parathyroid hormone, and bone health.	The Journal of clinical endocrinology and metabolism	2011	39
21183586	5741	Moe SM	Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2011	65
21389978	5741	Isakova T	Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.	Kidney international	2011	205
21406649	5741	Palmer SC	Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.	JAMA	2011	121
21625888	5741	Ardawi MS	High prevalence of vitamin D deficiency among healthy Saudi Arabian men: relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors.	Osteoporosis international 	2012	37
21939825	5741	Kestenbaum B	Vitamin D, parathyroid hormone, and cardiovascular events among older adults.	Journal of the American College of Cardiology	2011	52
22052943	5741	Wesseling-Perry K	Early skeletal and biochemical alterations in pediatric chronic kidney disease.	Clinical journal of the American Society of Nephrology 	2012	33
22431675	5741	Gallagher JC	Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.	Annals of internal medicine	2012	51
23129826	5741	Pavik I	Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.	Nephrology, dialysis, transplantation 	2013	31
23243213	5741	Scialla JJ	Mineral metabolites and CKD progression in African Americans.	Journal of the American Society of Nephrology 	2013	28
23922354	5741	Bouillon R	Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine.	The Journal of clinical endocrinology and metabolism	2013	38
24690624	5741	Theodoratou E	Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials.	BMJ	2014	104
25162666	5741	Eastell R	Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.	The Journal of clinical endocrinology and metabolism	2014	23
25646793	5741	Yu EW	Two-year changes in bone density after Roux-en-Y gastric bypass surgery.	The Journal of clinical endocrinology and metabolism	2015	16
24476432	5806	Cunha C	Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.	The New England journal of medicine	2014	45
17065684	5950	Cho YM	Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.	Diabetes care	2006	81
17595259	5950	Yao-Borengasser A	Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.	The Journal of clinical endocrinology and metabolism	2007	57
18316031	5950	Isken A	RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome.	Cell metabolism	2008	68
21782034	5950	Berry DC	Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis.	Biochimica et biophysica acta	2012	35
21835764	5950	Kotnik P	RBP4: a controversial adipokine.	European journal of endocrinology	2011	43
23023528	5950	Mata NL	Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration.	Retina	2013	28
23105095	5950	Alapatt P	Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).	The Journal of biological chemistry	2013	27
24670599	5950	Pirazzi C	PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.	Human molecular genetics	2014	34
2195340	5972	Levine B	Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.	The New England journal of medicine	1990	235
6382011	5972	Cohn JN	Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.	The New England journal of medicine	1984	292
10432325	5972	Sort P	Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.	The New England journal of medicine	1999	143
12614096	5972	Grumbach MM	Management of the clinically inapparent adrenal mass ("incidentaloma").	Annals of internal medicine	2003	85
15837256	5972	Milliez P	Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.	Journal of the American College of Cardiology	2005	138
16157788	5972	Cornelissen VA	Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors.	Hypertension	2005	88
17161262	5972	Rossi GP	A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.	Journal of the American College of Cardiology	2006	107
17372031	5972	Forman JP	Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.	Hypertension	2007	204
17942703	5972	Bodyak N	Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.	Proceedings of the National Academy of Sciences of the United States of America	2007	72
19289633	5972	BÃ¶ger RH	Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.	Circulation	2009	61
20515678	5972	Tomaschitz A	Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.	Clinica chimica acta; international journal of clinical chemistry	2010	43
23121378	5972	Parving HH	Cardiorenal end points in a trial of aliskiren for type 2 diabetes.	The New England journal of medicine	2012	133
23558162	5972	He FJ	Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.	BMJ	2013	123
23633321	5972	He FJ	Effect of longer-term modest salt reduction on blood pressure.	The Cochrane database of systematic reviews	2013	35
23753408	5972	Savard S	Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.	Hypertension	2013	33
24334175	5972	Cherney DZ	Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.	Circulation	2014	105
24343093	5972	Hsu TW	Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.	JAMA internal medicine	2014	28
25595565	5972	Goicoechea M	Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.	American journal of kidney diseases 	2015	31
1549777	6462	Cunningham CC	Actin-binding protein requirement for cortical stability and efficient locomotion.	Science	1992	149
7202083	6462	SÃ¶dergÃ¥rd R	Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature.	Journal of steroid biochemistry	1982	232
8757191	6462	Gann PH	Prospective study of sex hormone levels and risk of prostate cancer.	Journal of the National Cancer Institute	1996	115
10523012	6462	Vermeulen A	A critical evaluation of simple methods for the estimation of free testosterone in serum.	The Journal of clinical endocrinology and metabolism	1999	437
11158037	6462	Harman SM	Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.	The Journal of clinical endocrinology and metabolism	2001	316
12928347	6462	Key TJ	Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.	Journal of the National Cancer Institute	2003	232
15482761	6462	Jensen TK	Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men.	Fertility and sterility	2004	78
15900045	6462	Kaaks R	Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).	Journal of the National Cancer Institute	2005	88
16322344	6462	Kaaks R	Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.	Endocrine-related cancer	2005	121
16394089	6462	Kupelian V	Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.	The Journal of clinical endocrinology and metabolism	2006	78
16537739	6462	Ding EL	Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.	JAMA	2006	235
17148559	6462	Travison TG	The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men.	The Journal of clinical endocrinology and metabolism	2007	63
18230794	6462	Endogenous Hormones and Prostate Cancer Collaborative Group.	Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.	Journal of the National Cancer Institute	2008	137
18518773	6462	MellstrÃ¶m D	Older men with low serum estradiol and high serum SHBG have an increased risk of fractures.	Journal of bone and mineral research 	2008	58
19211133	6462	Meeker JD	Polybrominated diphenyl ether (PBDE) concentrations in house dust are related to hormone levels in men.	The Science of the total environment	2009	48
19261274	6462	Chavarro JE	Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic.	Fertility and sterility	2010	53
19584177	6462	LeBlanc ES	The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men.	The Journal of clinical endocrinology and metabolism	2009	48
19657112	6462	Ding EL	Sex hormone-binding globulin and risk of type 2 diabetes in women and men.	The New England journal of medicine	2009	139
20525905	6462	Bhasin S	Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.	The Journal of clinical endocrinology and metabolism	2010	243
20573783	6462	Krassas GE	Thyroid function and human reproductive health.	Endocrine reviews	2010	91
22614972	6462	Campbell KL	Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial.	Journal of clinical oncology 	2012	37
23283524	6462	Zhang X	Postmenopausal plasma sex hormone levels and breast cancer risk over 20Â years of follow-up.	Breast cancer research and treatment	2013	42
23425925	6462	Camacho EM	Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.	European journal of endocrinology	2013	36
20691429	6530	Hannestad J	Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.	Biological psychiatry	2010	50
23583454	6530	Eshleman AJ	Substituted methcathinones differ in transporter and receptor interactions.	Biochemical pharmacology	2013	45
24048210	6530	Pietrzak RH	Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.	JAMA psychiatry	2013	26
9126740	6531	Volkow ND	Relationship between subjective effects of cocaine and dopamine transporter occupancy.	Nature	1997	130
9417971	6531	Gunn RN	Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.	NeuroImage	1997	167
9537821	6531	Tatsumi M	Pharmacological profile of antidepressants and related compounds at human monoamine transporters.	European journal of pharmacology	1997	121
9763484	6531	McCann UD	Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with 11CWIN-35,428.	The Journal of neuroscience 	1998	123
9766762	6531	Volkow ND	Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.	The American journal of psychiatry	1998	112
10649826	6531	Heinz A	Genotype influences in vivo dopamine transporter availability in human striatum.	Neuropsychopharmacology 	2000	116
10823899	6531	Saunders C	Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2000	99
11160455	6531	Volkow ND	Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.	The Journal of neuroscience 	2001	104
11229977	6531	Volkow ND	Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.	The American journal of psychiatry	2001	223
11292651	6531	Lee FJ	Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.	FASEB journal 	2001	88
11911442	6531	Fuke S	The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.	The pharmacogenomics journal	2001	90
15024426	6531	Khoshbouei H	N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.	PLoS biology	2004	80
15590952	6531	Fahn S	Levodopa and the progression of Parkinson's disease.	The New England journal of medicine	2004	180
15872345	6531	van Dyck CH	Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene.	Journal of nuclear medicine 	2005	80
16192352	6531	Rueda MR	Training, maturation, and genetic influences on the development of executive attention.	Proceedings of the National Academy of Sciences of the United States of America	2005	154
16309561	6531	VanNess SH	The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density.	BMC genetics	2005	73
16518646	6531	Johanson CE	Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers.	Psychopharmacology	2006	65
16943558	6531	Sasaki A	Social context-dependent singing-regulated dopamine.	The Journal of neuroscience 	2006	72
17267664	6531	Bolan EA	D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.	Molecular pharmacology	2007	63
17825265	6531	Howell LL	Monoamine transporters and psychostimulant addiction.	Biochemical pharmacology	2008	55
18413464	6531	Schwarzschild MA	Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.	Archives of neurology	2008	66
18617632	6531	Binda F	Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.	Molecular pharmacology	2008	53
19091889	6531	van de Giessen E	Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3.	Journal of nuclear medicine 	2009	48
19293415	6531	Volkow ND	Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.	JAMA	2009	127
19478460	6531	Kurian MA	Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.	The Journal of clinical investigation	2009	50
19590691	6531	Ritz BR	Dopamine transporter genetic variants and pesticides in Parkinson's disease.	Environmental health perspectives	2009	57
19738093	6531	Volkow ND	Evaluating dopamine reward pathway in ADHD: clinical implications.	JAMA	2009	129
19890261	6531	Franke B	Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.	Neuropsychopharmacology 	2010	46
20048223	6531	Nakamura K	Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.	Archives of general psychiatry	2010	68
20846908	6531	Iranzo A	Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study corrected.	The Lancet. Neurology	2010	47
22514303	6531	Sakrikar D	Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.	The Journal of neuroscience 	2012	39
23065479	6531	Dale RC	Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.	Brain 	2012	43
23170765	6531	Cameron KN	Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.	British journal of pharmacology	2013	32
23371489	6531	Cameron K	Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.	Psychopharmacology	2013	29
24102293	6531	Calipari ES	Extended access of cocaine self-administration results in tolerance to the dopamine-elevating and locomotor-stimulating effects of cocaine.	Journal of neurochemistry	2014	21
24911152	6531	Hansen FH	Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.	The Journal of clinical investigation	2014	21
26171719	6531	Hryhorczuk C	Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.	Neuropsychopharmacology 	2016	13
8632190	6532	Heils A	Allelic variation of human serotonin transporter gene expression.	Journal of neurochemistry	1996	376
8929413	6532	Lesch KP	Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.	Science	1996	867
11602621	6532	Eddahibi S	Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.	The Journal of clinical investigation	2001	100
11803458	6532	Bennett AJ	Early experience and serotonin transporter gene variation interact to influence primate CNS function.	Molecular psychiatry	2002	135
12130784	6532	Hariri AR	Serotonin transporter genetic variation and the response of the human amygdala.	Science	2002	485
12869766	6532	Caspi A	Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.	Science	2003	1436
12973026	6532	Ichise M	Linearized reference tissue parametric imaging methods: application to 11CDASB positron emission tomography studies of the serotonin transporter in human brain.	Journal of cerebral blood flow and metabolism 	2003	143
15188158	6532	Coates MD	Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.	Gastroenterology	2004	161
15563601	6532	Kaufman J	Social supports and serotonin transporter gene moderate depression in maltreated children.	Proceedings of the National Academy of Sciences of the United States of America	2004	187
15592465	6532	Heinz A	Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter.	Nature neuroscience	2005	164
15635638	6532	Feinn R	Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2005	74
15699291	6532	Hariri AR	A susceptibility gene for affective disorders and the response of the human amygdala.	Archives of general psychiatry	2005	217
15867106	6532	Kendler KS	The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication.	Archives of general psychiatry	2005	165
15880108	6532	Pezawas L	5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.	Nature neuroscience	2005	483
16154545	6532	Surtees PG	Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder.	Biological psychiatry	2006	76
16212676	6532	SjÃ¶berg RL	Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene.	The international journal of neuropsychopharmacology	2006	70
16389202	6532	Sekine Y	Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.	Archives of general psychiatry	2006	76
16390888	6532	Parsey RV	Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain.	The American journal of psychiatry	2006	73
16402131	6532	Wendland JR	Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531.	Molecular psychiatry	2006	168
16442081	6532	Hariri AR	Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing.	Biological psychiatry	2006	101
16530463	6532	Hariri AR	Genetics of emotional regulation: the role of the serotonin transporter in neural function.	Trends in cognitive sciences	2006	195
16606791	6532	Eddahibi S	Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.	Circulation	2006	62
16642437	6532	Hu XZ	Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.	American journal of human genetics	2006	307
16934775	6532	Taylor SE	Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology.	Biological psychiatry	2006	120
17146470	6532	Serretti A	Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.	Molecular psychiatry	2007	96
17406646	6532	Dannlowski U	5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression.	Neuropsychopharmacology 	2008	51
17700575	6532	Uher R	The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis.	Molecular psychiatry	2008	149
17956909	6532	Kish SJ	Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.	Brain 	2008	67
17974934	6532	Kilpatrick DG	The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults.	The American journal of psychiatry	2007	113
18005940	6532	Gotlib IH	HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.	Biological psychiatry	2008	136
18458203	6532	Eaton WW	Population-based study of first onset and chronicity in major depressive disorder.	Archives of general psychiatry	2008	72
18546120	6532	MunafÃ² MR	5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2009	62
18687345	6532	Spiller R	Serotonin and GI clinical disorders.	Neuropharmacology	2008	66
18691701	6532	MunafÃ² MR	Gene X environment interactions at the serotonin transporter locus.	Biological psychiatry	2009	164
18801474	6532	Lotrich FE	Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.	Biological psychiatry	2009	61
18824000	6532	Murphy DL	How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.	Neuropharmacology	2008	61
18957375	6532	Prasad HC	Enhanced activity of human serotonin transporter variants associated with autism.	Philosophical transactions of the Royal Society of London. Series B, Biological sciences	2009	48
19207629	6532	Kochanska G	Interplay of genes and early mother-child relationship in the development of self-regulation from toddler to preschool age.	Journal of child psychology and psychiatry, and allied disciplines	2009	48
19213730	6532	Andersen J	Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.	The Journal of biological chemistry	2009	47
19228812	6532	Koenen KC	Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment.	American journal of epidemiology	2009	46
19324793	6532	Fox E	Looking on the bright side: biased attention and the human serotonin transporter gene.	Proceedings. Biological sciences	2009	57
19437301	6532	Gibb BE	Children's attentional biases and 5-HTTLPR genotype: potential mechanisms linking mother and child depression.	Journal of clinical child and adolescent psychology 	2009	49
19439600	6532	Pacheco J	Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism.	The Journal of neuroscience 	2009	51
19531786	6532	Risch N	Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.	JAMA	2009	439
19685963	6532	Beevers CG	Association of the serotonin transporter gene promoter region (5-HTTLPR) polymorphism with biased attention for emotional stimuli.	Journal of abnormal psychology	2009	61
19739105	6532	Beach SRH	Methylation at SLC6A4 is linked to family history of child abuse: an examination of the Iowa Adoptee sample.	American journal of medical genetics. Part B, Neuropsychiatric genetics 	2010	63
19864286	6532	Chiao JY	Culture-gene coevolution of individualism-collectivism and the serotonin transporter gene.	Proceedings. Biological sciences	2010	65
19884608	6532	Xie P	Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations.	Archives of general psychiatry	2009	86
20006325	6532	Way BM	The serotonin transporter promoter polymorphism is associated with cortisol response to psychosocial stress.	Biological psychiatry	2010	43
20231323	6532	Caspi A	Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits.	The American journal of psychiatry	2010	355
20398062	6532	Kinnally EL	Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques.	Genes, brain, and behavior	2010	54
20591416	6532	van IJzendoorn MH	Methylation matters: interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma.	Biological psychiatry	2010	48
21047622	6532	Homberg JR	Looking on the bright side of serotonin transporter gene variation.	Biological psychiatry	2011	93
21247998	6532	Johnson BA	Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.	The American journal of psychiatry	2011	52
21608084	6532	Koenen KC	SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder.	Depression and anxiety	2011	45
22745770	6532	Wang D	Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression.	PloS one	2012	33
22833190	6532	Hankin BL	Differential susceptibility in youth: evidence that 5-HTTLPR x positive parenting is associated with positive affect 'for better and worse'.	Translational psychiatry	2011	43
22945032	6532	Miller R	The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cortisol stress reactivity: a meta-analysis.	Molecular psychiatry	2013	31
23154100	6532	Bailer UF	Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.	Psychiatry research	2013	25
25086606	6532	Nikolova YS	Beyond genotype: serotonin transporter epigenetic modification predicts human brain function.	Nature neuroscience	2014	31
27049939	6532	Coleman JA	X-ray structures and mechanism of the human serotonin transporter.	Nature	2016	33
9091669	7018	Looker AC	Prevalence of iron deficiency in the United States.	JAMA	1997	146
9186882	7018	Hunsicker LG	Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.	Kidney international	1997	116
9600939	7018	Ren M	Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes.	Proceedings of the National Academy of Sciences of the United States of America	1998	168
12521995	7018	Cook JD	The quantitative assessment of body iron.	Blood	2003	103
16113265	7018	Hissen AH	The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence.	Infection and immunity	2005	70
19484405	7018	Anderson GJ	Mammalian iron transport.	Cellular and molecular life sciences 	2009	52
20201089	7018	Lu M	FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease.	American journal of hematology	2010	81
21348856	7018	Wang J	Regulation of cellular iron metabolism.	The Biochemical journal	2011	163
21855608	7018	Brissot P	Non-transferrin bound iron: a key role in iron overload and iron toxicity.	Biochimica et biophysica acta	2012	71
25060056	7018	Lewis JB	Ferric citrate controls phosphorus and delivers iron in patients on dialysis.	Journal of the American Society of Nephrology 	2015	24
26166707	7018	Gao M	Glutaminolysis and Transferrin Regulate Ferroptosis.	Molecular cell	2015	36
27941245	7018	Rapido F	Prolonged red cell storage before transfusion increases extravascular hemolysis.	The Journal of clinical investigation	2017	11
18801935	7038	Hoofnagle AN	Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.	Clinical chemistry	2008	76
19860577	7038	American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer.	Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.	Thyroid 	2009	970
26462967	7038	Haugen BR	2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.	Thyroid 	2016	328
11062477	8074	ADHR Consortium.	Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.	Nature genetics	2000	277
12711740	8074	Jonsson KB	Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.	The New England journal of medicine	2003	176
14633152	8074	Larsson T	Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.	Kidney international	2003	147
15284207	8074	Bai X	Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.	Endocrinology	2004	73
15590700	8074	Benet-PagÃ¨s A	An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.	Human molecular genetics	2005	113
15613425	8074	Ferrari SL	Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.	The Journal of clinical endocrinology and metabolism	2005	99
15917335	8074	Gutierrez O	Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.	Journal of the American Society of Nephrology 	2005	195
16735491	8074	Antoniucci DM	Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.	The Journal of clinical endocrinology and metabolism	2006	103
17063170	8074	Nishida Y	Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.	Kidney international	2006	60
17656479	8074	Fliser D	Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.	Journal of the American Society of Nephrology 	2007	169
17699549	8074	Perwad F	Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.	American journal of physiology. Renal physiology	2007	66
17710231	8074	Ichikawa S	A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.	The Journal of clinical investigation	2007	102
18687639	8074	GutiÃ©rrez OM	Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.	The New England journal of medicine	2008	368
19181315	8074	Mirza MA	Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.	Atherosclerosis	2009	90
19395730	8074	Jean G	High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.	Nephrology, dialysis, transplantation 	2009	73
19524924	8074	Mirza MA	Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.	Atherosclerosis	2009	85
20507943	8074	Wolf M	Forging forward with 10 burning questions on FGF23 in kidney disease.	Journal of the American Society of Nephrology 	2010	67
20525642	8074	Seiler S	FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment.	Nephrology, dialysis, transplantation 	2010	47
20966399	8074	Mirza MA	Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.	Arteriosclerosis, thrombosis, and vascular biology	2011	39
21030580	8074	Vervloet MG	Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.	Clinical journal of the American Society of Nephrology 	2011	43
21436289	8074	Wolf M	Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.	Journal of the American Society of Nephrology 	2011	65
21880793	8074	Imel EA	Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.	The Journal of clinical endocrinology and metabolism	2011	45
21903574	8074	Kendrick J	FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.	Journal of the American Society of Nephrology 	2011	120
22034506	8074	GutiÃ©rrez OM	Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.	Clinical journal of the American Society of Nephrology 	2011	36
22109743	8074	Desjardins L	FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.	Osteoporosis international 	2012	50
22492635	8074	Lim K	Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.	Circulation	2012	99
22622492	8074	Wolf M	Update on fibroblast growth factor 23 in chronic kidney disease.	Kidney international	2012	59
22703926	8074	Ix JH	Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).	Journal of the American College of Cardiology	2012	82
22951890	8074	ÃrnlÃ¶v J	Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.	Kidney international	2013	36
23187128	8074	Smith RC	Circulating Î±Klotho influences phosphate handling by controlling FGF23 production.	The Journal of clinical investigation	2012	32
23389416	8074	Scialla JJ	Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.	Kidney international	2013	54
23505057	8074	Wolf M	Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.	Journal of bone and mineral research 	2013	44
24686452	8074	Scialla JJ	Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.	Nature reviews. Nephrology	2014	25
25967123	8074	Isakova T	Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.	Journal of the American Society of Nephrology 	2015	17
25971439	8074	Chonchol M	Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study.	Journal of the American Society of Nephrology 	2016	13
26059012	8074	Moe SM	Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.	Circulation	2015	23
10092513	9370	Arita Y	Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.	Biochemical and biophysical research communications	1999	684
10845877	9370	Hotta K	Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.	Arteriosclerosis, thrombosis, and vascular biology	2000	433
10982546	9370	Ouchi N	Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway.	Circulation	2000	273
11222466	9370	Ouchi N	Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages.	Circulation	2001	182
11334417	9370	Hotta K	Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.	Diabetes	2001	131
11502817	9370	Yang WS	Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.	The Journal of clinical endocrinology and metabolism	2001	125
11752030	9370	Zoccali C	Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.	Journal of the American Society of Nephrology 	2002	91
12354786	9370	Vasseur F	Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.	Human molecular genetics	2002	94
12524229	9370	Kumada M	Association of hypoadiponectinemia with coronary artery disease in men.	Arteriosclerosis, thrombosis, and vascular biology	2003	215
12540592	9370	Tschritter O	Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.	Diabetes	2003	94
12611609	9370	DÃ­ez JJ	The role of the novel adipocyte-derived hormone adiponectin in human disease.	European journal of endocrinology	2003	150
12687327	9370	Cnop M	Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.	Diabetologia	2003	242
12736161	9370	Bruun JM	Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans.	American journal of physiology. Endocrinology and metabolism	2003	103
12829629	9370	Iwaki M	Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.	Diabetes	2003	133
12860835	9370	Ouchi N	Association of hypoadiponectinemia with impaired vasoreactivity.	Hypertension	2003	83
12878598	9370	Waki H	Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.	The Journal of biological chemistry	2003	173
14654554	9370	Miyoshi Y	Association of serum adiponectin levels with breast cancer risk.	Clinical cancer research 	2003	103
14699128	9370	Pajvani UB	Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.	The Journal of biological chemistry	2004	226
14752031	9370	Kobayashi H	Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin.	Circulation research	2004	125
15001594	9370	Mantzoros C	Adiponectin and breast cancer risk.	The Journal of clinical endocrinology and metabolism	2004	116
15096450	9370	Kumada M	Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages.	Circulation	2004	108
15123570	9370	Iwashima Y	Hypoadiponectinemia is an independent risk factor for hypertension.	Hypertension	2004	111
15181024	9370	Goldstein BJ	Adiponectin: A novel adipokine linking adipocytes and vascular function.	The Journal of clinical endocrinology and metabolism	2004	105
15502375	9370	Ryo M	Adiponectin as a biomarker of the metabolic syndrome.	Circulation journal 	2004	102
16157772	9370	Kistorp C	Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.	Circulation	2005	107
16288122	9370	Wei EK	Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.	Journal of the National Cancer Institute	2005	120
16380500	9370	Lara-Castro C	Adiponectin multimeric complexes and the metabolic syndrome trait cluster.	Diabetes	2006	103
16464169	9370	Okamoto Y	Adiponectin: a key adipocytokine in metabolic syndrome.	Clinical science	2006	86
16651465	9370	Ohashi K	Adiponectin replenishment ameliorates obesity-related hypertension.	Hypertension	2006	95
16732021	9370	Hara K	Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome.	Diabetes care	2006	104
17192291	9370	KÃ¶rner A	Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies.	The Journal of clinical endocrinology and metabolism	2007	57
17213279	9370	Tworoger SS	Plasma adiponectin concentrations and risk of incident breast cancer.	The Journal of clinical endocrinology and metabolism	2007	80
17224929	9370	CÃ´tÃ© M	Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.	International journal of obesity	2007	67
17227956	9370	Potenza MA	EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.	American journal of physiology. Endocrinology and metabolism	2007	59
17374708	9370	Anderson PD	Innate immunity modulates adipokines in humans.	The Journal of clinical endocrinology and metabolism	2007	56
17495599	9370	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	61
18202126	9370	Schraw T	Plasma adiponectin complexes have distinct biochemical characteristics.	Endocrinology	2008	53
18265479	9370	Barb D	Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.	The American journal of clinical nutrition	2007	97
18503774	9370	Ratziu V	Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.	Gastroenterology	2008	97
19079714	9370	Hugo ER	Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes.	Environmental health perspectives	2008	104
19083400	9370	Kajiyama S	Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.	Nutrition research	2008	61
19106328	9370	Liu E	Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults.	The Journal of nutrition	2009	69
19138981	9370	Zakikhani M	The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase.	Cancer prevention research	2008	72
19584347	9370	Li S	Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis.	JAMA	2009	215
19756488	9370	Finucane FM	Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals.	Diabetologia	2009	60
20018283	9370	Heid IM	Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals.	Atherosclerosis	2010	57
21040935	9370	Polyzos SA	Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.	Metabolism	2011	38
21084397	9370	MannerÃ¥s-Holm L	Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.	The Journal of clinical endocrinology and metabolism	2011	40
21734787	9370	Buechler C	Adiponectin, a key adipokine in obesity related liver diseases.	World journal of gastroenterology	2011	50
22226221	9370	Wronska A	Structural and biochemical characteristics of various white adipose tissue depots.	Acta physiologica	2012	59
22306490	9370	Halldorsson TI	Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study.	Environmental health perspectives	2012	46
22508243	9370	Savard C	Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.	Hepatology	2013	45
22837379	9370	Sideleva O	Obesity and asthma: an inflammatory disease of adipose tissue not the airway.	American journal of respiratory and critical care medicine	2012	42
26978208	9370	Tyrrell J	Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight.	JAMA	2016	19
16963244	9933	Chalon S	Omega-3 fatty acids and monoamine neurotransmission.	Prostaglandins, leukotrienes, and essential fatty acids	2006	67
22282329	9933	Wu JH	Association of plasma phospholipid long-chain Ï-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.	Circulation	2012	41
23546563	9933	Mozaffarian D	Plasma phospholipid long-chain Ï-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.	Annals of internal medicine	2013	40
23843441	9933	Brasky TM	Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.	Journal of the National Cancer Institute	2013	52
24351702	9933	de Oliveira Otto MC	Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.	Journal of the American Heart Association	2013	27
25897862	9933	Fasano E	Long-chain n-3 PUFA against breast and prostate cancer: Which are the appropriate doses for intervention studies in animals and humans?	Critical reviews in food science and nutrition	2017	5
26068959	9933	Hooper L	Reduction in saturated fat intake for cardiovascular disease.	The Cochrane database of systematic reviews	2015	30
15579727	10135	Ye SQ	Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury.	American journal of respiratory and critical care medicine	2005	92
15604363	10135	Fukuhara A	Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.	Science	2005	272
16186392	10135	Berndt J	Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.	Diabetes	2005	87
16234302	10135	Chen MP	Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2006	79
16414972	10135	Otero M	Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.	Annals of the rheumatic diseases	2006	81
17237424	10135	Moschen AR	Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.	Journal of immunology	2007	132
18081738	10135	Jarrar MH	Adipokines and cytokines in non-alcoholic fatty liver disease.	Alimentary pharmacology and therapeutics	2008	69
18093861	10135	Antuna-Puente B	Adipokines: the missing link between insulin resistance and obesity.	Diabetes and metabolism	2008	108
20847813	10135	Wang Z	Inflammation, a link between obesity and cardiovascular disease.	Mediators of inflammation	2010	67
21377179	10135	Jorge ML	The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus.	Metabolism	2011	41
23102619	10135	Yoshino J	Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.	Cell metabolism	2012	76
12839961	10406	HellstrÃ¶m I	The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.	Cancer research	2003	133
15161682	10406	Lu KH	Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.	Clinical cancer research 	2004	109
16343244	10406	Bast RC Jr	New tumor markers: CA125 and beyond.	International journal of gynecological cancer 	2005	102
18061248	10406	Moore RG	The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.	Gynecologic oncology	2008	116
18851871	10406	Moore RG	A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.	Gynecologic oncology	2009	117
19337252	10406	Huhtinen K	Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.	British journal of cancer	2009	49
20042715	10406	Anderson GL	Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.	Journal of the National Cancer Institute	2010	65
20368574	10406	Yurkovetsky Z	Development of a multimarker assay for early detection of ovarian cancer.	Journal of clinical oncology 	2010	71
20471625	10406	Moore RG	Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.	American journal of obstetrics and gynecology	2010	53
21304524	10406	Van Gorp T	HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.	British journal of cancer	2011	48
17108811	10599	Pasanen MK	SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.	Pharmacogenetics and genomics	2006	79
19785645	10599	Kalliokoski A	Impact of OATP transporters on pharmacokinetics.	British journal of pharmacology	2009	113
19901119	10599	TreviÃ±o LR	Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.	Journal of clinical oncology 	2009	81
21178985	10599	Donnelly LA	Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.	Clinical pharmacology and therapeutics	2011	39
21245207	10599	Niemi M	Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake.	Pharmacological reviews	2011	88
23233662	10599	Ramsey LB	Genome-wide study of methotrexate clearance replicates SLCO1B1.	Blood	2013	29
23942138	10599	Carr DF	SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.	Clinical pharmacology and therapeutics	2013	27
10398604	10673	Moore PA	BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.	Science	1999	235
11407690	10673	Cheema GS	Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.	Arthritis and rheumatism	2001	142
12427767	10673	Mackay F	BAFF AND APRIL: a tutorial on B cell survival.	Annual review of immunology	2003	198
12525388	10673	Mariette X	The level of BLyS (BAFF) correlates with the titre of autoantibodies in human SjÃ¶gren's syndrome.	Annals of the rheumatic diseases	2003	86
12566413	10673	Scapini P	G-CSF-stimulated neutrophils are a prominent source of functional BLyS.	The Journal of experimental medicine	2003	81
14673998	10673	Stohl W	B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.	Arthritis and rheumatism	2003	86
15070697	10673	Moreaux J	BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.	Blood	2004	106
15353552	10673	Moir S	Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.	The Journal of experimental medicine	2004	75
16477017	10673	Gottenberg JE	Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary SjÃ¶gren's syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2006	113
17433868	10673	Mackay F	B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.	Current opinion in immunology	2007	61
17942754	10673	Bossen C	TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.	Blood	2008	81
17947475	10673	Sarantopoulos S	High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.	Clinical cancer research 	2007	65
18668552	10673	Petri M	Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.	Arthritis and rheumatism	2008	70
19168788	10673	Sarantopoulos S	Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.	Blood	2009	86
19483719	10673	Doreau A	Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.	Nature immunology	2009	171
19521398	10673	Mackay F	Cracking the BAFF code.	Nature reviews. Immunology	2009	202
20039404	10673	Jacobi AM	Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.	Arthritis and rheumatism	2010	45
20683439	10673	Voulgarelis M	Pathogenetic mechanisms in the initiation and perpetuation of SjÃ¶gren's syndrome.	Nature reviews. Rheumatology	2010	43
21482945	10673	Pellkofer HL	Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.	Neurology	2011	39
22275291	10673	Stohl W	Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.	Arthritis and rheumatism	2012	43
22325903	10673	Ginzler EM	Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial.	Arthritis research and therapy	2012	34
22736090	10673	Brkic Z	Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.	Annals of the rheumatic diseases	2013	28
23299618	10673	Yates NL	HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.	Mucosal immunology	2013	33
24363401	10673	Kitko CL	Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.	Blood	2014	25
24504026	10673	Jourdan M	IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.	Leukemia	2014	22
25630041	10673	Wada NI	The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.	AIDS	2015	50
1373735	10959	Grunfeld C	Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.	The Journal of clinical endocrinology and metabolism	1992	150
1967191	10959	Fahey JL	The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.	The New England journal of medicine	1990	152
2467383	10959	Larder BA	HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.	Science	1989	301
3643678	10959	Gelderblom HR	Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.	Virology	1987	159
6189183	10959	BarrÃ©-Sinoussi F	Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).	Science	1983	1031
7509000	10959	Richman DD	Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.	Journal of virology	1994	131
7887550	10959	Mellors JW	Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.	Annals of internal medicine	1995	158
12960819	10959	Fiebig EW	Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.	AIDS	2003	363
20702636	10959	Wright JK	Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.	Journal of virology	2010	43
9828245	11093	Furlan M	von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.	The New England journal of medicine	1998	153
9828246	11093	Tsai HM	Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.	The New England journal of medicine	1998	158
11586351	11093	Levy GG	Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.	Nature	2001	235
12393397	11093	Dong JF	ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.	Blood	2002	166
12637323	11093	Vesely SK	ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.	Blood	2003	82
15801961	11093	Kokame K	FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.	British journal of haematology	2005	88
18574040	11093	Sadler JE	Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.	Blood	2008	64
20032506	11093	Kremer Hovinga JA	Survival and relapse in patients with thrombotic thrombocytopenic purpura.	Blood	2010	64
20686117	11093	George JN	How I treat patients with thrombotic thrombocytopenic purpura: 2010.	Blood	2010	52
21902819	11093	Loirat C	Atypical hemolytic uremic syndrome.	Orphanet journal of rare diseases	2011	94
9613910	22796	Downs JR	Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.	JAMA	1998	444
16316964	22796	Pischon T	Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.	Circulation	2005	74
17030687	22796	Kastelein JJ	Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.	Circulation	2006	62
18423809	22796	Qunibi W	A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.	American journal of kidney diseases 	2008	53
19571328	22796	Dubuc G	A new method for measurement of total plasma PCSK9: clinical applications.	Journal of lipid research	2010	46
20525997	22796	Welder G	High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol.	Journal of lipid research	2010	43
23083789	22796	Ference BA	Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.	Journal of the American College of Cardiology	2012	61
23141812	22796	Koren MJ	Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study.	Lancet	2012	39
24468148	22796	Gylling H	Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.	Atherosclerosis	2014	33
17068132	26291	Kharitonenkov A	The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.	Endocrinology	2007	153
18252893	26291	Zhang X	Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.	Diabetes	2008	164
18680716	26291	GÃ¤lman C	The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.	Cell metabolism	2008	110
19487637	26291	Chavez AO	Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.	Diabetes care	2009	63
19702724	26291	Mraz M	Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.	Clinical endocrinology	2009	58
20451522	26291	Dushay J	Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.	Gastroenterology	2010	102
20675007	26291	Li H	Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.	Journal of hepatology	2010	66
20730630	26291	Itoh N	Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.	Cell and tissue research	2010	46
21820356	26291	Suomalainen A	FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.	The Lancet. Neurology	2011	53
25083607	26291	Fisher FM	Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.	Gastroenterology	2014	29
25577300	26291	Chen S	Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.	Digestive and liver disease 	2015	18
25685689	26291	Dushay JR	Fructose ingestion acutely stimulates circulating FGF21 levels in humans.	Molecular metabolism	2015	29
9237695	26503	Kalayanarooj S	Early clinical and laboratory indicators of acute dengue illness.	The Journal of infectious diseases	1997	108
14499785	26503	Harrison SA	The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.	The American journal of gastroenterology	2003	85
18053320	26503	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	150
18291570	26503	Ozer J	The current state of serum biomarkers of hepatotoxicity.	Toxicology	2008	136
19043581	26503	Weissman JR	Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.	PloS one	2008	54
20815808	26503	Gui J	Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.	Clinical science	2011	67
22828276	26503	Cox CL	Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans.	Nutrition and metabolism	2012	30
22846613	26503	Bala S	Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection.	Journal of translational medicine	2012	42
22993296	26503	Pollock NR	A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing.	Science translational medicine	2012	38
23183526	26503	Suzuki Y	Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options.	Journal of hepatology	2013	47
23396737	26503	Wong VW	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.	Annals of hepatology	2013	39
23485521	26503	Bernstein DL	Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.	Journal of hepatology	2013	35
23928932	26503	Venkatesh SK	Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B.	European radiology	2014	30
24436062	26503	Konerman MA	Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.	Hepatology	2014	21
25349205	26503	Schulman G	Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.	Journal of the American Society of Nephrology 	2015	25
25645567	26503	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	16
12370282	57817	Nicolas G	The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.	The Journal of clinical investigation	2002	302
17475779	57817	De Domenico I	The molecular mechanism of hepcidin-mediated ferroportin down-regulation.	Molecular biology of the cell	2007	108
18166790	57817	Kemna EH	Hepcidin: from discovery to differential diagnosis.	Haematologica	2008	51
18628991	57817	Swinkels DW	Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry.	PloS one	2008	52
18689548	57817	Ganz T	Immunoassay for human serum hepcidin.	Blood	2008	151
19293425	57817	Theurl I	Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.	Blood	2009	74
21989113	57817	Kroot JJ	Hepcidin in human iron disorders: diagnostic implications.	Clinical chemistry	2011	36
22306005	57817	Ganz T	Hepcidin and iron homeostasis.	Biochimica et biophysica acta	2012	145
24204002	57817	Bacchetta J	Suppression of iron-regulatory hepcidin by vitamin D.	Journal of the American Society of Nephrology 	2014	21
25236655	57817	Vater A	Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer(Â®) therapeutics.	Drug discovery today	2015	16
26314490	57817	Lopez A	Iron deficiency anaemia.	Lancet	2016	19
6310399	94025	Bast RC Jr	A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.	The New England journal of medicine	1983	227
9728644	94025	Xu Y	Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.	JAMA	1998	105
11369781	94025	Yin BW	Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16.	The Journal of biological chemistry	2001	122
15547181	94025	Vasey PA	Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.	Journal of the National Cancer Institute	2004	84
18414853	94025	Cho H	Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment.	Cancer immunology, immunotherapy 	2009	101
18468571	94025	Nossov V	The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?	American journal of obstetrics and gynecology	2008	61
19395008	94025	Chi DS	Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.	Gynecologic oncology	2009	53
20888993	94025	Rustin GJ	Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.	Lancet	2010	72
24081806	94025	Wu XS	Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma.	Annals of surgical oncology	2014	21
24462730	94025	Williams KA	Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer.	Gynecologic oncology	2014	26
25707631	94025	Nick AM	A framework for a personalized surgical approach to ovarian cancer.	Nature reviews. Clinical oncology	2015	24
25964255	94025	Menon U	Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.	Journal of clinical oncology 	2015	24
12483741	114548	Aksentijevich I	De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.	Arthritis and rheumatism	2002	134
14872505	114548	Hawkins PN	Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.	Arthritis and rheumatism	2004	89
15541451	114548	Hoffman HM	Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.	Lancet	2004	130
16470011	114548	Dinarello CA	Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process.	The American journal of clinical nutrition	2006	77
16899778	114548	Goldbach-Mansky R	Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.	The New England journal of medicine	2006	182
18668535	114548	Hoffman HM	Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.	Arthritis and rheumatism	2008	108
19494217	114548	Lachmann HJ	Use of canakinumab in the cryopyrin-associated periodic syndrome.	The New England journal of medicine	2009	137
21508263	114548	Niemi K	Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.	Journal of immunology	2011	63
23633957	114548	Negash AA	IL-1Î² production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.	PLoS pathogens	2013	88
24513871	114548	Alcocer-GÃ³mez E	NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.	Brain, behavior, and immunity	2014	24
24952504	114548	Baroja-Mazo A	The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.	Nature immunology	2014	100
25744023	114548	Kaushal V	Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.	Cell death and differentiation	2015	17
11588264	116519	Pennacchio LA	An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.	Science	2001	186
19185284	116519	Ferrucci L	Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study.	American journal of human genetics	2009	59
25487149	116519	Do R	Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.	Nature	2015	85
22237023	252995	BostrÃ¶m P	A PGC1-Î±-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.	Nature	2012	570
23018146	252995	Huh JY	FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.	Metabolism	2012	127
23219488	252995	Stengel A	Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.	Peptides	2013	59
23369227	252995	Choi YK	Serum irisin levels in new-onset type 2 diabetes.	Diabetes research and clinical practice	2013	56
23619195	252995	Liu JJ	Lower circulating irisin is associated with type 2 diabetes mellitus.	Journal of diabetes and its complications	2013	59
23665283	252995	Zhang HJ	Irisin is inversely associated with intrahepatic triglyceride contents in obese adults.	Journal of hepatology	2013	29
24057291	252995	Park KH	Circulating irisin in relation to insulin resistance and the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2013	55
24140091	252995	Polyzos SA	Irisin in patients with nonalcoholic fatty liver disease.	Metabolism	2014	26
24191966	252995	Hecksteden A	Irisin and exercise training in humans - results from a randomized controlled training trial.	BMC medicine	2013	28
24297848	252995	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	40
24709991	252995	Yan B	Association of serum irisin with metabolic syndrome in obese Chinese adults.	PloS one	2014	22
25749243	252995	Albrecht E	Irisin - a myth rather than an exercise-inducible myokine.	Scientific reports	2015	40
26278051	252995	Jedrychowski MP	Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry.	Cell metabolism	2015	42
16465619	255738	Kotowski IK	A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.	American journal of human genetics	2006	137
17435765	255738	Cunningham D	Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia.	Nature structural and molecular biology	2007	91
17452316	255738	Zhang DW	Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.	The Journal of biological chemistry	2007	136
18033751	255738	Careskey HE	Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.	Journal of lipid research	2008	60
18250299	255738	Kwon HJ	Molecular basis for LDL receptor recognition by PCSK9.	Proceedings of the National Academy of Sciences of the United States of America	2008	79
19351729	255738	Lakoski SG	Genetic and metabolic determinants of plasma PCSK9 levels.	The Journal of clinical endocrinology and metabolism	2009	68
20627678	255738	Maxfield FR	Cholesterol, the central lipid of mammalian cells.	Current opinion in cell biology	2010	64
20719861	255738	Rios J	Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia.	Human molecular genetics	2010	50
22463922	255738	McKenney JM	Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy.	Journal of the American College of Cardiology	2012	82
23113833	255738	Roth EM	Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia.	The New England journal of medicine	2012	70
23128163	255738	Sullivan D	Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.	JAMA	2012	53
23400816	255738	Kosenko T	Low density lipoprotein binds to proprotein convertase subtilisin/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation.	The Journal of biological chemistry	2013	39
24094767	255738	Fitzgerald K	Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.	Lancet	2014	71
24585268	255738	Sjouke B	Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.	European heart journal	2015	30
24625727	255738	Seidah NG	PCSK9: a key modulator of cardiovascular health.	Circulation research	2014	53
24694531	255738	Stroes E	Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab.	Journal of the American College of Cardiology	2014	70
25070550	255738	Rashid S	Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.	Circulation	2014	23
25282519	255738	Raal FJ	PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.	Lancet	2015	66
25282520	255738	Raal FJ	Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial.	Lancet	2015	66
25778403	255738	Romagnuolo R	Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin/kexin type 9 through the low density lipoprotein receptor.	The Journal of biological chemistry	2015	27
25915661	255738	Navarese EP	Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.	Annals of internal medicine	2015	45
